BioMedLib Search Engine
[ goto HOMEPAGE ]
Find more relevant answers, faster!
Skip to content
Advanced Search
Search History
MeSH Query
Page Format
Query is expanded
Login
Skip to content
Export Citations
Search Results
RSS
Email
Articles' Details
Start new query
Reset All
Refine your query
(more in Advanced-Search):
Search all of MEDLINE
Focus on the recent 5 years
Focus on the current year
Focus on the last 30 days
More choices ...
Focus on articles with free fulltexts
More choices ...
Do simple 'keyword' search (no query expansion)
[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click
here to
RESET
all values
Click
here to
GO BACK
without resetting any value
Advanced Search
Submit one or more of the following items, and they will be searched along with your query in the search box above.
Any submit button will submit all of the items you have changed.
+
Publication-Date
Published in the last:
30 days
60 days
90 days
6 months
12 months
this year
2 years
3 years
5 years
10 years
Or published in the following date range: From (yyyy/mm/dd - month and day are optional)
to ('to' is optional)
+
Full Text
Retrieve articles with hyperlinks to:
full text (either free or subscription)
free full text
subscription full text
no full text link
+
Sort-Order
Sort the retrieved articles by:
relevance
publication date
+
Language
And with languages:
English
French
German
Italian
Japanese
Russian
Spanish
More languages:
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Bengali
Bosnian
Bulgarian
Catalan
Chinese
Czech
Danish
Dutch
Esperanto
Estonian
Finnish
Georgian
Scottish Gaelic
Greek, Modern
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Kinyarwanda
Korean
Latin
Latvian
Lithuanian
Macedonian
Malayalam
Maori
Malay
Multiple languages
Norwegian
Persian
Polish
Portuguese
Pushto
Romanian
Sanskrit
Serbian
Croatian
Slovak
Slovenian
Swedish
Thai
Turkish
Ukrainian
Undetermined
Urdu
Vietnamese
Welsh
+
Publication-Type
And with publication types:
Clinical Trial
Editorial
Letter
Meta-Analysis
Practice Guideline
Randomized Controlled Trial
Review
More publication types:
Addresses
Bibliography
Biography
Case Reports
Classical Article
Clinical Conference
Clinical Trial, Phase I
Clinical Trial, Phase II
Clinical Trial, Phase III
Clinical Trial, Phase IV
Comment
Comparative Study
Congresses
Consensus Development Conference
Consensus Development Conference, NIH
Controlled Clinical Trial
Corrected and Republished Article
Dictionary
Directory
Duplicate Publication
English Abstract
Evaluation Studies
Festschrift
Government Publications
Guideline
Historical Article
Interactive Tutorial
Interview
Introductory Journal Article
In Vitro
Journal Article
Lectures
Legal Cases
Legislation
Multicenter Study
News
Newspaper Article
Overall
Patient Education Handout
Periodical Index
Portraits
Published Erratum
Retracted Publication
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Retraction of Publication
Scientific Integrity Review
Technical Report
Twin Study
Validation Studies
+
Species
And for:
Humans
Animals
+
Gender
And for:
Male
Female
+
Age
And for these age groups:
Newborn: birth to 1 month
Infant: 1 to 23 months
Preschool child: 2 to 5 years
Child: 6 to 12 years
Adolescent: 13 to 18 years
Adult: 19 to 44 years
Middle aged: 45 to 64 years
Aged: 65+ years
80 and over: 80+ years
+
Title
And for this query matching the titles:
+
Transliterated-Title
And for this query matching the title in original language:
+
Abstract
And for this query matching the abstratcs:
+
Major-Mesh
And for this query matching the MeSH-Major terms:
+
Mesh
And for this query matching any MeSH terms:
+
Journal
And for one or more of these journal abbreviated names:
OR
OR
(see
title abbreviations
)
+
Volume
And with journal volume number:
+
Issue
And with journal issue number:
+
Page
And with page number:
+
ISSN
And with ISSN:
+
Publication-Place
And with journal's country of publication:
+
Author
And for...
all these author names:
AND
AND
(see
help
)
one or more of these author names:
OR
OR
but not having any of these unwanted author names:
NOT
NOT
+
Affiliation
And with affiliation to:
+
Has-Abstract
Find MEDLINE records with the abstract status:
has abstract
does not have abstract
include both record types
include both record types but rank higher the records having abstract (the default BML behavior)
+
PMID
Show me only articles for these PMIDs (PubMed IDs):
+
Semantic-Type
And with semantic types:
A. Entity
A1. Physical Object
A1.1. Organism
A1.1.1. Archaeon
A1.1.2. Bacterium
A1.1.3. Eukaryote
A1.1.3.1. Animal
A1.1.3.1.1. Vertebrate
A1.1.3.1.1.1. Amphibian
A1.1.3.1.1.2. Bird
A1.1.3.1.1.3. Fish
A1.1.3.1.1.4. Mammal
A1.1.3.1.1.4.1. Human
A1.1.3.1.1.5. Reptile
A1.1.3.2. Fungus
A1.1.3.3. Plant
A1.1.4. Virus
A1.2. Anatomical Structure
A1.2.1. Embryonic Structure
A1.2.2. Anatomical Abnormality
A1.2.2.1. Congenital Abnormality
A1.2.2.2. Acquired Abnormality
A1.2.3. Fully Formed Anatomical Structure
A1.2.3.1. Body Part, Organ, or Organ Component
A1.2.3.2. Tissue
A1.2.3.3. Cell
A1.2.3.4. Cell Component
A1.2.3.5. Gene or Genome
A1.3. Manufactured Object
A1.3.1. Medical Device
A1.3.1.1. Drug Delivery Device
A1.3.2. Research Device
A1.3.3. Clinical Drug
A1.4. Substance
A1.4.1. Chemical
A1.4.1.1. Chemical Viewed Functionally
A1.4.1.1.1. Pharmacologic Substance
A1.4.1.1.1.1. Antibiotic
A1.4.1.1.2. Biomedical or Dental Material
A1.4.1.1.3. Biologically Active Substance
A1.4.1.1.3.1. Neuroreactive Substance or Biogenic Amine
A1.4.1.1.3.2. Hormone
A1.4.1.1.3.3. Enzyme
A1.4.1.1.3.4. Vitamin
A1.4.1.1.3.5. Immunologic Factor
A1.4.1.1.3.6. Receptor
A1.4.1.1.4. Indicator, Reagent, or Diagnostic Aid
A1.4.1.1.5. Hazardous or Poisonous Substance
A1.4.1.2. Chemical Viewed Structurally
A1.4.1.2.1. Organic Chemical
A1.4.1.2.1.5. Nucleic Acid, Nucleoside, or Nucleotide
A1.4.1.2.1.6. Organophosphorus Compound
A1.4.1.2.1.7. Amino Acid, Peptide, or Protein
A1.4.1.2.1.8. Carbohydrate
A1.4.1.2.1.9. Lipid
A1.4.1.2.1.9.1. Steroid
A1.4.1.2.1.9.2. Eicosanoid
A1.4.1.2.2. Inorganic Chemical
A1.4.1.2.3. Element, Ion, or Isotope
A1.4.2. Body Substance
A1.4.3. Food
A2. Conceptual Entity
A2.1. Idea or Concept
A2.1.1. Temporal Concept
A2.1.2. Qualitative Concept
A2.1.3. Quantitative Concept
A2.1.4. Functional Concept
A2.1.4.1. Body System
A2.1.5. Spatial Concept
A2.1.5.1. Body Space or Junction
A2.1.5.2. Body Location or Region
A2.1.5.3. Molecular Sequence
A2.1.5.3.1. Nucleotide Sequence
A2.1.5.3.2. Amino Acid Sequence
A2.1.5.3.3. Carbohydrate Sequence
A2.1.5.4. Geographic Area
A2.2. Finding
A2.2.1. Laboratory or Test Result
A2.2.2. Sign or Symptom
A2.3. Organism Attribute
A2.3.1. Clinical Attribute
A2.4. Intellectual Product
A2.4.1. Classification
A2.4.2. Regulation or Law
A2.5. Language
A2.6. Occupation or Discipline
A2.6.1. Biomedical Occupation or Discipline
A2.7. Organization
A2.7.1. Health Care Related Organization
A2.7.2. Professional Society
A2.7.3. Self-help or Relief Organization
A2.8. Group Attribute
A2.9. Group
A2.9.1. Professional or Occupational Group
A2.9.2. Population Group
A2.9.3. Family Group
A2.9.4. Age Group
A2.9.5. Patient or Disabled Group
B. Event
B1. Activity
B1.1. Behavior
B1.1.1. Social Behavior
B1.1.2. Individual Behavior
B1.2. Daily or Recreational Activity
B1.3. Occupational Activity
B1.3.1. Health Care Activity
B1.3.1.1. Laboratory Procedure
B1.3.1.2. Diagnostic Procedure
B1.3.1.3. Therapeutic or Preventive Procedure
B1.3.2. Research Activity
B1.3.2.1. Molecular Biology Research Technique
B1.3.3. Governmental or Regulatory Activity
B1.3.4. Educational Activity
B1.4. Machine Activity
B2. Phenomenon or Process
B2.1. Human-caused Phenomenon or Process
B2.1.1. Environmental Effect of Humans
B2.2. Natural Phenomenon or Process
B2.2.1. Biologic Function
B2.2.1.1. Physiologic Function
B2.2.1.1.1. Organism Function
B2.2.1.1.1.1. Mental Process
B2.2.1.1.2. Organ or Tissue Function
B2.2.1.1.3. Cell Function
B2.2.1.1.4. Molecular Function
B2.2.1.1.4.1. Genetic Function
B2.2.1.2. Pathologic Function
B2.2.1.2.1. Disease or Syndrome
B2.2.1.2.1.1. Mental or Behavioral Dysfunction
B2.2.1.2.1.2. Neoplastic Process
B2.2.1.2.2. Cell or Molecular Dysfunction
B2.2.1.2.3. Experimental Model of Disease
B2.3. Injury or Poisoning
Page Format
Any submit button will submit all of the items you have changed.
[theme]
Use this page design theme:
original
twenty ten
[shown]
Results per page:
5
10
20
50
100
200
500
[expand/collapse]
show these sections expanded by default:
Advanced search
MeSH query
Search history
Page format
Query expansion
Articles details
Export citations
Email
[text size]
use this font size for text:
25%
50%
75%
100%
125%
150%
200%
or enter your choice of font size:
[page width]
use this page width (relative to the default initial value):
25%
50%
75%
100%
125%
150%
200%
or enter your choice of page width:
[highlight color]
use this color to highlight query words in the articles:
red
green
blue
black
purple
yellow
orange
navy
olive
maroon
none
[query history]
maximum number of queries shown in the history section:
[annotate]
Annotate these parts of each article:
title
abstract
both
none
Reset all values
Find best MeSH terms for
Search History
1
adenocarcinoma alveolar 2005:2010[pubdate] *count=100
4033 results
Searchbox
Export
PDF
RSS
Email
Delete
Email this search result to the following email address:
[X] Close
Expand the query
'
adenocarcinoma alveolar
' expanded to all its synonyms;
details
Email the results to the following email address:
Export the checked citations in RIS format (RIS format is used by RefWorks, Endnote, among others).
Items 1 to 100 of about 4033
1.
Yokoyama KK, Murata T, Pan J, Nakade K, Kishikawa S, Ugai H, Kimura M, Kujime Y, Hirose M, Masuzaki S, Yamasaki T, Kurihara C, Okubo M, Nakano Y, Kusa Y, Yoshikawa A, Inabe K, Ueno K, Obata Y:
Genetic materials at the gene engineering division, RIKEN BioResource Center.
Exp Anim
; 2010;59(2):115-24
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The genetic resources include cloned DNAs, gene libraries (e.g., cDNA and genomic DNA cloned into phage, cosmid,
BAC
, phosmid, and YAC), vectors, hosts, recombinant viruses, and ordered library sets derived from animal cells, including human and mouse cells, microorganisms, and viruses.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20484845.001).
[ISSN]
1881-7122
[Journal-full-title]
Experimental animals
[ISO-abbreviation]
Exp. Anim.
[Language]
ENG
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Review
[Publication-country]
Japan
[Number-of-references]
34
2.
Palti Y, Rodriguez MF, Gahr SA, Purcell MK, Rexroad CE 3rd, Wiens GD:
Identification, characterization and genetic mapping of TLR1 loci in rainbow trout (Oncorhynchus mykiss).
Fish Shellfish Immunol
; 2010 May-Jun;28(5-6):918-26
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Two TLR1 loci were identified from a rainbow trout
bacterial
artificial chromosome (
BAC
) library using DNA sequencing and genetic linkage analyses.
Full length cDNA clone and direct sequencing of four
BACs
revealed an intact omTLR1 open reading frame (ORF) located on chromosome 14 and a second locus on chromosome 25 that contains a TLR1 pseudogene.
However, due to the lack of TLR6 and 10 genes in teleost genomes and up-regulation of TLR1 mRNA in response to LPS and
bacterial
infection in other fish species we hypothesize an important role for omTLR1 in anti-microbial immunity.
Therefore, the identification
of a
TLR2 ortholog in rainbow trout and the development of assays to measure ligand binding and downstream signaling are critical for future elucidation of omTLR1 functions.
COS Scholar Universe.
author profiles
.
ZFIN.
ZFIN
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Published by Elsevier Ltd.
(PMID = 20153434.001).
[ISSN]
1095-9947
[Journal-full-title]
Fish & shellfish immunology
[ISO-abbreviation]
Fish Shellfish Immunol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
0 / RNA, Messenger; 0 / Toll-Like Receptor 1
3.
Saul SM, Brzezinski JA 4th, Altschuler RA, Shore SE, Rudolph DD, Kabara LL, Halsey KE, Hufnagel RB, Zhou J, Dolan DF, Glaser T:
Math5 expression and function in the central auditory system.
Mol Cell Neurosci
; 2008 Jan;37(1):153-69
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The basic helix-loop-helix (bHLH) transcription factor Math5 (Atoh7) is required for retinal ganglion
cell
(RGC) and optic nerve development.
Math5 expression in the CN was verified by mRNA in situ hybridization, and the identity of positive neurons was confirmed morphologically using a Math5-Cre
BAC
transgene with an alkaline phosphatase reporter.
These temporal changes are consistent with a higher-level auditory processing
disorder
involving the CN, potentially affecting the integration of binaural sensory information.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
BROMODEOXYURIDINE
.
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Evol Dev. 2003 Sep-Oct;5(5):532-41
[
12950631.001
]
[Cites]
Nat Neurosci. 2003 Oct;6(10):1091-100
[
14513037.001
]
[Cites]
J Neurosci. 2003 Oct 8;23(27):9199-207
[
14534254.001
]
[Cites]
Exp Brain Res. 1966;1(3):220-35
[
5920550.001
]
[Cites]
J Neurophysiol. 1990 May;63(5):1169-90
[
2358868.001
]
[Cites]
Hear Res. 1990 Nov;49(1-3):363-90
[
2292507.001
]
[Cites]
J Comp Neurol. 1991 Feb 15;304(3):387-407
[
2022755.001
]
[Cites]
J Comp Neurol. 1991 Dec 22;314(4):684-706
[
1816271.001
]
[Cites]
Science. 1999 Jun 11;284(5421):1837-41
[
10364557.001
]
[Cites]
Curr Opin Neurobiol. 1999 Aug;9(4):389-93
[
10448164.001
]
[Cites]
Science. 1962 Nov 23;138(3543):893-5
[
13952991.001
]
[Cites]
Hear Res. 2005 Jan;199(1-2):57-70
[
15574300.001
]
[Cites]
J Assoc Res Otolaryngol. 2004 Dec;5(4):411-26
[
15675004.001
]
[Cites]
Neurol Res. 2005 Jun;27(4):436-40
[
15949244.001
]
[Cites]
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2540-51
[
15980246.001
]
[Cites]
Nat Neurosci. 2005 Oct;8(10):1335-42
[
16136041.001
]
[Cites]
Neuron. 2005 Oct 6;48(1):17-24
[
16202705.001
]
[Cites]
Neuron. 2005 Oct 6;48(1):31-43
[
16202707.001
]
[Cites]
Am J Anat. 1982 Feb;163(2):103-30
[
7072613.001
]
[Cites]
J Neurophysiol. 1982 Jun;47(6):987-1016
[
7108581.001
]
[Cites]
J Comp Neurol. 1982 Aug 20;209(4):409-24
[
7130465.001
]
[Cites]
J Comp Neurol. 1983 Feb 1;213(4):448-63
[
6300200.001
]
[Cites]
J Mol Appl Genet. 1983;2(1):101-9
[
6302193.001
]
[Cites]
J Acoust Soc Am. 1985 Jul;78(1 Pt 2):328-33
[
2993393.001
]
[Cites]
J Comp Neurol. 1986 May 22;247(4):457-76
[
3722446.001
]
[Cites]
Brain Res. 1986 Jul 2;377(1):147-54
[
2425899.001
]
[Cites]
J Neurophysiol. 1986 Aug;56(2):261-86
[
3760921.001
]
[Cites]
Brain Res. 1988 May 16;468(2):233-42
[
3260120.001
]
[Cites]
Brain. 1988 Dec;111 ( Pt 6):1453-74
[
3208066.001
]
[Cites]
J Neurocytol. 1988 Oct;17(5):711-25
[
2463341.001
]
[Cites]
Exp Brain Res. 1988;73(2):263-84
[
3215304.001
]
[Cites]
J Comp Neurol. 1989 Apr 22;282(4):595-616
[
2723154.001
]
[Cites]
J Comp Neurol. 1989 May 22;283(4):474-80
[
2745750.001
]
[Cites]
J Comp Neurol. 1990 May 1;295(1):136-54
[
2341631.001
]
[Cites]
J Comp Neurol. 2006 Mar 1;495(1):100-12
[
16432905.001
]
[Cites]
Anat Rec A Discov Mol Cell Evol Biol. 2006 Apr;288(4):358-69
[
16550576.001
]
[Cites]
Neuron. 2006 Apr 20;50(2):205-18
[
16630833.001
]
[Cites]
J Neurosci Methods. 2006 Jun 15;153(2):214-20
[
16406043.001
]
[Cites]
J Comp Neurol. 1967 May;130(1):77-86
[
4962091.001
]
[Cites]
J Comp Neurol. 1967 Sep;131(1):27-54
[
6069501.001
]
[Cites]
J Comp Neurol. 1969 Aug;136(4):453-84
[
5801446.001
]
[Cites]
J Comp Neurol. 1974 Jun 1;155(3):251-300
[
4134212.001
]
[Cites]
J Am Aud Soc. 1979 Mar-Apr;4(5):173-8
[
511644.001
]
[Cites]
J Comp Neurol. 1980 Aug 15;192(4):687-702
[
7419749.001
]
[Cites]
J Comp Neurol. 1980 Dec 15;194(4):877-904
[
7204645.001
]
[Cites]
J Comp Neurol. 1981 Mar 20;197(1):141-52
[
6164700.001
]
[Cites]
J Comp Neurol. 1981 Mar 20;197(1):169-84
[
7229124.001
]
[Cites]
Neurosci Lett. 1981 Oct 23;26(2):143-9
[
7301202.001
]
[Cites]
J Comp Neurol. 1993 Feb 8;328(2):161-84
[
8423239.001
]
[Cites]
J Comp Neurol. 1993 May 8;331(2):245-60
[
8509501.001
]
[Cites]
J Neurosci Res. 1993 Sep 1;36(1):88-98
[
8230324.001
]
[Cites]
Cell Tissue Res. 1993 Dec;274(3):487-92
[
8293446.001
]
[Cites]
J Neurophysiol. 1994 Mar;71(3):1022-36
[
8201399.001
]
[Cites]
Hear Res. 1994 Apr;74(1-2):1-21
[
8040081.001
]
[Cites]
J Comp Neurol. 1994 Jun 1;344(1):83-100
[
7520457.001
]
[Cites]
Brain. 1994 Oct;117 ( Pt 5):1127-41
[
7953594.001
]
[Cites]
Cell. 1994 Dec 16;79(6):1025-34
[
8001130.001
]
[Cites]
Hear Res. 1995 Jan;82(1):109-24
[
7744707.001
]
[Cites]
Development. 1995 Jul;121(7):2019-30
[
7635049.001
]
[Cites]
Hear Res. 1995 Jun;86(1-2):77-81
[
8567424.001
]
[Cites]
J Neurosci. 1995 Dec;15(12):8011-22
[
8613738.001
]
[Cites]
J Neurosci. 1996 Jun 1;16(11):3775-89
[
8642420.001
]
[Cites]
Hear Res. 1996 Apr;93(1-2):28-51
[
8735067.001
]
[Cites]
Hear Res. 1996 Apr;93(1-2):52-71
[
8735068.001
]
[Cites]
Scand Audiol. 1996;25(2):133-41
[
8738639.001
]
[Cites]
Hear Res. 1996 Dec 1;102(1-2):1-14
[
8951445.001
]
[Cites]
J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):628-31
[
8971114.001
]
[Cites]
Nature. 1997 May 8;387(6629):176-8
[
9144287.001
]
[Cites]
Mech Dev. 1997 Jul;65(1-2):111-22
[
9256349.001
]
[Cites]
Curr Opin Neurobiol. 1997 Aug;7(4):487-92
[
9287194.001
]
[Cites]
J Comp Neurol. 1997 Sep 22;386(2):178-202
[
9295146.001
]
[Cites]
Nature. 1997 Nov 13;390(6656):169-72
[
9367153.001
]
[Cites]
Hear Res. 1998 Jan;115(1-2):61-81
[
9472736.001
]
[Cites]
Hear Res. 1998 Jan;115(1-2):162-74
[
9472745.001
]
[Cites]
Development. 1998 Feb;125(3):381-91
[
9425134.001
]
[Cites]
J Physiol. 1998 May 15;509 ( Pt 1):183-94
[
9547392.001
]
[Cites]
Development. 1998 Dec;125(23):4821-33
[
9806930.001
]
[Cites]
Neuroreport. 1998 Oct 26;9(15):3383-6
[
9855285.001
]
[Cites]
Annu Rev Physiol. 1999;61:477-96
[
10099698.001
]
[Cites]
Genetics. 1999 Apr;151(4):1531-45
[
10101175.001
]
[Cites]
Dev Biol. 1999 Apr 15;208(2):281-92
[
10191045.001
]
[Cites]
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5251-6
[
10220452.001
]
[Cites]
Brain Res. 2006 May 26;1091(1):217-23
[
16574081.001
]
[Cites]
J Comp Neurol. 2007 Oct 10;504(5):533-49
[
17701984.001
]
[Cites]
Mol Cell Neurosci. 2007 Dec;36(4):435-48
[
17900924.001
]
[Cites]
Annu Rev Physiol. 1999;61:497-519
[
10099699.001
]
[Cites]
Trends Neurosci. 1999 Nov;22(11):497-504
[
10529817.001
]
[Cites]
J Comp Neurol. 1999 Dec 13;415(2):160-74
[
10545157.001
]
[Cites]
J Neurocytol. 1998 Nov;27(11):841-64
[
10644202.001
]
[Cites]
Development. 2000 Mar;127(5):1039-48
[
10662643.001
]
[Cites]
Hear Res. 2000 Feb;140(1-2):77-90
[
10675636.001
]
[Cites]
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4333-8
[
10760300.001
]
[Cites]
Dev Dyn. 2000 Apr;217(4):361-7
[
10767080.001
]
[Cites]
Neuron. 2000 Mar;25(3):549-61
[
10774724.001
]
[Cites]
Genes Dev. 2000 Aug 1;14(15):1852-65
[
10921900.001
]
[Cites]
J Neurosci. 2000 Dec 15;20(24):9162-73
[
11124994.001
]
[Cites]
Genes Dev. 2001 Jan 1;15(1):24-9
[
11156601.001
]
[Cites]
Curr Opin Neurobiol. 2001 Feb;11(1):82-8
[
11179876.001
]
[Cites]
Development. 2001 Jul;128(13):2497-508
[
11493566.001
]
[Cites]
Nat Genet. 2001 Sep;29(1):61-5
[
11528393.001
]
[Cites]
Neuroscience. 2001;106(1):79-88
[
11564418.001
]
[Cites]
J Neurophysiol. 2001 Nov;86(5):2299-311
[
11698520.001
]
[Cites]
Nat Rev Neurosci. 2002 Jan;3(1):53-64
[
11823805.001
]
[Cites]
Methods. 2001 Dec;25(4):402-8
[
11846609.001
]
[Cites]
Mamm Genome. 2002 Feb;13(2):95-101
[
11889557.001
]
[Cites]
J Neurophysiol. 2002 May;87(5):2262-70
[
11976365.001
]
[Cites]
Nat Rev Neurosci. 2002 Jul;3(7):517-30
[
12094208.001
]
[Cites]
J Neurosci. 2003 Mar 15;23(6):2314-22
[
12657690.001
]
[Cites]
Neuroscientist. 2003 Apr;9(2):127-43
[
12708617.001
]
[Cites]
Brain Res Bull. 2003 Jun 15;60(5-6):457-74
[
12787867.001
]
[Cites]
Nat Rev Neurosci. 2003 Jul;4(7):540-50
[
12838329.001
]
[Cites]
Ear Hear. 2003 Aug;24(4):332-41
[
12923424.001
]
(PMID = 17977745.001).
[ISSN]
1044-7431
[Journal-full-title]
Molecular and cellular neurosciences
[ISO-abbreviation]
Mol. Cell. Neurosci.
[Language]
ENG
[Grant]
United States / NIGMS NIH HHS / GM / R01 GM067840-04; United States / NIDDK NIH HHS / DK / P60 DK20572; United States / NIDCD NIH HHS / DC / R01 DC04825; United States / NEI NIH HHS / EY / T32 EY013934; United States / NIGMS NIH HHS / GM / T32 GM07544; United States / NIDCD NIH HHS / DC / P30 DC005188; United States / NIGMS NIH HHS / GM / R01 GM067840; United States / NIDDK NIH HHS / DK / P60 DK020572; United States / NEI NIH HHS / EY / R01 EY14259; United States / NEI NIH HHS / EY / R01 EY014259-03; United States / NEI NIH HHS / EY / EY014259-03; United States / NIGMS NIH HHS / GM / GM067840-04; United States / NIDCD NIH HHS / DC / T32 DC00011; United States / NIGMS NIH HHS / GM / T32 GM007544; United States / NEI NIH HHS / EY / R01 EY014259; United States / NIDCD NIH HHS / DC / P30 DC05188; United States / NIDCD NIH HHS / DC / T32 DC000011; United States / NIDCD NIH HHS / DC / R01 DC004825
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural
[Publication-country]
United States
[Chemical-registry-number]
0 / 2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; 0 / Atoh7 protein, mouse; 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Nerve Tissue Proteins; 0 / RNA, Messenger; 0 / Stilbamidines; EC 3.2.1.23 / beta-Galactosidase; G34N38R2N1 / Bromodeoxyuridine
[Other-IDs]
NLM/ NIHMS38894; NLM/ PMC2266824
Advertisement
4.
Wester U, Bondeson ML, Edeby C, Annerén G:
Clinical and molecular characterization of individuals with 18p deletion: a genotype-phenotype correlation.
Am J Med Genet A
; 2006 Jun 1;140(11):1164-71
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The aims of present study were to clinically and molecularly characterize the syndrome further in seven subjects with
de
novo 18p deletions and to perform genotype-phenotype correlation.
All seven subjects had
terminal
deletions and no interstitial deletion was observed with subtelomeric FISH analyses.
To define the extent of the 18p deletions and the parental origin of the deletion microsatellite- and FISH analyses were performed on genomic DNA and on lymphoblastoid
cell
lines of the study participants.
Totally 19 chromosomes, 18 specific polymorphic microsatellite markers, and 5
BAC
clones were used.
Genetics Home Reference.
consumer health - chromosome 18
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2006 Wiley-Liss, Inc.
(PMID = 16691587.001).
[ISSN]
1552-4825
[Journal-full-title]
American journal of medical genetics. Part A
[ISO-abbreviation]
Am. J. Med. Genet. A
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
5.
Owonikoko TK, Ramalingam SS, Kanterewicz B, Balius TE, Belani CP, Hershberger PA:
Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.
Int J Cancer
; 2010 Feb 1;126(3):743-55
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Vorinostat increases carboplatin and paclitaxel activity in non-small-
cell lung cancer
cells.
We observed a 53% response rate in non-small
cell lung cancer
(NSCLC) patients treated with vorinostat plus paclitaxel/carboplatin in a Phase I trial.
Vorinostat addition to carboplatin or paclitaxel led to significantly greater growth inhibition than chemotherapy alone in all 4
cell
lines.
Genetic Alliance.
consumer health - Lung Cancer
.
Genetic Alliance.
consumer health - Non-small cell lung cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
Vorinostat
.
Hazardous Substances Data Bank.
TAXOL
.
Hazardous Substances Data Bank.
CARBOPLATIN
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Oncol Rep. 2006 Jan;15(1):187-91
[
16328054.001
]
[Cites]
Cancer Chemother Pharmacol. 2006 Jan;57(2):257-67
[
16028101.001
]
[Cites]
Cancer Res. 2006 May 15;66(10):5409-18
[
16707469.001
]
[Cites]
BMC Cancer. 2006;6:183
[
16834771.001
]
[Cites]
Mol Cancer Ther. 2006 Aug;5(8):1967-74
[
16928817.001
]
[Cites]
Mol Cancer Ther. 2006 Aug;5(8):2086-95
[
16928830.001
]
[Cites]
Cancer Res. 2006 Sep 1;66(17):8838-46
[
16951201.001
]
[Cites]
Nat Rev Drug Discov. 2006 Sep;5(9):769-84
[
16955068.001
]
[Cites]
J Cell Biol. 1981 Nov;91(2 Pt 1):479-87
[
6118377.001
]
[Cites]
Biochemistry. 1995 Jul 4;34(26):8474-80
[
7599137.001
]
[Cites]
Am J Physiol. 1995 Jun;268(6 Pt 1):L1012-20
[
7611423.001
]
[Cites]
Cancer Res. 1998 Aug 15;58(16):3620-6
[
9721870.001
]
[Cites]
Clin Cancer Res. 1997 Mar;3(3):449-54
[
9815704.001
]
[Cites]
Nat Rev Drug Discov. 2005 Apr;4(4):307-20
[
15789122.001
]
[Cites]
Mol Cell. 2005 Jun 10;18(6):617-22
[
15949437.001
]
[Cites]
Mol Cell Biol. 2005 Aug;25(16):7158-69
[
16055725.001
]
[Cites]
Clin Cancer Res. 2006 Sep 15;12(18):5570-7
[
17000694.001
]
[Cites]
Mol Cancer Ther. 2006 Nov;5(11):2767-76
[
17121923.001
]
[Cites]
Cancer Res. 2006 Dec 1;66(23):11298-304
[
17145876.001
]
[Cites]
N Engl J Med. 2006 Dec 14;355(24):2542-50
[
17167137.001
]
[Cites]
Scand J Gastroenterol. 2007 Jan;42(1):103-16
[
17190770.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8071-6
[
17470784.001
]
[Cites]
Clin Cancer Res. 2007 Jun 15;13(12):3605-10
[
17510206.001
]
[Cites]
Biochem Pharmacol. 2007 Sep 1;74(5):659-71
[
17498667.001
]
[Cites]
Oncologist. 2007 Oct;12(10):1247-52
[
17962618.001
]
[Cites]
Pulm Pharmacol Ther. 1999;12(5):291-302
[
10545285.001
]
[Cites]
J Natl Cancer Inst. 2000 Aug 2;92(15):1210-6
[
10922406.001
]
[Cites]
Cancer Chemother Pharmacol. 2001 May;47(5):429-36
[
11391859.001
]
[Cites]
Nature. 2002 May 23;417(6887):455-8
[
12024216.001
]
[Cites]
Anticancer Res. 2002 May-Jun;22(3):1497-504
[
12168829.001
]
[Cites]
Curr Cancer Drug Targets. 2002 Dec;2(4):337-53
[
12470210.001
]
[Cites]
EMBO J. 2003 Mar 3;22(5):1168-79
[
12606581.001
]
[Cites]
Anticancer Res. 2003 Jan-Feb;23(1A):499-503
[
12680257.001
]
[Cites]
Oncol Rep. 2003 Nov-Dec;10(6):1663-82
[
14534679.001
]
[Cites]
Cancer Res. 2003 Nov 1;63(21):7291-300
[
14612526.001
]
[Cites]
Cancer Res. 2003 Nov 15;63(22):7891-9
[
14633718.001
]
[Cites]
Cancer Res. 2004 Jan 1;64(1):316-21
[
14729640.001
]
[Cites]
Semin Oncol. 2004 Feb;31(1 Suppl 1):68-74
[
14981583.001
]
[Cites]
Cytometry A. 2004 Apr;58(2):99-110
[
15057963.001
]
(PMID = 19621389.001).
[ISSN]
1097-0215
[Journal-full-title]
International journal of cancer
[ISO-abbreviation]
Int. J. Cancer
[Language]
ENG
[Grant]
United States / NCI NIH HHS / CA / CA090440-08; United States / NCI NIH HHS / CA / P50 CA090440; United States / NCI NIH HHS / CA / R01 CA132844-01A2; United States / NCI NIH HHS / CA / P50 CA90440; United States / NCI NIH HHS / CA / CA132844-01A2; United States / NCI NIH HHS / CA / P50 CA090440-08; United States / NCI NIH HHS / CA / R01 CA132844
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / DNA, Neoplasm; 0 / Histone Deacetylase Inhibitors; 0 / Histones; 0 / Hydroxamic Acids; 0 / Neoplasm Proteins; 0 / Tubulin; 58IFB293JI / vorinostat; BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel
[Other-IDs]
NLM/ NIHMS137936; NLM/ PMC2795066
6.
Wislez M, Antoine M, Baudrin L, Poulot V, Neuville A, Pradere M, Longchampt E, Isaac-Sibille S, Lebitasy MP, Cadranel J:
Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
Lung Cancer
; 2010 May;68(2):185-91
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Non-mucinous and mucinous subtypes of
adenocarcinoma
with
bronchioloalveolar carcinoma
features differ by biomarker expression and in the response to gefitinib.
There is no optimal established therapy for treating advanced or recurrent
adenocarcinoma
with
bronchioloalveolar carcinoma
features (ADC-
BAC
), and it remains unclear whether chemotherapy achieves therapeutic results comparable to those seen in the more common non-small
lung carcinoma
subtypes.
In order to improve the decisions made during the treatment of advanced ADC-
BAC
, we attempted to better characterize the mucinous and non-mucinous ADC-
BAC
subtypes.
Fifty pathological samples were obtained from 62 patients included in a multicenter prospective phase II trial (IFCT0401) conducted to evaluate gefitinib as a first-line therapy for non-resectable ADC-
BAC
.
We demonstrated that demographic data, clinical characteristics and stage at presentation (extrathoracic versus
lung
metastasis, as well as TNM staging) did not distinguish between the two subtypes.
In contrast, three biological markers (PAS staining, TTF-1 expression and EGFR genomic gain combined with mutation analysis) enabled us to independently segregate all but 2 of the 50 patients into the mucinous and non-mucinous ADC-
BAC
subtypes.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/
diagnosis
.
Adenocarcinoma
, Mucinous /
diagnosis
. DNA-Binding Proteins / metabolism.
Lung
Neoplasms /
diagnosis
. Receptor, Epidermal Growth Factor / genetics
[MeSH-minor]
Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Biomarkers, Tumor / genetics. Biomarkers, Tumor / metabolism. DNA Mutational Analysis.
Disease
Progression. Drug Resistance, Neoplasm. Female. Humans. Male. Middle Aged. Quinazolines / therapeutic use
MedlinePlus Health Information.
consumer health - Lung Cancer
.
ClinicalTrials.gov.
clinical trials - ClinicalTrials.gov
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
(PMID = 19581016.001).
[ISSN]
1872-8332
[Journal-full-title]
Lung cancer (Amsterdam, Netherlands)
[ISO-abbreviation]
Lung Cancer
[Language]
eng
[Publication-type]
Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
[Publication-country]
Ireland
[Chemical-registry-number]
0 / Biomarkers, Tumor; 0 / DNA-Binding Proteins; 0 / Quinazolines; 0 / TTF1 protein, human; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
7.
Venkatraman L, Kalangutkar A, Russell CF:
Primary hyperparathyroidism and metastatic carcinoma within parathyroid gland.
J Clin Pathol
; 2007 Sep;60(9):1058-60
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary hyperparathyroidism and metastatic
carcinoma
within parathyroid gland.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ secondary. Hyperparathyroidism, Primary / complications.
Lung
Neoplasms. Parathyroid Neoplasms / secondary
Genetic Alliance.
consumer health - Hyperparathyroidism, primary
.
Genetic Alliance.
consumer health - Parathyroid carcinoma
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Am J Health Syst Pharm. 2001 Nov 15;58 Suppl 3:S4-7
[
11757205.001
]
[Cites]
Arch Pathol Lab Med. 2002 Dec;126(12):1511-4
[
12456213.001
]
[Cites]
World J Surg. 2003 Mar;27(3):339-42
[
12607063.001
]
[Cites]
Intern Med. 2004 Apr;43(4):310-4
[
15168774.001
]
[Cites]
Am J Med. 1972 Jun;52(6):797-808
[
4337783.001
]
[Cites]
Laryngoscope. 1981 Nov;91(11):1937-40
[
7300542.001
]
[Cites]
Am J Pathol. 1984 Jan;114(1):131-6
[
6140849.001
]
[Cites]
Recent Prog Horm Res. 1986;42:705-50
[
3016837.001
]
[Cites]
Cancer. 1987 Oct 1;60(7):1620-4
[
3621132.001
]
[Cites]
South Med J. 1988 Nov;81(11):1467
[
2847330.001
]
[Cites]
Head Neck. 1993 Jan-Feb;15(1):20-3
[
8416851.001
]
[Cites]
Acta Med Austriaca. 2004 Aug;31(3):81-4
[
15515483.001
]
[Cites]
N Engl J Med. 2005 Jan 27;352(4):373-9
[
15673803.001
]
[Cites]
Ann Thorac Cardiovasc Surg. 2002 Jun;8(3):151-3
[
12472397.001
]
(PMID = 17761743.001).
[ISSN]
0021-9746
[Journal-full-title]
Journal of clinical pathology
[ISO-abbreviation]
J. Clin. Pathol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
England
[Other-IDs]
NLM/ PMC1972420
8.
Lin W, Huang YW, Zhou XD, Ma Y:
In vitro toxicity of silica nanoparticles in human lung cancer cells.
Toxicol Appl Pharmacol
; 2006 Dec 15;217(3):252-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
In vitro toxicity of silica nanoparticles in human
lung cancer
cells.
The cytotoxicity of 15-nm and 46-nm silica nanoparticles was investigated by using crystalline silica (Min-U-Sil 5) as a positive control in cultured human
bronchoalveolar carcinoma
-derived cells.
Exposure to 15-nm or 46-nm SiO(2) nanoparticles for 48 h at dosage levels between 10 and 100 microg/ml decreased
cell
viability in a dose-dependent manner.
Cell
viability decreased significantly as a function of both nanoparticle dosage (10-100 microg/ml) and exposure time (24 h, 48 h, and 72 h).
In summary, exposure to SiO(2) nanoparticles results in a dose-dependent cytotoxicity in cultural human
bronchoalveolar carcinoma
-derived cells that is closely correlated to increased oxidative stress.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ drug therapy.
Lung
Neoplasms / drug therapy. Nanoparticles / toxicity. Silicon Dioxide / toxicity
[MeSH-minor]
Cell
Line, Tumor.
Cell
Survival / drug effects. Chromatography, High Pressure Liquid. Dose-Response Relationship, Drug. Glutathione / metabolism. Humans. L-Lactate Dehydrogenase / metabolism. Lipid Peroxidation / drug effects. Malondialdehyde / metabolism. Oxidative Stress / drug effects. Particle Size. Reactive Oxygen Species / metabolism
Genetic Alliance.
consumer health - Lung Cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
MALONALDEHYDE
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
Toxicol Appl Pharmacol. 2007 Apr 15;220(2):225; author reply 226
[
17350663.001
]
(PMID = 17112558.001).
[ISSN]
0041-008X
[Journal-full-title]
Toxicology and applied pharmacology
[ISO-abbreviation]
Toxicol. Appl. Pharmacol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Reactive Oxygen Species; 4Y8F71G49Q / Malondialdehyde; 7631-86-9 / Silicon Dioxide; EC 1.1.1.27 / L-Lactate Dehydrogenase; GAN16C9B8O / Glutathione
9.
Conner JA, Goel S, Gunawan G, Cordonnier-Pratt MM, Johnson VE, Liang C, Wang H, Pratt LH, Mullet JE, DeBarry J, Yang L, Bennetzen JL, Klein PE, Ozias-Akins P:
Sequence analysis of bacterial artificial chromosome clones from the apospory-specific genomic region of Pennisetum and Cenchrus.
Plant Physiol
; 2008 Jul;147(3):1396-411
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Sequence analysis
of bacterial
artificial chromosome clones from the apospory-specific genomic region of Pennisetum and Cenchrus.
Thirty-two ASGR
bacterial
artificial chromosomes (
BACs
) isolated from both species and one ASGR-recombining
BAC
from P. squamulatum, which together cover approximately 2.7 Mb of DNA, were used to investigate the genomic structure of this region.
Phrap assembly of 4,521 high-quality reads generated 1,341 contiguous sequences (contigs; 730 from the ASGR and 30 from the ASGR-recombining
BAC
in P. squamulatum, plus 580 from
the C
. ciliaris ASGR).
These putative coding regions were further analyzed in silico with reference to the rice (Oryza sativa) and sorghum (Sorghum bicolor) genomes using the resources at Gramene (www.gramene.org) and Phytozome (www.phytozome.net) and by hybridization against sorghum
BAC
filters.
[MeSH-minor]
Arabidopsis Proteins / genetics. Chromosomes, Artificial,
Bacterial
. Cloning, Molecular. DNA Transposable Elements. Gene Duplication. Genome, Plant. Molecular Sequence Data. Oryza / genetics. Sequence Analysis, DNA. Sorghum / genetics. Synteny. Transcription Factors / genetics
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Science. 2000 Dec 15;290(5499):2114-7
[
11118139.001
]
[Cites]
Planta. 2007 Nov;226(6):1353-62
[
17628826.001
]
[Cites]
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8714-9
[
11447285.001
]
[Cites]
Plant Mol Biol. 2002 Mar-Apr;48(5-6):821-7
[
11999852.001
]
[Cites]
Hereditas. 2001;135(1):19-25
[
12035611.001
]
[Cites]
Plant Cell. 2002 Aug;14(8):1737-49
[
12172019.001
]
[Cites]
Nature. 2003 Mar 27;422(6930):433-8
[
12660784.001
]
[Cites]
Genetics. 2003 Mar;163(3):1069-82
[
12663545.001
]
[Cites]
Curr Opin Plant Biol. 2003 Apr;6(2):128-33
[
12667868.001
]
[Cites]
Plant J. 2003 Jun;34(5):605-21
[
12787243.001
]
[Cites]
Heredity (Edinb). 1999 Dec;83 ( Pt 6):715-21
[
10651916.001
]
[Cites]
Genetics. 2000 May;155(1):379-90
[
10790411.001
]
[Cites]
Plant Cell. 2000 May;12(5):637-46
[
10810140.001
]
[Cites]
Genetics. 2003 Sep;165(1):367-86
[
14504243.001
]
[Cites]
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D360-3
[
14681434.001
]
[Cites]
Mol Genet Genomics. 2004 Jan;270(6):539-48
[
14648202.001
]
[Cites]
Plant Physiol. 2004 Apr;134(4):1733-41
[
15064383.001
]
[Cites]
Mol Genet Genomics. 2004 May;271(4):377-86
[
15014981.001
]
[Cites]
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14349-54
[
15388850.001
]
[Cites]
Biochim Biophys Acta. 1979 Apr 26;562(2):192-206
[
444525.001
]
[Cites]
Hoppe Seylers Z Physiol Chem. 1980 Aug;361(8):1223-33
[
7409756.001
]
[Cites]
Curr Biol. 1995 Jul 1;5(7):737-9
[
7583118.001
]
[Cites]
Heredity (Edinb). 1998 Jan;80 ( Pt 1):33-9
[
9474774.001
]
[Cites]
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5127-32
[
9560240.001
]
[Cites]
Genetics. 2005 Feb;169(2):1169-73
[
15489512.001
]
[Cites]
Curr Opin Plant Biol. 2005 Apr;8(2):135-41
[
15752992.001
]
[Cites]
Bioinformatics. 2005 Aug 15;21(16):3422-3
[
15976072.001
]
[Cites]
Nature. 2005 Aug 11;436(7052):793-800
[
16100779.001
]
[Cites]
Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13206-11
[
16141333.001
]
[Cites]
Plant Physiol. 2005 Aug;138(4):1898-902
[
16172096.001
]
[Cites]
Theor Appl Genet. 2005 Oct;111(6):1042-51
[
16133318.001
]
[Cites]
Plant Physiol. 2005 Oct;139(2):869-84
[
16169961.001
]
[Cites]
Curr Opin Genet Dev. 2005 Dec;15(6):621-7
[
16219458.001
]
[Cites]
Plant Physiol. 2006 Mar;140(3):963-71
[
16415213.001
]
[Cites]
Theor Appl Genet. 2006 Apr;112(6):1179-91
[
16463157.001
]
[Cites]
BMC Bioinformatics. 2006;7:115
[
16522212.001
]
[Cites]
Genetics. 2006 May;173(1):389-400
[
16547108.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17638-43
[
17101966.001
]
[Cites]
Nature. 2000 Dec 14;408(6814):796-815
[
11130711.001
]
(PMID = 18508959.001).
[ISSN]
0032-0889
[Journal-full-title]
Plant physiology
[ISO-abbreviation]
Plant Physiol.
[Language]
eng
[Databank-accession-numbers]
GENBANK/ ED544199/ ED548719/ EU559277/ EU559280
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
[Publication-country]
United States
[Chemical-registry-number]
0 / Arabidopsis Proteins; 0 / BABY BOOM protein, Arabidopsis; 0 / DNA Transposable Elements; 0 / Transcription Factors
[Other-IDs]
NLM/ PMC2442526
10.
van Duin M, van Marion R, Watson JE, Paris PL, Lapuk A, Brown N, Oseroff VV, Albertson DG, Pinkel D, de Jong P, Nacheva EP, Dinjens W, van Dekken H, Collins C:
Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization.
Cytometry A
; 2005;63(1):10-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Construction and application
of a
full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization.
METHODS: A minimal tiling path contig of 702 8q-specific
bacterial
artificial chromosome (
BAC
) clones was generated with a novel computational tool (
BAC
Contig Assembler).
BAC
clones were amplified by degenerative oligonucleotide primer (DOP) polymerase chain reaction and subsequently printed onto glass slides.
For validation of the array DNA samples of gastroesophageal and prostate
cancer cell
lines, and chronic myeloid leukemia specimens were used, which were previously characterized by multicolor fluorescence in situ hybridization and conventional CGH.
The 8q array was further tested with paraffin-embedded prostate
cancer
specimens.
In comparison with conventional CGH, the resolution of the detected changes was much improved, which was demonstrated by an amplicon of 0.7 Mb and a deletion of 0.6 Mb, both spanned by only six
BAC
clones.
[MeSH-minor]
Adenocarcinoma
/ genetics. Cardia. Chromosome Aberrations. Fixatives. Formaldehyde. Humans. In Situ Hybridization, Fluorescence. Male. Nucleic Acid Hybridization. Oligonucleotide Array Sequence Analysis. Prostatic Neoplasms / genetics. Stomach Neoplasms / genetics. Tumor Cells, Cultured
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
FORMALDEHYDE
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15619731.001).
[ISSN]
1552-4922
[Journal-full-title]
Cytometry. Part A : the journal of the International Society for Analytical Cytology
[ISO-abbreviation]
Cytometry A
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / CA89520
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
[Publication-country]
United States
[Chemical-registry-number]
0 / Fixatives; 1HG84L3525 / Formaldehyde
11.
Xie SG, Shi DW, Wen DH, Wang R, Xi DL:
Control of bromate and THM precursors using ozonation combined system.
Biomed Environ Sci
; 2007 Jun;20(3):217-25
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The biological activated carbon (
BAC
) filter could effectively reduce CHCl3FP and CHCl2BrFP, but increase CHClBr2FP.
MedlinePlus Health Information.
consumer health - Ozone
.
Hazardous Substances Data Bank.
OZONE
.
Hazardous Substances Data Bank.
CHLORINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17672213.001).
[ISSN]
0895-3988
[Journal-full-title]
Biomedical and environmental sciences : BES
[ISO-abbreviation]
Biomed. Environ. Sci.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Bromates; 0 / Trihalomethanes; 4R7X1O2820 / Chlorine; 66H7ZZK23N / Ozone
12.
Boross P, Breukel C, van Loo PF, van der Kaa J, Claassens JW, Bujard H, Schönig K, Verbeek JS:
Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Genesis
; 2009 Nov;47(11):729-35
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus
BAC
vector.
The generation
of cell
type specific inducible Cre transgenic mice is the most challenging and limiting part in the development of spatio-temporally controlled knockout mouse models.
Here we report the generation and characterization
of a
B lymphocyte-specific tamoxifen-inducible Cre transgenic mouse strain, LC-1-hCD19-CreER(T2).
[MeSH-major]
B-Lymphocytes / metabolism. Chromosomes, Artificial,
Bacterial
. Gene Expression Regulation / drug effects. Integrases / genetics. Tamoxifen / pharmacology. Transgenes
Hazardous Substances Data Bank.
TAMOXIFEN
.
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
SciCrunch.
Marmoset Gene list: Data: Gene Annotation
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
(c) 2009 Wiley-Liss, Inc.
(PMID = 19621440.001).
[ISSN]
1526-968X
[Journal-full-title]
Genesis (New York, N.Y. : 2000)
[ISO-abbreviation]
Genesis
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antigens, CD19; 0 / DNA Primers; 094ZI81Y45 / Tamoxifen; EC 2.7.7.- / Cre recombinase; EC 2.7.7.- / Integrases
13.
Shintani Y, Ohta M, Iwasaki T, Ikeda N, Tomita E, Nagano T, Kawahara K:
A case of micronodular pneumocyte hyperplasia diagnosed through surgical resection.
Ann Thorac Cardiovasc Surg
; 2010 Aug;16(1):45-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Micronodular pneumocyte hyperplasia (MNPH) is often associated with tuberous sclerosis
complex
and/or lymphangioleiomyomatosis.
We present the case
of a
45-year-old woman with MNPH without evidence of either.
A preoperative high-resolution chest computed topographic scan demonstrated a ground-glass opacity 8 mm in diameter that revealed the possibility of atypical adenomatous hyperplasia (AAH) or
bronchioloalveolar carcinoma
(
BAC
).
Therefore an S3 segmentectomy of the right
lung
was performed, and the specimens revealed the characteristic histological and immunohistological features of MNPH.
Solitary MNPH is extremely rare and requires to be distinguished from AAH or
BAC
on a computed tomographic scan; therefore surgical resection may be required to definitely rule out malignancy.
[MeSH-major]
Pneumocytes / pathology. Solitary Pulmonary Nodule /
diagnosis
[MeSH-minor]
Biopsy.
Diagnosis
, Differential. Female. Humans. Hyperplasia. Immunohistochemistry. Middle Aged. Predictive Value of Tests. Tomography, X-Ray Computed
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20190710.001).
[ISSN]
2186-1005
[Journal-full-title]
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
[ISO-abbreviation]
Ann Thorac Cardiovasc Surg
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
14.
Jain D, Joshi K, Jindal SK:
Precursor lesions of adenocarcinoma lung--two case reports.
Indian J Pathol Microbiol
; 2005 Jul;48(3):399-402
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Precursor lesions of
adenocarcinoma
lung
--two case reports.
Although precursor lesions of bronchogenic squamous
cell carcinoma
are well documented, the preinvasive lesions of pulmonary
adenocarcinoma
are seen very rarely.
It has been hypothesized that there is a stepwise progression of
alveolar
epithelial hyperplasia to atypical
alveolar
hyperplasia and subsequently to malignancy in the pathogenesis of peripheral
adenocarcinoma
of the
lung
.
In the present paper we would like to share our experience of two cases of pulmonary
adenocarcinoma
with their precursor lesions in the form of atypical
alveolar
hyperplasia.
[MeSH-major]
Adenocarcinoma
/ pathology.
Lung
Diseases, Interstitial / pathology.
Lung
Neoplasms / pathology. Precancerous Conditions / pathology. Pulmonary Alveoli / pathology
MedlinePlus Health Information.
consumer health - Interstitial Lung Diseases
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16761769.001).
[ISSN]
0377-4929
[Journal-full-title]
Indian journal of pathology & microbiology
[ISO-abbreviation]
Indian J Pathol Microbiol
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
India
15.
Findley SD, Cannon S, Varala K, Du J, Ma J, Hudson ME, Birchler JA, Stacey G:
A fluorescence in situ hybridization system for karyotyping soybean.
Genetics
; 2010 Jul;185(3):727-44
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The development
of a
universal soybean (Glycine max [L.
We used genetically anchored
BAC
clones both to identify individual chromosomes in metaphase spreads and to complete a FISH-based karyotyping cocktail that permitted simultaneous identification of all 20 chromosome pairs.
These studies led to the identification and characterization
of a
reciprocal chromosome translocation between chromosomes 11 and 13 in two accessions of wild soybean.
[MeSH-minor]
Base Sequence. Chromosomes, Artificial,
Bacterial
. DNA, Plant. Molecular Sequence Data. Nucleic Acid Hybridization
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Plant Cell. 2002 Aug;14(8):1691-704
[
12172016.001
]
[Cites]
Science. 2001 Aug 10;293(5532):1098-102
[
11498581.001
]
[Cites]
Plant Physiol. 2004 May;135(1):59-70
[
15141067.001
]
[Cites]
Theor Appl Genet. 2004 Jun;109(1):122-8
[
14991109.001
]
[Cites]
Plant Cell. 2004 Jul;16(7):1667-78
[
15208399.001
]
[Cites]
Genome. 2004 Aug;47(4):764-8
[
15284882.001
]
[Cites]
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13554-9
[
15342909.001
]
[Cites]
Biochem Genet. 1978 Feb;16(1-2):45-68
[
565635.001
]
[Cites]
Biochim Biophys Acta. 1979 Jan 26;561(1):167-83
[
570420.001
]
[Cites]
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9394-8
[
2594775.001
]
[Cites]
J Mol Biol. 1990 Oct 5;215(3):403-10
[
2231712.001
]
[Cites]
Plant Mol Biol. 1991 Jul;17(1):101-9
[
1868210.001
]
[Cites]
Plant Mol Biol. 1995 Nov;29(4):857-62
[
8541510.001
]
[Cites]
Chromosome Res. 1997 Sep;5(6):363-73
[
9364938.001
]
[Cites]
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13073-8
[
9789043.001
]
[Cites]
Biotech Histochem. 1999 May;74(3):160-6
[
10416789.001
]
[Cites]
Genetics. 2005 Feb;169(2):1169-73
[
15489512.001
]
[Cites]
Genetics. 2005 Jul;170(3):1221-30
[
15879505.001
]
[Cites]
Plant J. 2006 Mar;45(5):857-62
[
16460517.001
]
[Cites]
Curr Opin Plant Biol. 2006 Apr;9(2):104-9
[
16458041.001
]
[Cites]
Genetics. 2006 Mar;172(3):1893-900
[
16361231.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16666-71
[
17068128.001
]
[Cites]
Curr Opin Plant Biol. 2007 Apr;10(2):109-15
[
17289425.001
]
[Cites]
Genetics. 2007 May;176(1):685-96
[
17339218.001
]
[Cites]
BMC Genomics. 2007;8:132
[
17524145.001
]
[Cites]
BMC Genomics. 2007;8:330
[
17880721.001
]
[Cites]
BMC Genomics. 2007;8:427
[
18031571.001
]
[Cites]
Genome. 2008 Apr;51(4):294-302
[
18356965.001
]
[Cites]
Theor Appl Genet. 2008 Apr;116(6):745-53
[
18214422.001
]
[Cites]
Cytogenet Genome Res. 2008;120(3-4):351-7
[
18504364.001
]
[Cites]
Genetics. 1948 Jan;33(1):131
[
18933709.001
]
[Cites]
Plant Physiol. 2009 Nov;151(3):1167-74
[
19605552.001
]
[Cites]
J Hered. 2009 Nov-Dec;100(6):798-801
[
19451208.001
]
[Cites]
Nature. 2010 Jan 14;463(7278):178-83
[
20075913.001
]
[Cites]
BMC Genomics. 2010;11:38
[
20078886.001
]
[Cites]
BMC Genomics. 2010;11:113
[
20163715.001
]
[Cites]
Theor Appl Genet. 2003 Aug;107(4):745-50
[
12783169.001
]
[Cites]
Nucleic Acids Res. 2003 Jul 1;31(13):3672-8
[
12824391.001
]
(PMID = 20421607.001).
[ISSN]
1943-2631
[Journal-full-title]
Genetics
[ISO-abbreviation]
Genetics
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
[Publication-country]
United States
[Chemical-registry-number]
0 / DNA, Plant
[Other-IDs]
NLM/ PMC2907198
16.
Buchanan W, Roddick F, Porter N:
Removal of VUV pre-treated natural organic matter by biologically activated carbon columns.
Water Res
; 2008 Jul;42(13):3335-42
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The system uses sufficient VUV radiation (16J cm(-2)) to significantly enhance the production of biologically degradable moieties prior to treatment with biologically activated carbon (
BAC
).
The VUV-
BAC
process decreased the overall dissolved organic carbon (DOC) concentration
of a
natural water sample by 54% and 44% for the virgin carbon and previously used
BAC
, respectively.
Furthermore, VUV-
BAC
treatment decreased the trihalomethane (THM) formation potential (THMFP) by 60-70% and the haloacetic acid (HAA) formation potential (HAAFP) by 74%.
The BAC
systems effectively removed the hydrogen peroxide residual produced by VUV irradiation.
Although nitrite formation can result from VUV treatment of natural organic matter (NOM), none was detected before or after
BAC
treatment.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
CARBON
.
Hazardous Substances Data Bank.
HYDROGEN PEROXIDE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18502470.001).
[ISSN]
0043-1354
[Journal-full-title]
Water research
[ISO-abbreviation]
Water Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Biological Products; 0 / Nitrates; 0 / Organic Chemicals; 7440-44-0 / Carbon; BBX060AN9V / Hydrogen Peroxide
17.
Ou SH, Zell JA:
Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
J Thorac Oncol
; 2008 Mar;3(3):216-27
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Validation study of the proposed IASLC staging revisions of the T4 and M non-small
cell lung cancer
descriptors using data from 23,583 patients in the California
Cancer
Registry.
BACKGROUND: We performed a validation study of the proposed International Association for the Study
of Lung Cancer
(IASLC) tumor, node, metastasis (TNM) and stage grouping revisions on advanced nonbronchioloalveolar
carcinoma
(non-
BAC
) non-small
cell lung cancer
(NSCLC).
METHODS: Twenty-three thousand five hundred eighty-three patients from the California
Cancer
Registry between 1999 and 2003 with histologically confirmed non-
BAC
NSCLC and complete TNM staging were identified and reclassified according to the IASLC proposed TNM revisions and new stage groupings.
Surveillance, Epidemiology, and End Results extent
of disease
codes were used to identify various T4 and M descriptors.
T4 due to additional nodules had significant survival advantage over other T4 and M descriptors among non-
BAC
NSCLC and individual histology and warrants down-staging to T3.
CONCLUSIONS: IASLC has greatly improved the T4 and M descriptors allowing better prognostication of advanced non-
BAC
NSCLC.
[MeSH-major]
Carcinoma
, Non-Small-
Cell Lung
/ secondary. Heart Neoplasms / secondary.
Lung
Neoplasms / pathology. Neoplasm Staging / methods. Pleural Neoplasms / secondary. Registries / statistics & numerical data
Genetic Alliance.
consumer health - Lung Cancer
.
Genetic Alliance.
consumer health - Non-small cell lung cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18317063.001).
[ISSN]
1556-1380
[Journal-full-title]
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
[ISO-abbreviation]
J Thorac Oncol
[Language]
eng
[Grant]
United States / NCCDPHP CDC HHS / DP / 1U58DP00807-01; United States / NCI NIH HHS / PC / N01-PC-35136; United States / NCI NIH HHS / PC / N01-PC-35139; United States / NCI NIH HHS / PC / N01-PC-54404
[Publication-type]
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Validation Studies
[Publication-country]
United States
18.
Devillard E, McIntosh FM, Newbold CJ, Wallace RJ:
Rumen ciliate protozoa contain high concentrations of conjugated linoleic acids and vaccenic acid, yet do not hydrogenate linoleic acid or desaturate stearic acid.
Br J Nutr
; 2006 Oct;96(4):697-704
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
In incubations with ruminal microbial fractions (
bacterial
fraction (
BAC
), protozoal fraction (PRO)), LA metabolism was very similar in strained ruminal fluid (SRF) and in
the BAC
, while the PRO had LA-metabolising activity an order of magnitude lower.
The absence of an alternative route of VA/CLA formation via desaturation of stearate was confirmed by incubations of SRF,
BAC
or PRO with [14C]stearate.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
STEARIC ACID
.
Hazardous Substances Data Bank.
LINOLEIC ACID
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17010229.001).
[ISSN]
0007-1145
[Journal-full-title]
The British journal of nutrition
[ISO-abbreviation]
Br. J. Nutr.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Linoleic Acids, Conjugated; 0 / Oleic Acids; 0 / Stearic Acids; 143-25-9 / 11-octadecenoic acid; 4ELV7Z65AP / stearic acid; 9KJL21T0QJ / Linoleic Acid
19.
Toonkel RL, Borczuk AC, Powell CA:
Tgf-beta signaling pathway in lung adenocarcinoma invasion.
J Thorac Oncol
; 2010 Feb;5(2):153-7
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Tgf-beta signaling pathway in
lung
adenocarcinoma
invasion.
The histologic distinction between
bronchioloalveolar carcinoma
and other
adenocarcinomas
is tissue invasion.
The clinical importance
of lung
adenocarcinoma
invasion is supported by several recent studies indicating that the risk of death in nonmucinous
bronchioloalveolar carcinoma
is significantly lower than that of pure invasive tumors and in tumors with greater than 0.5 cm of fibrosis or linear invasion.
Subsequent studies showed that the CC chemokine regulated on activation, normal T
cell
expressed, and presumably secreted was up-regulated in invasive tumors and was required for invasion in cells with repressed levels of the transforming growth factor-beta type II receptor.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Clin Invest. 2002 Jun;109(12):1607-15
[
12070308.001
]
[Cites]
Nat Med. 2002 Aug;8(8):816-24
[
12118244.001
]
[Cites]
Lung Cancer. 2002 Nov;38(2):143-7
[
12399125.001
]
[Cites]
Cancer. 2002 Dec 15;95(12):2546-54
[
12467069.001
]
[Cites]
Eur J Cardiothorac Surg. 2003 Mar;23(3):409-14
[
12614815.001
]
[Cites]
Nat Rev Cancer. 2003 Jun;3(6):453-8
[
12778135.001
]
[Cites]
Lung Cancer. 2003 Jun;40(3):281-7
[
12781426.001
]
[Cites]
Am J Surg Pathol. 2003 Jul;27(7):937-51
[
12826886.001
]
[Cites]
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8430-5
[
12808151.001
]
[Cites]
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8621-3
[
12861075.001
]
[Cites]
J Clin Invest. 2003 Oct;112(7):1116-24
[
14523048.001
]
[Cites]
Ann Thorac Cardiovasc Surg. 2003 Oct;9(5):295-300
[
14672525.001
]
[Cites]
Cancer Res. 2003 Dec 1;63(23):8284-92
[
14678987.001
]
[Cites]
Nat Rev Cancer. 2003 Nov;3(11):807-21
[
14557817.001
]
[Cites]
Am J Surg Pathol. 2004 Feb;28(2):198-206
[
15043309.001
]
[Cites]
Clin Cancer Res. 2004 Apr 1;10(7):2359-67
[
15073112.001
]
[Cites]
J Immunol. 2004 Jun 15;172(12):7335-40
[
15187109.001
]
[Cites]
Cancer Res. 2004 Jul 1;64(13):4523-30
[
15231662.001
]
[Cites]
Cancer Res. 2004 Jul 15;64(14):4687-92
[
15256431.001
]
[Cites]
Br J Cancer. 1993 May;67(5):1015-21
[
8388229.001
]
[Cites]
Cancer Genet Cytogenet. 2006 Aug;169(1):39-44
[
16875935.001
]
[Cites]
Cancer Res. 2006 Oct 15;66(20):9837-44
[
17047044.001
]
[Cites]
Genes Dev. 2006 Nov 15;20(22):3147-60
[
17114585.001
]
[Cites]
Cancer Cell. 2007 Feb;11(2):147-60
[
17292826.001
]
[Cites]
Mod Pathol. 2007 Feb;20(2):233-41
[
17192789.001
]
[Cites]
J Clin Invest. 2007 May;117(5):1305-13
[
17415413.001
]
[Cites]
Ann Thorac Surg. 2007 Nov;84(5):1675-9
[
17954084.001
]
[Cites]
Cancer Cell. 2008 Jan;13(1):23-35
[
18167337.001
]
[Cites]
Oncogene. 2008 Jan 17;27(4):557-64
[
17653092.001
]
[Cites]
Cancer Res. 2008 May 15;68(10):3835-43
[
18483268.001
]
[Cites]
Am J Surg Pathol. 2008 Jun;32(6):810-27
[
18391747.001
]
[Cites]
J Cancer Res Clin Oncol. 2008 Aug;134(8):919-25
[
18421475.001
]
[Cites]
Nat Med. 2008 Aug;14(8):822-7
[
18641660.001
]
[Cites]
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18758-63
[
19022904.001
]
[Cites]
Am J Surg Pathol. 2009 Mar;33(3):462-9
[
19092635.001
]
[Cites]
Proc Am Thorac Soc. 2009 Apr 15;6(2):152-8
[
19349483.001
]
[Cites]
Biochim Biophys Acta. 2009 Jul;1793(7):1165-73
[
19339207.001
]
[Cites]
Cancer. 1999 Oct 15;86(8):1455-62
[
10526273.001
]
[Cites]
J Natl Cancer Inst. 1999 Dec 15;91(24):2096-101
[
10601380.001
]
[Cites]
Oncogene. 1999 Dec 2;18(51):7280-6
[
10602482.001
]
[Cites]
Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):159-68
[
10708963.001
]
[Cites]
Ann Thorac Surg. 2000 Mar;69(3):893-7
[
10750779.001
]
[Cites]
Anticancer Res. 2000 May-Jun;20(3A):1499-502
[
10928062.001
]
[Cites]
Lung Cancer. 2000 Sep;29(3):179-88
[
10996420.001
]
[Cites]
Exp Lung Res. 2000 Dec;26(8):685-707
[
11195465.001
]
[Cites]
Lung Cancer. 2001 Feb-Mar;31(2-3):181-91
[
11165397.001
]
[Cites]
Exp Cell Res. 2001 Mar 10;264(1):169-84
[
11237532.001
]
[Cites]
Nat Rev Mol Cell Biol. 2000 Dec;1(3):169-78
[
11252892.001
]
[Cites]
Cancer. 2001 Mar 1;91(5):964-71
[
11251948.001
]
[Cites]
Nat Genet. 2001 Oct;29(2):117-29
[
11586292.001
]
[Cites]
J Biol Chem. 2001 Dec 14;276(50):46707-13
[
11590169.001
]
[Cites]
Am J Pathol. 2002 Jan;160(1):347-55
[
11786428.001
]
[Cites]
Eur Respir J. 2001 Dec;18(6):1059-68
[
11829087.001
]
[Cites]
Am J Respir Crit Care Med. 2002 Feb 15;165(4):508-13
[
11850344.001
]
[Cites]
Eur J Clin Invest. 2002 Mar;32(3):193-8
[
11895471.001
]
[Cites]
Nat Rev Cancer. 2001 Oct;1(1):46-54
[
11900251.001
]
[Cites]
Science. 1995 Jun 2;268(5215):1336-8
[
7761852.001
]
[Cites]
Gastroenterology. 1996 Feb;110(2):375-82
[
8566583.001
]
[Cites]
Oncol Res. 1997;9(2):89-98
[
9167190.001
]
[Cites]
Cancer Res. 1998 Jul 15;58(14):3101-4
[
9679977.001
]
[Cites]
Prostate. 1998 Sep 15;37(1):19-29
[
9721065.001
]
[Cites]
Curr Biol. 1998 Nov 19;8(23):1243-52
[
9822576.001
]
[Cites]
Br J Cancer. 1999 Mar;79(7-8):1005-11
[
10098728.001
]
[Cites]
Lancet. 1999 Jul 10;354(9173):99-105
[
10408484.001
]
[Cites]
AIDS Res Hum Retroviruses. 1999 Jul 1;15(10):869-74
[
10408723.001
]
[Cites]
Cancer Res. 2004 Dec 15;64(24):9002-11
[
15604265.001
]
[Cites]
J Clin Oncol. 2005 Mar 20;23(9):2078-93
[
15774796.001
]
[Cites]
Cancer Res. 2005 Mar 15;65(6):2296-302
[
15781643.001
]
[Cites]
Cancer Res. 2005 Apr 15;65(8):3374-9
[
15833871.001
]
[Cites]
Am J Respir Crit Care Med. 2005 Sep 15;172(6):729-37
[
15976377.001
]
[Cites]
Br J Cancer. 2005 Nov 14;93(10):1157-67
[
16251876.001
]
[Cites]
Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):29-40
[
16289860.001
]
[Cites]
Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):41-58
[
16310402.001
]
[Cites]
Cancer Res. 2006 Feb 15;66(4):2202-9
[
16489022.001
]
[Cites]
Lung Cancer. 2006 Apr;52(1):1-7
[
16499994.001
]
[Cites]
J Immunol. 2006 Apr 15;176(8):4968-78
[
16585593.001
]
[Cites]
J Clin Oncol. 2006 Apr 10;24(11):1679-88
[
16549822.001
]
[Cites]
Arch Immunol Ther Exp (Warsz). 2006 Mar-Apr;54(2):143-7
[
16648974.001
]
[Cites]
Genes Dev. 2006 May 15;20(10):1331-42
[
16702406.001
]
[Cites]
Oncogene. 2006 Jun 8;25(24):3408-23
[
16186809.001
]
[Cites]
Cancer Res. 2006 Jul 1;66(13):6714-21
[
16818646.001
]
(PMID = 20101143.001).
[ISSN]
1556-1380
[Journal-full-title]
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
[ISO-abbreviation]
J Thorac Oncol
[Language]
ENG
[Grant]
United States / NCI NIH HHS / CA / CA120174-04; United States / NCI NIH HHS / CA / R01 CA120174; United States / NCI NIH HHS / CA / R01 CA120174-04
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Chemokine CCL5; 0 / Transforming Growth Factor beta
[Number-of-references]
81
[Other-IDs]
NLM/ NIHMS251531; NLM/ PMC2992959
20.
Yue W, Miao Y, Li X, Wu X, Zhao A, Nakagaki M:
Cloning and expression of manganese superoxide dismutase of the silkworm, Bombyx mori by Bac-to-Bac/BmNPV Baculovirus expression system.
Appl Microbiol Biotechnol
; 2006 Nov;73(1):181-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Cloning and expression of manganese superoxide dismutase of the silkworm, Bombyx mori by
Bac
-to-
Bac
/BmNPV Baculovirus expression system.
In this paper, we used the total fat body RNA of silkworm, Bombyx mori L. to clone and sequence a 648-bp Mn-SOD cDNA fragment through
RT
-PCR.
Furthermore, a newly established
Bac
-to-
Bac
/BmNPV Baculovirus expression system was used to overexpress the recombinant Mn-SOD enzyme in silkworm larvae.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16804693.001).
[ISSN]
0175-7598
[Journal-full-title]
Applied microbiology and biotechnology
[ISO-abbreviation]
Appl. Microbiol. Biotechnol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Germany
[Chemical-registry-number]
0 / DNA, Complementary; 63231-63-0 / RNA; EC 1.15.1.1 / Superoxide Dismutase
21.
Výborný P, Sejcková L:
[Antiglaucoma drugs--content of preservatives and the patient's compliance].
Cesk Slov Oftalmol
; 2006 Jul;62(4):270-2, 274
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The authors compare the benzalconium chloride (
BAC
) concentrations in individual drug used for glaucoma treating.
The daily dose
of BAC
was calculated according to the drop's size and
BAC
concentration.
The daily dose
of BAC
differs depending on the selected therapy markedly--doses in the range from 0 to 10 micrograms were found.
The BAC
concentration is one of important factors affecting the patient's compliance in the treatment of the primary open angle glaucoma.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16895060.001).
[ISSN]
1211-9059
[Journal-full-title]
Ceská a slovenská oftalmologie : casopis Ceské oftalmologické spolecnosti a Slovenské oftalmologické spolecnosti
[ISO-abbreviation]
Cesk Slov Oftalmol
[Language]
cze
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Czech Republic
[Chemical-registry-number]
0 / Benzalkonium Compounds; 0 / Ophthalmic Solutions; 0 / Preservatives, Pharmaceutical
22.
Dar M, Giesler T, Richardson R, Cai C, Cooper M, Lavasani S, Kille P, Voet T, Vermeesch J:
Development of a novel ozone- and photo-stable HyPer5 red fluorescent dye for array CGH and microarray gene expression analysis with consistent performance irrespective of environmental conditions.
BMC Biotechnol
; 2008;8:86
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Development
of a
novel ozone- and photo-stable HyPer5 red fluorescent dye for array CGH and microarray gene expression analysis with consistent performance irrespective of environmental conditions.
In high resolution array CGH experiments, HyPer5 is demonstrated to detect chromosomal aberrations at loci 2p21-16.3 and 15q26.3-26.2 from three patient sample using
bacterial
artificial chromosome (
BAC
) arrays.
MedlinePlus Health Information.
consumer health - Ozone
.
Hazardous Substances Data Bank.
OZONE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Biotechniques. 2002 Sep;33(3):620-8, 630
[
12238772.001
]
[Cites]
Nucleic Acids Res. 2003 Oct 1;31(19):5676-84
[
14500831.001
]
[Cites]
Anal Chem. 2003 Sep 1;75(17):4672-5
[
14632079.001
]
[Cites]
Bioconjug Chem. 1993 Mar-Apr;4(2):105-11
[
7873641.001
]
[Cites]
Mol Biotechnol. 2007 Jul;36(3):175-83
[
17873405.001
]
[Cites]
Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5814-9
[
15827123.001
]
[Cites]
BMC Genomics. 2006;7:260
[
17042939.001
]
[Cites]
BMC Biotechnol. 2007;7:8
[
17295919.001
]
[Cites]
Nat Genet. 2007 Jul;39(7 Suppl):S16-21
[
17597776.001
]
[Cites]
Science. 1997 Oct 24;278(5338):680-6
[
9381177.001
]
(PMID = 19014508.001).
[ISSN]
1472-6750
[Journal-full-title]
BMC biotechnology
[ISO-abbreviation]
BMC Biotechnol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
0 / Carbocyanines; 0 / DNA, Complementary; 0 / Fluorescent Dyes; 66H7ZZK23N / Ozone
[Other-IDs]
NLM/ PMC2613886
23.
Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, Steffan JS, Thompson LM, Wetzel R, Yang XW:
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.
Neuron
; 2009 Dec 24;64(6):828-40
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced
disease
pathogenesis in HD mice.
The N-
terminal
17 amino acids of huntingtin (NT17) can be phosphorylated on serines 13 and 16; however, the significance of these modifications in Huntington's
disease
pathogenesis remains unknown.
In this study, we developed
BAC
transgenic mice expressing full-length mutant huntingtin (fl-mhtt) with serines 13 and 16 mutated to either aspartate (phosphomimetic or SD) or alanine (phosphoresistant or SA).
However, fl-mhtt-induced
disease
pathogenesis, including motor and psychiatric-like behavioral deficits, mhtt aggregation, and selective neurodegeneration are abolished in SD but preserved in SA mice.
Together, our findings demonstrate that serines 13 and 16 are critical determinants of fl-mhtt-induced
disease
pathogenesis in vivo, supporting the targeting of huntingtin NT17 domain and its modifications in HD therapy.
MedlinePlus Health Information.
consumer health - Huntington's Disease
.
COS Scholar Universe.
author profiles
.
PhosphoSitePlus.
gene/protein/disease-specific - PhosphoSitePlus® - comprehensive post-translational modification resource
.
Faculty of 1000.
commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine.
(subscription/membership/fee required).
Hazardous Substances Data Bank.
(L)-ALANINE
.
Hazardous Substances Data Bank.
L-SERINE
.
Hazardous Substances Data Bank.
(L)-ASPARTIC ACID
.
Jackson Laboratory JAX®Mice Database.
culture/stock collections - FVB/N-Tg(HTT*97Q)IXwy/J
(subscription/membership/fee required).
Jackson Laboratory JAX®Mice Database.
culture/stock collections - FVB-Tg(HTT*)1Xwy/J
(subscription/membership/fee required).
Jackson Laboratory JAX®Mice Database.
culture/stock collections - FVB-Tg(HTT*97Q)LXwy/J
(subscription/membership/fee required).
Jackson Laboratory JAX®Mice Database.
culture/stock collections - FVB/N-Tg(HTT*97Q)LXwy/ChdiJ
(subscription/membership/fee required).
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
SciCrunch.
Marmoset Gene list: Data: Gene Annotation
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
2009 Elsevier Inc. All rights reserved.
[Cites]
Cell. 2003 May 16;113(4):457-68
[
12757707.001
]
[Cites]
J Cell Biol. 2009 Dec 28;187(7):1083-99
[
20026656.001
]
[Cites]
J Comp Neurol. 2003 Oct 6;465(1):11-26
[
12926013.001
]
[Cites]
Sci STKE. 2003 Nov 4;2003(207):pe48
[
14600292.001
]
[Cites]
Science. 2004 Apr 2;304(5667):100-4
[
15064418.001
]
[Cites]
Nat Rev Neurosci. 2004 May;5(5):373-84
[
15100720.001
]
[Cites]
Methods Mol Biol. 2004;277:103-28
[
15201452.001
]
[Cites]
Nat Med. 2004 Jul;10 Suppl:S2-9
[
15272266.001
]
[Cites]
Nat Med. 2004 Jul;10 Suppl:S10-7
[
15272267.001
]
[Cites]
Cell. 1993 Mar 26;72(6):971-83
[
8458085.001
]
[Cites]
Nat Genet. 1995 Oct;11(2):155-63
[
7550343.001
]
[Cites]
J R Coll Physicians Lond. 1996 May-Jun;30(3):221-31
[
8811597.001
]
[Cites]
Cell. 1997 Aug 8;90(3):537-48
[
9267033.001
]
[Cites]
Science. 1997 Sep 26;277(5334):1990-3
[
9302293.001
]
[Cites]
Nat Biotechnol. 1997 Sep;15(9):859-65
[
9306400.001
]
[Cites]
Nat Genet. 1997 Dec;17(4):404-10
[
9398841.001
]
[Cites]
J Neuropathol Exp Neurol. 1998 May;57(5):369-84
[
9596408.001
]
[Cites]
J Neurosci. 1999 Apr 1;19(7):2522-34
[
10087066.001
]
[Cites]
Nat Genet. 2005 Feb;37(2):198-204
[
15654337.001
]
[Cites]
Neuron. 2005 May 5;46(3):433-44
[
15882643.001
]
[Cites]
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11563-8
[
16061794.001
]
[Cites]
Nat Rev Genet. 2005 Oct;6(10):743-55
[
16205714.001
]
[Cites]
Nat Neurosci. 2006 Jun;9(6):824-31
[
16699508.001
]
[Cites]
Cell. 2006 Jun 16;125(6):1179-91
[
16777606.001
]
[Cites]
Nat Genet. 2000 Nov;26(3):300-6
[
11062468.001
]
[Cites]
Nat Cell Biol. 2002 Feb;4(2):160-4
[
11813001.001
]
[Cites]
Dev Cell. 2002 Jun;2(6):831-7
[
12062094.001
]
[Cites]
Neuron. 2002 Aug 29;35(5):843-54
[
12372280.001
]
[Cites]
Genome Res. 2002 Dec;12(12):1992-8
[
12466304.001
]
[Cites]
Neuron. 2003 May 8;38(3):375-87
[
12741986.001
]
[Cites]
Lancet. 2003 May 10;361(9369):1642-4
[
12747895.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11045-50
[
16832050.001
]
[Cites]
J Biol Chem. 2006 Aug 18;281(33):23686-97
[
16782707.001
]
[Cites]
Methods Enzymol. 2006;412:106-22
[
17046655.001
]
[Cites]
Methods Enzymol. 2006;413:34-74
[
17046390.001
]
[Cites]
Hum Mol Genet. 2007 Jan 1;16(1):61-77
[
17135277.001
]
[Cites]
Annu Rev Neurosci. 2007;30:575-621
[
17417937.001
]
[Cites]
J Neurosci. 2007 Jul 4;27(27):7318-28
[
17611284.001
]
[Cites]
Nat Rev Neurosci. 2007 Sep;8(9):663-72
[
17684513.001
]
[Cites]
Hum Mol Genet. 2007 Nov 1;16(21):2600-15
[
17704510.001
]
[Cites]
Neurosci Lett. 2008 Jan 24;431(1):45-50
[
18078716.001
]
[Cites]
Neuron. 2008 Mar 27;57(6):809-18
[
18367082.001
]
[Cites]
Curr Protoc Neurosci. 2005 May;Chapter 5:Unit 5.20
[
18428622.001
]
[Cites]
J Neurosci. 2008 Jun 11;28(24):6182-95
[
18550760.001
]
[Cites]
J Neurosci. 2008 Sep 3;28(36):9013-20
[
18768695.001
]
[Cites]
Trends Neurosci. 2008 Oct;31(10):521-8
[
18778858.001
]
[Cites]
Neuroscience. 2008 Dec 2;157(3):606-20
[
18854207.001
]
[Cites]
FASEB J. 2009 Feb;23(2):451-63
[
18854435.001
]
[Cites]
Nat Struct Mol Biol. 2009 Apr;16(4):380-9
[
19270701.001
]
[Cites]
Cell. 2009 Apr 3;137(1):60-72
[
19345187.001
]
[Cites]
Science. 2009 Jun 5;324(5932):1327-30
[
19498170.001
]
[Cites]
Neurobiol Dis. 2009 Sep;35(3):319-36
[
19464370.001
]
[Cites]
J Biol Chem. 2009 Oct 23;284(43):29427-36
[
19710014.001
]
[Cites]
Hum Mol Genet. 2003 Jul 1;12(13):1555-67
[
12812983.001
]
(PMID = 20064390.001).
[ISSN]
1097-4199
[Journal-full-title]
Neuron
[ISO-abbreviation]
Neuron
[Language]
ENG
[Grant]
United States / NINDS NIH HHS / NS / NS049501-04; United States / NINDS NIH HHS / NS / R01 NS049501; United States / NINDS NIH HHS / NS / NS049501-05; United States / NINDS NIH HHS / NS / 2R01NS45491; United States / NINDS NIH HHS / NS / R24 NS045491; United States / NINDS NIH HHS / NS / R01 NS049501-04; United States / NINDS NIH HHS / NS / R01 NS039074; United States / NIA NIH HHS / AG / R01AG019322; United States / NINDS NIH HHS / NS / R01NS049501; United States / NINDS NIH HHS / NS / NS049501-03; United States / NINDS NIH HHS / NS / R01 NS049501-01; United States / NINDS NIH HHS / NS / NS045283; United States / NINDS NIH HHS / NS / R01 NS049501-05; United States / NINDS NIH HHS / NS / 3R01NS049501-05S1; United States / NINDS NIH HHS / NS / 2R01NS39074; United States / NINDS NIH HHS / NS / NS049501-02; United States / NINDS NIH HHS / NS / R01 NS049501-03; United States / NINDS NIH HHS / NS / R01 NS045283; United States / NINDS NIH HHS / NS / R01 NS052789; United States / NIA NIH HHS / AG / R01 AG019322; United States / NIA NIH HHS / AG / P01 AG022074; United States / NINDS NIH HHS / NS / R01 NS049501-02; United States / NINDS NIH HHS / NS / NS049501-05S1; United States / NINDS NIH HHS / NS / NS049501-01; United States / NINDS NIH HHS / NS / NS52789; United States / NINDS NIH HHS / NS / R01 NS049501-05S1; United States / NIA NIH HHS / AG / 2P01AG022074
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Amyloid; 0 / HTT protein, human; 0 / Nerve Tissue Proteins; 0 / Nuclear Proteins; 30KYC7MIAI / Aspartic Acid; 452VLY9402 / Serine; OF5P57N2ZX / Alanine
[Other-IDs]
NLM/ NIHMS161315; NLM/ PMC2807408
24.
Yamamoto R, Uenishi H, Yasue H, Takagaki Y, Sato E:
The genomic structure and a novel alternatively spliced form of porcine pTalpha chain.
Mol Immunol
; 2007 Jan;44(4):591-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
A complete genomic nucleotide sequence for porcine pTalpha gene was obtained from
a BAC
clone, which revealed a novel exon 2 missing in human and murine counterparts.
Using thymocyte RNA and
RT
-PCR, three types of porcine pTalpha-chain cDNA sequences, pTalpha1, pTalpha2 and pTalpha3, were obtained.
Using
RT
-PCR, pTalpha3 appeared expressed predominantly in the thymocyte RNA.
[MeSH-major]
Alternative Splicing. Genome. Membrane Glycoproteins / genetics. Receptors,
Antigen
, T-
Cell
, alpha-beta / genetics. Swine / genetics
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16712934.001).
[ISSN]
0161-5890
[Journal-full-title]
Molecular immunology
[ISO-abbreviation]
Mol. Immunol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
0 / Membrane Glycoproteins; 0 / Receptors, Antigen, T-Cell, alpha-beta; 0 / pre-T cell receptor alpha
25.
Qiao Y, Liu X, Harvard C, Nolin SL, Brown WT, Koochek M, Holden JJ, Lewis ME, Rajcan-Separovic E:
Large-scale copy number variants (CNVs): distribution in normal subjects and FISH/real-time qPCR analysis.
BMC Genomics
; 2007;8:167
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
In order to understand their potential significance and to facilitate interpretation of array-CGH findings in constitutional disorders and cancers, we studied 27 normal individuals (9 Caucasian; 9 African American; 9 Hispanic) using commercially available 1 Mb resolution
BAC
array (Spectral Genomics).
A selection of CNVs was further analyzed by FISH and real-time quantitative PCR (
RT
-qPCR).
FISH analysis of 6 CNVs (4 previously reported and 2 novel CNVs) in normal subjects resulted in the confirmation of copy number changes for 1 of 2 novel CNVs and 2 of 4 known CNvs. Three CNVs tested by FISH were further validated by
RT
-qPCR and comparable data were obtained.
This included the lack of copy number change by both
RT
-qPCR and FISH for clone RP11-100C24, one of the most common known copy number variants, as well as confirmation of deletions for clones RP11-89M16 and RP5-1011O17.
Further study
of a
small selection of CNVs indicated concordant and discordant array vs. FISH/
RT
-qPCR results.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Ann Biol Clin (Paris). 2004 Mar-Apr;62(2):203-12
[
15047473.001
]
[Cites]
Am J Hum Genet. 2007 Jan;80(1):91-104
[
17160897.001
]
[Cites]
Nat Genet. 2004 Sep;36(9):949-51
[
15286789.001
]
[Cites]
Nat Genet. 2004 Sep;36(9):931-2
[
15340426.001
]
[Cites]
Cytogenet Cell Genet. 1996;75(4):243-7
[
9067434.001
]
[Cites]
Science. 1998 May 15;280(5366):1077-82
[
9582121.001
]
[Cites]
Eur J Hum Genet. 2005 Feb;13(2):260-3
[
15494738.001
]
[Cites]
Science. 2005 Mar 4;307(5714):1434-40
[
15637236.001
]
[Cites]
Am J Hum Genet. 2005 Jul;77(1):78-88
[
15918152.001
]
[Cites]
Nat Genet. 2005 Jul;37(7):727-32
[
15895083.001
]
[Cites]
J Med Genet. 2005 Sep;42(9):699-705
[
16141005.001
]
[Cites]
Am J Hum Genet. 2005 Oct;77(4):606-16
[
16175506.001
]
[Cites]
Am J Med Genet A. 2005 Dec 15;139(3):173-85
[
16283669.001
]
[Cites]
Nat Genet. 2006 Jan;38(1):75-81
[
16327808.001
]
[Cites]
Nat Genet. 2006 Jan;38(1):82-5
[
16327809.001
]
[Cites]
Nat Genet. 2006 Jan;38(1):9-11
[
16380720.001
]
[Cites]
BMC Genomics. 2005;6:180
[
16351727.001
]
[Cites]
Nat Rev Genet. 2006 Feb;7(2):85-97
[
16418744.001
]
[Cites]
Nat Genet. 2006 Jan;38(1):86-92
[
16468122.001
]
[Cites]
Nature. 2006 Feb 16;439(7078):851-5
[
16482158.001
]
[Cites]
Genome Res. 2006 Aug;16(8):949-61
[
16809666.001
]
[Cites]
Nature. 2006 Nov 23;444(7118):444-54
[
17122850.001
]
[Cites]
Science. 2004 Jul 23;305(5683):525-8
[
15273396.001
]
(PMID = 17565693.001).
[ISSN]
1471-2164
[Journal-full-title]
BMC genomics
[ISO-abbreviation]
BMC Genomics
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Other-IDs]
NLM/ PMC1920519
26.
Kerstens HH, Kollers S, Kommadath A, Del Rosario M, Dibbits B, Kinders SM, Crooijmans RP, Groenen MA:
Mining for single nucleotide polymorphisms in pig genome sequence data.
BMC Genomics
; 2009;10:4
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Available
BAC
and
BAC
-end sequences and their naming and mapping information, all obtained from SangerInstitute FTP site, served as a rough assembly
of a
reference genome.
[MeSH-minor]
Animals. Chromosomes, Artificial,
Bacterial
. Cluster Analysis. Genetic Markers. Sequence Alignment. Sequence Analysis, DNA / methods
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Genome Res. 1999 Feb;9(2):167-74
[
10022981.001
]
[Cites]
J Mol Biol. 1990 Oct 5;215(3):403-10
[
2231712.001
]
[Cites]
Genome Res. 1999 Sep;9(9):868-77
[
10508846.001
]
[Cites]
Anim Biotechnol. 2005;16(1):41-54
[
15926262.001
]
[Cites]
Genomics. 1996 Jan 1;31(1):123-6
[
8808290.001
]
[Cites]
Nucleic Acids Res. 1997 Jul 15;25(14):2745-51
[
9207020.001
]
[Cites]
Nucleic Acids Res. 1998 Feb 15;26(4):967-73
[
9461455.001
]
[Cites]
Genome Res. 1998 Mar;8(3):175-85
[
9521921.001
]
[Cites]
Genome Res. 1998 Mar;8(3):186-94
[
9521922.001
]
[Cites]
Nat Genet. 1998 Jul;19(3):233-40
[
9662394.001
]
[Cites]
Genome Res. 1998 Jul;8(7):748-54
[
9685323.001
]
[Cites]
Hum Mutat. 1998;12(4):221-5
[
9744471.001
]
[Cites]
BMC Genomics. 2005;6:70
[
15885146.001
]
[Cites]
Am J Hum Genet. 2005 Sep;77(3):454-67
[
16080120.001
]
[Cites]
Nat Genet. 2006 Mar;38(3):375-81
[
16493422.001
]
[Cites]
Genes Immun. 2006 Jul;7(5):384-92
[
16738668.001
]
[Cites]
Nucleic Acids Res. 2007 Jan;35(Database issue):D650-3
[
17145712.001
]
[Cites]
Anim Genet. 2007 Jun;38(3):253-8
[
17433014.001
]
[Cites]
Bioinformatics. 2007 Jul 1;23(13):i387-91
[
17646321.001
]
[Cites]
Genome Res. 2007 Oct;17(10):1414-9
[
17673700.001
]
[Cites]
Nature. 2007 Oct 18;449(7164):851-61
[
17943122.001
]
[Cites]
Nat Genet. 2007 Nov;39(11):1329-37
[
17952073.001
]
[Cites]
Nucleic Acids Res. 2008 Jan;36(Database issue):D707-14
[
18000006.001
]
[Cites]
Genome Biol. 2007;8(7):R139
[
17625002.001
]
[Cites]
Science. 1998 May 15;280(5366):1077-82
[
9582121.001
]
[Cites]
Genome Res. 1999 Nov;9(11):1087-92
[
10568748.001
]
[Cites]
Nat Genet. 1999 Dec;23(4):452-6
[
10581034.001
]
[Cites]
J Comput Biol. 2000 Feb-Apr;7(1-2):203-14
[
10890397.001
]
[Cites]
Genome Res. 2002 Apr;12(4):627-39
[
11932247.001
]
[Cites]
Genome Res. 2002 Apr;12(4):656-64
[
11932250.001
]
[Cites]
Anim Genet. 2002 Jun;33(3):186-95
[
12030921.001
]
[Cites]
Comput Appl Biosci. 1988 Mar;4(1):11-7
[
3382986.001
]
[Cites]
Genome Res. 1999 Aug;9(8):677-9
[
10447503.001
]
(PMID = 19126189.001).
[ISSN]
1471-2164
[Journal-full-title]
BMC genomics
[ISO-abbreviation]
BMC Genomics
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Genetic Markers
[Other-IDs]
NLM/ PMC2637895
27.
Song J, Dong H, Ma C, Zhao B, Shang G:
Construction and functional characterization of an integrative form lambda Red recombineering Escherichia coli strain.
FEMS Microbiol Lett
; 2010 Aug 1;309(2):178-83
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
LS-GR shows high recombination efficiency for medium copy number vector and single copy number
BAC
vector modifications.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20618864.001).
[ISSN]
1574-6968
[Journal-full-title]
FEMS microbiology letters
[ISO-abbreviation]
FEMS Microbiol. Lett.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Recombinases; 0 / Viral Proteins
28.
Cheung SW, Shaw CA, Scott DA, Patel A, Sahoo T, Bacino CA, Pursley A, Li J, Erickson R, Gropman AL, Miller DT, Seashore MR, Summers AM, Stankiewicz P, Chinault AC, Lupski JR, Beaudet AL, Sutton VR:
Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics.
Am J Med Genet A
; 2007 Aug 1;143A(15):1679-86
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
We have developed a clinically validated, targeted
BAC
clone array as a platform for comparative genomic hybridization (aCGH) to enable detection
of a
wide range of pathologic copy number changes in DNA.
This enhanced ability of aCGH to detect mosaicism missed by routine chromosome analysis may be due to some combination of testing multiple
cell
lineages and/or failure of cytogenetically abnormal T lymphocytes to respond to mitogens.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
(c) 2007 Wiley-Liss, Inc.
(PMID = 17607705.001).
[ISSN]
1552-4833
[Journal-full-title]
American journal of medical genetics. Part A
[ISO-abbreviation]
Am. J. Med. Genet. A
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
29.
Eggermann T, Krause-Plonka I, Wollmann HA, Zerres K, Dai G, Meyer E, Bartsch O:
Supernumerary marker chromosome 7 and maternal uniparental disomy 7 in a boy with growth retardation and triangular face.
Clin Dysmorphol
; 2006 Jan;15(1):9-12
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Using fluorescence in situ hybridization and
BAC
clones, the supernumerary marker chromosome was found to be a highly deleted chromosome 7 with breakpoints within the pericentric euchromatin (partial trisomy 7).
Considering that the SMC(7) contributed very little, if any, to the phenotype of this boy, we propose that UPD7 studies should be carried out in children with pre- and postnatal growth retardation of unknown cause even in the absence
of a
SMC.
MedlinePlus Health Information.
consumer health - Growth Disorders
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16317300.001).
[ISSN]
0962-8827
[Journal-full-title]
Clinical dysmorphology
[ISO-abbreviation]
Clin. Dysmorphol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Euchromatin
30.
Swiercz R, Hałatek T, Majcherek W, Grzelińiska Z, Wasowicz W:
[Toxic effect of benzalkonium chloride on animals and humans].
Med Pr
; 2007;58(2):139-42
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Benzalkonium chloride (
BAC
) exerts toxic effects on microorganisms.
Various
BAC
-containing preparations used by people may induce a number of adverse effects on the human body.
Bearing in mind that
BAC
is widely used in different branches of the national economy, its toxic effect may cause a health problem of significant importance to humans.
The authors describe
BAC
toxic effects exerted on humans and laboratory animals as well as relevant hazards resulting from the use
of BAC
-contained preparations.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17926503.001).
[ISSN]
0465-5893
[Journal-full-title]
Medycyna pracy
[ISO-abbreviation]
Med Pr
[Language]
pol
[Publication-type]
English Abstract; Journal Article; Review
[Publication-country]
Poland
[Chemical-registry-number]
0 / Benzalkonium Compounds; 0 / Preservatives, Pharmaceutical
[Number-of-references]
25
31.
Summers RJ, Shehata BM, Bleacher JC, Stockwell C, Rapkin L:
Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation.
J Pediatr Surg
; 2010 Nov;45(11):2256-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Mucinous
adenocarcinoma
of the
lung
in association with congenital pulmonary airway malformation.
Congenital pulmonary airway malformation (CPAM) is a rare developmental
abnormality of the lung
that has been associated with the presence of rhabdomyosarcoma, pleuropulmonary blastoma, and most commonly
bronchioalveolar carcinoma
(
BAC
) of the
lung
.
Here, we report the case of an 8-year-old patient who developed KRAS mutation positive stage IV mucinous
adenocarcinoma
of the
lung
in association with CPAM.
This case reflects the previously recognized progression of CPAM to malignancy and suggests that
BAC
arising in CPAM may take a more aggressive course than previously recognized.
[MeSH-major]
Adenocarcinoma
, Mucinous /
diagnosis
. Cystic Adenomatoid Malformation
of Lung
, Congenital /
diagnosis
.
Lung
Neoplasms /
diagnosis
. Precancerous Conditions
[MeSH-minor]
Bronchoscopy. Child.
Diagnosis
, Differential. Female. Humans. Pneumonectomy / methods. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright © 2010 Elsevier Inc. All rights reserved.
(PMID = 21034957.001).
[ISSN]
1531-5037
[Journal-full-title]
Journal of pediatric surgery
[ISO-abbreviation]
J. Pediatr. Surg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
32.
Dunnick WA, Collins JT, Shi J, Westfield G, Fontaine C, Hakimpour P, Papavasiliou FN:
Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region.
J Exp Med
; 2009 Nov 23;206(12):2613-23
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Both class switch recombination (CSR) and somatic hypermutation (SHM) require transcription and the trans-acting factor activation-induced cytidine deaminase (AID), and must be up-regulated during
antigen
-dependent differentiation of B lymphocytes.
To test the role of the heavy chain 3' enhancers in both CSR and SHM, we used
a BAC
transgene of the entire heavy chain constant region locus.
Using Cre-loxP recombination to delete a 28-kb region that contains the four known 3' heavy chain enhancers, we isolated lines
of BAC
transgenic mice with an intact heavy chain locus and paired lines in the same chromosomal insertion site lacking the 3' enhancers.
COS Scholar Universe.
author profiles
.
Faculty of 1000.
commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine.
(subscription/membership/fee required).
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Cell. 1994 Jun 3;77(5):737-47
[
8205622.001
]
[Cites]
J Exp Med. 1983 Apr 1;157(4):1116-36
[
6403653.001
]
[Cites]
J Immunol. 1995 Jul 15;155(2):684-91
[
7608545.001
]
[Cites]
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5860-5
[
8650183.001
]
[Cites]
J Immunol. 1996 Jul 1;157(1):176-82
[
8683112.001
]
[Cites]
Nat Biotechnol. 1997 Sep;15(9):859-65
[
9306400.001
]
[Cites]
Int Immunol. 1998 Jun;10(6):799-806
[
9678761.001
]
[Cites]
J Exp Med. 1998 Oct 19;188(8):1421-31
[
9782119.001
]
[Cites]
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3000-5
[
10077626.001
]
[Cites]
Int Immunol. 1999 Oct;11(10):1709-13
[
10508189.001
]
[Cites]
Mol Cell Biol. 2005 Feb;25(4):1511-25
[
15684400.001
]
[Cites]
J Immunol. 2005 Apr 1;174(7):4113-9
[
15778370.001
]
[Cites]
J Exp Med. 2005 May 2;201(9):1459-66
[
15851486.001
]
[Cites]
J Immunol. 2005 May 15;174(10):6176-83
[
15879114.001
]
[Cites]
Blood. 2007 Jan 1;109(1):159-67
[
16968901.001
]
[Cites]
Science. 2007 Aug 31;317(5842):1227-30
[
17761884.001
]
[Cites]
Immunity. 2007 Nov;27(5):711-22
[
17980632.001
]
[Cites]
J Immunol. 2008 Feb 15;180(4):2019-23
[
18250404.001
]
[Cites]
PLoS Genet. 2009 Jan;5(1):e1000332
[
19132090.001
]
[Cites]
J Immunol. 2009 Jun 1;182(11):6926-32
[
19454689.001
]
[Cites]
Curr Top Microbiol Immunol. 2000;245(2):127-68
[
10533321.001
]
[Cites]
J Immunol. 1999 Dec 1;163(11):5758-62
[
10570257.001
]
[Cites]
EMBO J. 2000 May 15;19(10):2315-22
[
10811622.001
]
[Cites]
Cell. 2000 Sep 1;102(5):553-63
[
11007474.001
]
[Cites]
Cell. 2000 Sep 1;102(5):565-75
[
11007475.001
]
[Cites]
J Immunol. 2001 Mar 15;166(6):3659-62
[
11238604.001
]
[Cites]
J Immunol. 2001 Jul 15;167(2):811-20
[
11441087.001
]
[Cites]
Int Immunol. 2001 Aug;13(8):1003-12
[
11470770.001
]
[Cites]
Immunity. 2001 Aug;15(2):187-99
[
11520455.001
]
[Cites]
Trends Immunol. 2002 Jan;23(1):31-9
[
11801452.001
]
[Cites]
EMBO J. 1986 Jan;5(1):95-102
[
3007121.001
]
[Cites]
EMBO J. 1986 Dec 1;5(12):3259-66
[
3028778.001
]
[Cites]
J Immunol. 1987 May 15;138(10):3539-48
[
3106486.001
]
[Cites]
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2346-50
[
2494666.001
]
[Cites]
Gene. 1989 Apr 15;77(1):51-9
[
2744487.001
]
[Cites]
Cell. 1990 Nov 2;63(3):537-48
[
2121365.001
]
[Cites]
EMBO J. 1992 Jan;11(1):145-55
[
1740102.001
]
[Cites]
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6978-82
[
1495989.001
]
[Cites]
J Exp Med. 1993 Mar 1;177(3):797-809
[
8436910.001
]
[Cites]
Curr Biol. 2002 Oct 29;12(21):R725-7
[
12419200.001
]
[Cites]
Eur J Immunol. 2003 Aug;33(8):2108-13
[
12884284.001
]
[Cites]
Blood. 2003 Aug 15;102(4):1421-7
[
12714490.001
]
[Cites]
J Immunol. 2004 Nov 1;173(9):5531-9
[
15494502.001
]
[Cites]
Eur J Immunol. 1976 Aug;6(8):588-90
[
789096.001
]
[Cites]
Int Immunol. 1994 Apr;6(4):491-7
[
8018590.001
]
(PMID = 19887393.001).
[ISSN]
1540-9538
[Journal-full-title]
The Journal of experimental medicine
[ISO-abbreviation]
J. Exp. Med.
[Language]
ENG
[Grant]
United States / NCI NIH HHS / CA / P30 CA046592; United States / NIAID NIH HHS / AI / AI076057; United States / NCI NIH HHS / CA / CA46592; United States / NCI NIH HHS / CA / R01 CA098495; United States / NIAID NIH HHS / AI / R01 AI076057; United States / NCI NIH HHS / CA / CA098495
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / 3' Untranslated Regions; 0 / Immunoglobulin Heavy Chains; EC 2.7.7.- / Cre recombinase; EC 2.7.7.- / Integrases; EC 3.5.4.5 / Cytidine Deaminase
[Other-IDs]
NLM/ PMC2806627
33.
Liu H, Jiang H, Haltli B, Kulowski K, Muszynska E, Feng X, Summers M, Young M, Graziani E, Koehn F, Carter GT, He M:
Rapid cloning and heterologous expression of the meridamycin biosynthetic gene cluster using a versatile Escherichia coli-streptomyces artificial chromosome vector, pSBAC.
J Nat Prod
; 2009 Mar 27;72(3):389-95
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Herein we describe the development
of a
versatile Escherichia coli-Streptomyces shuttle
Bacterial
Artificial Chromosomal (
BAC
) conjugation vector, pSBAC, to facilitate the cloning, genetic manipulation, and heterologous expression of actinomycetes secondary metabolite biosynthetic gene clusters.
The success of heterologous expression of such a giant gene cluster demonstrates the versatility
of BAC
cloning technology and paves the road for future exploration of expression of the meridamycin biosynthetic pathway in various hosts, including strains that have been optimized for polyketide production.
[MeSH-major]
Escherichia coli / genetics. Genes,
Bacterial
/ genetics. Macrolides / chemical synthesis. Macrolides / metabolism. Polyketide Synthases / metabolism. Streptomyces / genetics
[MeSH-minor]
Chromosomes, Artificial. Chromosomes, Artificial,
Bacterial
/ metabolism. Cloning, Molecular. Genetic Vectors / chemical synthesis. Genetic Vectors / genetics. Molecular Structure
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19191550.001).
[ISSN]
1520-6025
[Journal-full-title]
Journal of natural products
[ISO-abbreviation]
J. Nat. Prod.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / 3-normeridamycin; 0 / Macrolides; 0 / meridamycin; 79956-01-7 / Polyketide Synthases
34.
Petersohn JD, Conquergood LR, Leung M:
Acute histologic effects and thermal distribution profile of disc biacuplasty using a novel water-cooled bipolar electrode system in an in vivo porcine model.
Pain Med
; 2008 Jan-Feb;9(1):26-32
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Disc biacuplasty (D-
BAC
) is a novel procedure that uses two water-cooled radiofrequency electrodes in a bipolar configuration to heat a large volume of the posterior annulus fibrosus.
METHODS: Seven porcine lumbar discs were treated with D-
BAC
to assess acute effects on the treated tissue in a "worst-case"in vivo model.
MedlinePlus Health Information.
consumer health - Herniated Disk
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18254764.001).
[ISSN]
1526-2375
[Journal-full-title]
Pain medicine (Malden, Mass.)
[ISO-abbreviation]
Pain Med
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
35.
Duchesne A, Eggen A:
Radiation hybrid mapping of genes and newly identified microsatellites in candidate regions for bovine arthrogryposis-palatoschisis and progressive ataxia based on comparative data from man, mouse and rat.
J Anim Breed Genet
; 2005 Apr;122 Suppl 1:28-35
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Primer pairs were designed for 15 loci around each candidate gene, in a region of about 20 megabases and were used to screen a bovine
Bacterial
Artificial Chromosome (
BAC
) library.
Eighteen microsatellites were found in the identified
BAC
clones, 11 on BTA24 and seven on BTA16.
[MeSH-major]
Arthrogryposis / veterinary. Ataxia / veterinary. Cattle Diseases / genetics. Cattle Diseases / pathology. Genetic Predisposition to
Disease
/ genetics
[MeSH-minor]
Animals. Cattle. Chromosomes, Artificial,
Bacterial
. DNA Primers. Humans. Mice. Microsatellite Repeats / genetics. Radiation Hybrid Mapping / veterinary. Rats
Genetic Alliance.
consumer health - Arthrogryposis Multiplex Congenita
.
Genetic Alliance.
consumer health - Ataxia
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
SciCrunch.
OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16130454.001).
[ISSN]
0931-2668
[Journal-full-title]
Journal of animal breeding and genetics = Zeitschrift für Tierzüchtung und Züchtungsbiologie
[ISO-abbreviation]
J. Anim. Breed. Genet.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Germany
[Chemical-registry-number]
0 / DNA Primers
36.
Dziadziuszko R, Siemiatkowska A, Limon J, Rzyman W, Jassem J, Bunn PA Jr, Varella-Garcia M, Hirsch FR:
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
J Thorac Oncol
; 2007 Jan;2(1):91-2
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Unusual chemosensitivity of advanced
bronchioalveolar carcinoma
after gefitinib response and progression: a case report.
Bronchioalveolar carcinoma
of the
lung
represents increasingly recognized clinical entity with relatively high probability of response to epidermal growth factor receptor tyrosine kinase inhibitors.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ drug therapy. Antineoplastic Agents / therapeutic use.
Lung
Neoplasms / drug therapy. Protein Kinase Inhibitors / therapeutic use. Quinazolines / therapeutic use. Receptor, Epidermal Growth Factor / genetics
[MeSH-minor]
Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy.
Disease
Progression. Female. Humans
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17410018.001).
[ISSN]
1556-1380
[Journal-full-title]
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
[ISO-abbreviation]
J Thorac Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antineoplastic Agents; 0 / Protein Kinase Inhibitors; 0 / Quinazolines; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
37.
Chen YP, Tseng CP, Liaw LL, Wang CL, Chen IC, Wu WJ, Wu MD, Yuan GF:
Cloning and characterization of monacolin K biosynthetic gene cluster from Monascus pilosus.
J Agric Food Chem
; 2008 Jul 23;56(14):5639-46
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
In the present study,
a bacterial
artificial chromosome (
BAC
) clone, mps01, was screened from
the BAC
library constructed from Monascus pilosus BCRC38072 genomic DNA.
[MeSH-minor]
Amino Acid Sequence. Chromosomes, Artificial,
Bacterial
. Molecular Sequence Data. Phylogeny. Polyketide Synthases / genetics. Polyketide Synthases / metabolism
Hazardous Substances Data Bank.
LOVASTATIN
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18578535.001).
[ISSN]
1520-5118
[Journal-full-title]
Journal of agricultural and food chemistry
[ISO-abbreviation]
J. Agric. Food Chem.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
79956-01-7 / Polyketide Synthases; 9LHU78OQFD / Lovastatin
38.
Chattoo JP, Stevens MP, Nair V:
Rapid identification of non-essential genes for in vitro replication of Marek's disease virus by random transposon mutagenesis.
J Virol Methods
; 2006 Aug;135(2):288-91
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Rapid identification of non-essential genes for in vitro replication of Marek's
disease
virus by random transposon mutagenesis.
Marek's
disease
virus (MDV) is a highly oncogenic alphaherpesvirus that induces rapid-onset T-
cell
lymphomas in poultry.
The construction of an infectious
bacterial
artificial chromosome (
BAC
) clone of the highly oncogenic RB-1B strain of MDV has been described previously.
Virus reconstituted from
the BAC
clone induced rapid-onset lymphomas in chickens very similar to the wildtype viruses.
In this paper, the construction
of a
high-density random transposon-insertion mutant library of the RB-1B
BAC
clone using a high throughput in vitro transposon mutagenesis technique is described.
[MeSH-minor]
Chromosomes, Artificial,
Bacterial
. Open Reading Frames
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16650486.001).
[ISSN]
0166-0934
[Journal-full-title]
Journal of virological methods
[ISO-abbreviation]
J. Virol. Methods
[Language]
eng
[Grant]
United Kingdom / Biotechnology and Biological Sciences Research Council / / BBS/B/10544
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / DNA Transposable Elements
39.
Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K:
Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice.
Toxicology
; 2010 Sep 10;275(1-3):65-71
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Magnetite iron nanoparticles have been widely used as contrast agents and in thermal therapy for
cancer
.
When mice were treated with iron oxide nanoparticles (250 microg/kg, 500 microg/kg, and 1mg/kg) by a single intratracheal instillation, the level of intracellular reduced glutathione (GSH) was decreased in the cells
of bronchoalveolar
lavage (BAL) fluid.
The arrest
of cell
cycles in G1 phase was observed, but S-phase was significantly decreased.
Formation of microgranuloma, which is one of the indicators for chronic inflammatory response, was observed in the
alveolar
space.
In addition, distribution of B
cell
and CD8+ T
cell
in blood lymphocytes was increased at day 28.
[MeSH-major]
Ferric Compounds / toxicity. Inflammation Mediators / toxicity.
Lung
/ drug effects.
Lung
/ metabolism. Nanoparticles / toxicity. Trachea / drug effects
Hazardous Substances Data Bank.
FERRIC OXIDE
.
Hazardous Substances Data Bank.
HEMATITE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
(c) 2010 Elsevier Ireland Ltd. All rights reserved.
(PMID = 20540983.001).
[ISSN]
1879-3185
[Journal-full-title]
Toxicology
[ISO-abbreviation]
Toxicology
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
Ireland
[Chemical-registry-number]
0 / Ferric Compounds; 0 / Inflammation Mediators; 1K09F3G675 / ferric oxide
40.
Maver A, Medica I, Salobir B, Tercelj-Zorman M, Sabovic M, Petrovic D, Peterlin B:
Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis
; 2008 Sep;25(1):29-35
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
BACKGROUND AND AIM OF THE WORK: Reduced expression and activity of the peroxisome proliferator-activated receptor gamma (PPARG) have been measured in cells
of bronchoalveolar
lavage fluid in sarcoidosis patients.
Genetic Alliance.
consumer health - Sarcoidosis
.
Genetic Alliance.
consumer health - Sarcoidosis 1
.
MedlinePlus Health Information.
consumer health - Sarcoidosis
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19070258.001).
[ISSN]
1124-0490
[Journal-full-title]
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
[ISO-abbreviation]
Sarcoidosis Vasc Diffuse Lung Dis
[Language]
ENG
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
Italy
[Chemical-registry-number]
0 / Heat-Shock Proteins; 0 / PPAR gamma; 0 / PPARGC1A protein, human; 0 / Transcription Factors; 9007-49-2 / DNA
41.
Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC 3rd, Deschamps C, Pairolero PC:
Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection.
Ann Thorac Surg
; 2006 Oct;82(4):1175-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Lung cancer
in octogenarians: factors affecting morbidity and mortality after pulmonary resection.
BACKGROUND: Predictors of morbidity and mortality after pulmonary resection for
lung cancer
in patients 80 years of age or older are unknown.
METHODS: The medical records of all patients 80 years of age or older who had pulmonary resection for
lung cancer
from January 1985 through September 2004 were reviewed.
The cancer
was squamous
cell carcinoma
in 143 patients (37.7%),
adenocarcinoma
in 166 (43.8%),
bronchoalveolar cell carcinoma
in 47 (12.4%), and other in 23 (6.1%).
CONCLUSIONS: Pulmonary resection for
lung cancer
in octogenarians is feasible.
[MeSH-major]
Adenocarcinoma
/ surgery.
Carcinoma
, Squamous
Cell
/ surgery.
Lung
Neoplasms / surgery. Pneumonectomy / statistics & numerical data
Genetic Alliance.
consumer health - Lung Cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16996903.001).
[ISSN]
1552-6259
[Journal-full-title]
The Annals of thoracic surgery
[ISO-abbreviation]
Ann. Thorac. Surg.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Netherlands
42.
Hahn C, Islamian AP, Renz H, Nockher WA:
Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation.
J Allergy Clin Immunol
; 2006 Apr;117(4):787-94
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
BACKGROUND: Eosinophil-epithelial
cell
interactions make a major contribution to asthmatic airway inflammation.
Neurotrophin levels are increased in
bronchoalveolar
lavage fluid during allergic asthma.
OBJECTIVE: We sought to investigate the role of neurotrophins as inflammatory mediators in eosinophil-epithelial
cell
interactions during the allergic immune response.
METHODS: Neurotrophin expression in
the lung
was investigated by means of immunohistochemistry and ELISA in a mouse model of chronic experimental asthma.
Coculture experiments were performed with airway epithelial cells and
bronchoalveolar
lavage fluid eosinophils.
RESULTS: Neurotrophin levels increased continuously during chronic allergic airway inflammation, and airway epithelial cells were the major source of NGF and BDNF within the inflamed
lung
.
Lung
eosinophils expressed the BDNF and NGF receptors tropomyosin-related kinase (Trk) A and TrkB, and coculture with airway epithelial cells resulted in enhanced epithelial neurotrophin production, as well as in prolonged survival of eosinophils.
[MeSH-minor]
Animals. Asthma / etiology. Asthma / pathology. Asthma / physiopathology. Base Sequence. Brain-Derived Neurotrophic Factor / biosynthesis.
Cell
Survival. Cytokines / pharmacology. Epithelial Cells / drug effects. Epithelial Cells / physiology. Female. Inflammation Mediators / metabolism. Mice. Mice, Inbred BALB C. Models, Biological. RNA, Messenger / genetics. RNA, Messenger / metabolism. Receptor, trkA / biosynthesis. Receptor, trkB / biosynthesis
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16630935.001).
[ISSN]
0091-6749
[Journal-full-title]
The Journal of allergy and clinical immunology
[ISO-abbreviation]
J. Allergy Clin. Immunol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Brain-Derived Neurotrophic Factor; 0 / Cytokines; 0 / Inflammation Mediators; 0 / Nerve Growth Factors; 0 / RNA, Messenger; EC 2.7.10.1 / Receptor, trkA; EC 2.7.10.1 / Receptor, trkB
43.
Boukakis G, Patrinou-Georgoula M, Lekarakou M, Valavanis C, Guialis A:
Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
BMC Cancer
; 2010;10:434
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Deregulated expression of hnRNP A/B proteins in human non-small
cell lung cancer
: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
The altered expression pattern of hnRNP A2/B1 and/or splicing variant B1 alone in human
lung cancer
and their potential to serve as molecular markers for early
diagnosis
remain issues of intense investigation.
The main objective of the present study was to use paired tumour/non-tumour biopsies from patients with non-small
cell lung cancer
(NSCLC) to investigate the expression profiles of hnRNP A1, A2/B1 and A3 in conjunction with ASF/SF2.
METHODS: We combined western blotting of tissue homogenates with immunohistochemical examination of fixed tissue sections and quantification of mRNA expression levels in tumour versus adjacent normal-looking areas of the
lung
in the same patient.
[MeSH-major]
Carcinoma
, Non-Small-
Cell Lung
/ genetics.
Carcinoma
, Non-Small-
Cell Lung
/ metabolism. Heterogeneous-Nuclear Ribonucleoprotein Group A-B / metabolism.
Lung
/ metabolism. RNA, Messenger / genetics
[MeSH-minor]
Adenocarcinoma
/ genetics.
Adenocarcinoma
/ metabolism.
Adenocarcinoma
/ secondary.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ genetics.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ metabolism.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ secondary. Aged. Blotting, Western.
Carcinoma
, Large
Cell
/ genetics.
Carcinoma
, Large
Cell
/ metabolism.
Carcinoma
, Large
Cell
/ secondary.
Carcinoma
, Squamous
Cell
/ genetics.
Carcinoma
, Squamous
Cell
/ metabolism.
Carcinoma
, Squamous
Cell
/ secondary. Female. Humans. Immunoenzyme Techniques.
Lung
Neoplasms / genetics.
Lung
Neoplasms / metabolism.
Lung
Neoplasms / pathology. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Nuclear Proteins / genetics. Nuclear Proteins / metabolism. RNA-Binding Proteins / genetics. RNA-Binding Proteins / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Serine-Arginine Splicing Factors. Survival Rate. Treatment Outcome
Genetic Alliance.
consumer health - Lung Cancer
.
Genetic Alliance.
consumer health - Non-small cell lung cancer
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Int J Oncol. 2000 Apr;16(4):763-7
[
10717246.001
]
[Cites]
Clin Cancer Res. 1999 Dec;5(12):4048-52
[
10632338.001
]
[Cites]
Cancer Res. 2001 Mar 1;61(5):1896-902
[
11280744.001
]
[Cites]
Anticancer Res. 2001 Mar-Apr;21(2A):979-84
[
11396191.001
]
[Cites]
Lung Cancer. 2001 Dec;34(3):341-50
[
11714531.001
]
[Cites]
Nat Rev Mol Cell Biol. 2002 Mar;3(3):195-205
[
11994740.001
]
[Cites]
Cancer Lett. 2002 Sep 26;183(2):215-20
[
12065097.001
]
[Cites]
Lung Cancer. 2003 Apr;40(1):45-53
[
12660006.001
]
[Cites]
J Pathol. 2003 May;200(1):88-94
[
12692846.001
]
[Cites]
Lung Cancer. 2003 Aug;41(2):131-43
[
12871776.001
]
[Cites]
Lung Cancer. 2003 Aug;41(2):179-86
[
12871781.001
]
[Cites]
Br J Cancer. 2003 Oct 20;89(8):1493-501
[
14562022.001
]
[Cites]
Cancer Res. 2003 Nov 15;63(22):7679-88
[
14633690.001
]
[Cites]
Mol Carcinog. 2004 Dec;41(4):187-96
[
15390079.001
]
[Cites]
Proc Natl Acad Sci U S A. 1989 Dec;86(24):9788-92
[
2557628.001
]
[Cites]
Annu Rev Biochem. 1993;62:289-321
[
8352591.001
]
[Cites]
Science. 1994 Jul 29;265(5172):615-21
[
8036511.001
]
[Cites]
Genomics. 1995 Jan 20;25(2):365-71
[
7789969.001
]
[Cites]
Exp Cell Res. 1995 Nov;221(1):187-96
[
7589244.001
]
[Cites]
J Biol Chem. 1996 May 3;271(18):10760-6
[
8631886.001
]
[Cites]
RNA. 1998 Apr;4(4):430-44
[
9630249.001
]
[Cites]
Clin Cancer Res. 1998 Jul;4(7):1631-40
[
9676837.001
]
[Cites]
Am J Respir Cell Mol Biol. 1998 Oct;19(4):554-62
[
9761751.001
]
[Cites]
Cancer Res. 1998 Dec 15;58(24):5818-24
[
9865741.001
]
[Cites]
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2237-46
[
9815620.001
]
[Cites]
Exp Cell Res. 1999 Feb 1;246(2):399-411
[
9925756.001
]
[Cites]
Mol Cell Biol. 1999 Mar;19(3):1720-30
[
10022859.001
]
[Cites]
Cancer Res. 1999 Apr 1;59(7):1404-7
[
10197602.001
]
[Cites]
Curr Opin Cell Biol. 1999 Jun;11(3):363-71
[
10395553.001
]
[Cites]
Int J Oncol. 2005 Mar;26(3):635-40
[
15703818.001
]
[Cites]
Genes Dev. 2005 Mar 15;19(6):643-64
[
15769940.001
]
[Cites]
Biochem Biophys Res Commun. 2005 Aug 5;333(3):888-95
[
15964549.001
]
[Cites]
J Cell Sci. 2005 Jul 15;118(Pt 14):3173-83
[
16014382.001
]
[Cites]
Biochim Biophys Acta. 2006 Apr;1765(2):85-100
[
16378690.001
]
[Cites]
Cancer Detect Prev. 2006;30(5):395-402
[
17067748.001
]
[Cites]
Clin Cancer Res. 2007 Mar 15;13(6):1638-42
[
17363515.001
]
[Cites]
Cancer Genomics Proteomics. 2007 May-Jun;4(3):233-9
[
17878526.001
]
[Cites]
Mol Carcinog. 2007 Nov;46(11):887-900
[
17477362.001
]
[Cites]
FEBS Lett. 2008 Jun 18;582(14):1977-86
[
18342629.001
]
[Cites]
Curr Med Chem. 2009;16(9):1047-61
[
19275611.001
]
[Cites]
Anticancer Res. 2009 Apr;29(4):1373-82
[
19414390.001
]
[Cites]
Am J Respir Cell Mol Biol. 2000 Nov;23(5):636-45
[
11062142.001
]
(PMID = 20716340.001).
[ISSN]
1471-2407
[Journal-full-title]
BMC cancer
[ISO-abbreviation]
BMC Cancer
[Language]
eng
[Publication-type]
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / HNRNPA3 protein, human; 0 / Heterogeneous-Nuclear Ribonucleoprotein Group A-B; 0 / Nuclear Proteins; 0 / RNA, Messenger; 0 / RNA-Binding Proteins; 0 / hnRNP A1; 170974-22-8 / Serine-Arginine Splicing Factors
[Other-IDs]
NLM/ PMC2933625
44.
Bruno AC, Baffa O, Carneiro AO:
Hybrid system for magnetic and acoustic measurement.
Conf Proc IEEE Eng Med Biol Soc
; 2009;2009:761-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
In order to improve the spatial resolution of Biosusceptometry of Alternate Current (
BAC
), we are suggesting the coupling
of a
Doppler ultrasonic transducer with
the BAC
system.
MedlinePlus Health Information.
consumer health - Ultrasound
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19964487.001).
[ISSN]
1557-170X
[Journal-full-title]
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference
[ISO-abbreviation]
Conf Proc IEEE Eng Med Biol Soc
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
45.
Liu HZ, Yang HZ, Mi S, Cui B, Hua F, Hu ZW:
Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice.
Yao Xue Xue Bao
; 2010 Aug;45(8):976-86
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Toll like receptor 2 mediates bleomycin-induced acute
lung
injury, inflammation and fibrosis in mice.
Anti-
cancer
drug bleomycin (BLM) can cause acute
lung
injury (ALI) which often results in pulmonary fibrosis due to a failure of resolving acute inflammatory response.
TLR2 inhibition attenuated BLM-induced increase of inflammatory cells in
bronchoalveolar
lavage fluid (BALF), and reversed the immunosuppressive microenvironment by enhancing TH1 response (P<0.05) and inhibiting TH2 (P<0.001), Treg (P<0.01) and TH17 (P<0.01) responses.
[MeSH-major]
Acute
Lung
Injury / metabolism. Cytokines / secretion. Inflammation / metabolism. Pulmonary Fibrosis / metabolism. Toll-Like Receptor 2 / metabolism
[MeSH-minor]
Animals. Bleomycin / toxicity.
Bronchoalveolar
Lavage Fluid. Cells, Cultured. Dendritic Cells / cytology. Dendritic Cells / metabolism. Interleukin-17 / secretion. Interleukin-23 / secretion. Interleukin-6 / secretion.
Lung
/ metabolism. MAP Kinase Signaling System. Male. Mice. Mice, Inbred C57BL. T-Lymphocytes, Regulatory / drug effects. Th1 Cells / drug effects. Th2 Cells / drug effects
MedlinePlus Health Information.
consumer health - Pulmonary Fibrosis
.
Hazardous Substances Data Bank.
BLEOMYCIN
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 21348427.001).
[ISSN]
0513-4870
[Journal-full-title]
Yao xue xue bao = Acta pharmaceutica Sinica
[ISO-abbreviation]
Yao Xue Xue Bao
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
China
[Chemical-registry-number]
0 / Cytokines; 0 / Interleukin-17; 0 / Interleukin-23; 0 / Interleukin-6; 0 / Tlr2 protein, mouse; 0 / Toll-Like Receptor 2; 11056-06-7 / Bleomycin
46.
Honey D, Caylor C, Luthi R, Kerrigan S:
Comparative alcohol concentrations in blood and vitreous fluid with illustrative case studies.
J Anal Toxicol
; 2005 Jul-Aug;29(5):365-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The vitreous alcohol concentration (VAC) exceeded the blood alcohol concentration (
BAC
) in 209 cases (71%).
In casework where the VAC >
BAC
, linear regression analysis indicated an R2 value of 0.958 (n = 209) and a VAC approximately 16% higher than
the BAC
.
The VAC/
BAC
ratio was more variable at lower
BACs
(< 0.1 g/100 mL).
Although VAC/
BAC
ratios were more consistent at concentrations of 0.1 g/100 mL and above, the overall ratio ranged from 1.01 to 2.20.
Of the 81 cases where
BAC
> VAC, a total of 24 cases indicated no vitreous alcohol.
Unlike the VAC/
BAC
data set which consisted of 97% femoral blood, the source of blood in
the BAC
> VAC data set was slightly more variable.
Of the 81 cases where
BAC
> VAC the blood source consisted of femoral (n = 68), heart (n = 8), pleural cavity (n = 2), carotid (n = 1), jugular (n = 1), and chest blood (n = 1).
Hazardous Substances Data Bank.
ETHANOL
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16105262.001).
[ISSN]
0146-4760
[Journal-full-title]
Journal of analytical toxicology
[ISO-abbreviation]
J Anal Toxicol
[Language]
eng
[Publication-type]
Case Reports; Comparative Study; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
3K9958V90M / Ethanol
47.
Xu F, Cheng DH, Di YF, Tan K, Li LY, Lu GX, Tan YQ:
[Identification of a cryptic 1p36.3 microdeletion in a patient with Prader-Willi-like syndrome features].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
; 2010 Oct;27(5):524-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Identification
of a
cryptic 1p36.3 microdeletion in a patient with Prader-Willi-like syndrome features].
OBJECTIVE: To determine the karyotype
of a
patient with Prader-Willi-like syndrome features.
RESULTS: No
abnormality
was discovered by high resolution karyotype analysis and methylation-specific PCR studies.
The deleted region was shown within a 4.2 Mb in the distal 1p by 3
BAC
FISH probes of 1p36 combined with real-time PCR technique.
Family pedigree investigation showed the chromosome
abnormality
was
de
novo.
Genetic Alliance.
consumer health - Prader-Willi syndrome
.
MedlinePlus Health Information.
consumer health - Prader-Willi Syndrome
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20931530.001).
[ISSN]
1003-9406
[Journal-full-title]
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
[ISO-abbreviation]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
[Language]
chi
[Publication-type]
Case Reports; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
China
48.
Reddy S, Dolzhanskaya N, Krogh J, Velinov M:
A novel 1.4 Mb de novo microdeletion of chromosome 1q21.3 in a child with microcephaly, dysmorphic features and mental retardation.
Eur J Med Genet
; 2009 Nov-Dec;52(6):443-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
A novel 1.4 Mb
de
novo microdeletion of chromosome 1q21.3 in a child with microcephaly, dysmorphic features and mental retardation.
About 1 Mb deletion in the chromosomal region 1q21.3 was identified using
BAC
array CGH analysis.
Genetic Alliance.
consumer health - Mental Retardation
.
Genetic Alliance.
consumer health - Microcephaly
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19772933.001).
[ISSN]
1878-0849
[Journal-full-title]
European journal of medical genetics
[ISO-abbreviation]
Eur J Med Genet
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
[Publication-country]
Netherlands
49.
Burtey S, Riera M, Ribe E, Pennekamp P, Passage E, Rance R, Dworniczak B, Fontés M:
Overexpression of PKD2 in the mouse is associated with renal tubulopathy.
Nephrol Dial Transplant
; 2008 Apr;23(4):1157-65
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Polycystin-2 (PC-2), a cation channel of the Trp family, is involved in autosomal dominant polycystic kidney
disease
(ADPKD) type 2 (ADPKD2).
In the present paper, we describe a mouse model for human PC-2 overexpression, obtained by inserting a human
bacterial
artificial chromosome (
BAC
) containing the PKD2 gene.
[MeSH-minor]
Animals. Blotting, Western.
Disease
Models, Animal. Extracellular Matrix Proteins / biosynthesis. Extracellular Matrix Proteins / genetics. Female. Humans. In Situ Hybridization, Fluorescence. Male. Mice. Mice, Inbred C57BL. Mice, Transgenic. Reverse Transcriptase Polymerase Chain Reaction. Severity of Illness Index
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18048422.001).
[ISSN]
1460-2385
[Journal-full-title]
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
[ISO-abbreviation]
Nephrol. Dial. Transplant.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Extracellular Matrix Proteins; 0 / TRPP Cation Channels; 0 / polycystic kidney disease 2 protein; 63231-63-0 / RNA
50.
Nguyen RL, Tam LW, Lefebvre PA:
The LF1 gene of Chlamydomonas reinhardtii encodes a novel protein required for flagellar length control.
Genetics
; 2005 Mar;169(3):1415-24
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Here we describe the positional cloning and molecular characterization of the LF1 gene using
a bacterial
artificial chromosome (
BAC
) library.
Rescue of the lf1 phenotype upon transformation was obtained with clones containing the complete LF1 gene as well as clones that lack the last two exons of the gene, indicating that only the amino-
terminal
portion of the LF1 gene product (LF1p) is required for function.
Although LF1 helps regulate flagellar length, the LF1p localizes almost exclusively in
the cell
body, with <1% of total cellular LF1p localizing to the flagella.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Biol Chem. 1999 Nov 26;274(48):34383-8
[
10567416.001
]
[Cites]
Cell. 1998 Dec 11;95(6):829-37
[
9865700.001
]
[Cites]
Biochim Biophys Acta. 2000 Jun 21;1492(1):1-14
[
10858526.001
]
[Cites]
Traffic. 2000 Jan;1(1):29-34
[
11208056.001
]
[Cites]
J Cell Biol. 2001 Apr 2;153(1):63-74
[
11285274.001
]
[Cites]
J Cell Biol. 2001 Oct 29;155(3):405-14
[
11684707.001
]
[Cites]
Mol Biol Cell. 2002 Nov;13(11):3859-69
[
12429830.001
]
[Cites]
Trends Cell Biol. 2002 Dec;12(12):551-5
[
12495842.001
]
[Cites]
Trends Genet. 2003 Mar;19(3):162-7
[
12615011.001
]
[Cites]
Curr Opin Genet Dev. 2003 Apr;13(2):207-14
[
12672499.001
]
[Cites]
Eukaryot Cell. 2003 Apr;2(2):362-79
[
12684385.001
]
[Cites]
Mol Biol Cell. 2003 May;14(5):2041-56
[
12802074.001
]
[Cites]
Curr Biol. 2003 Jul 1;13(13):1145-9
[
12842015.001
]
[Cites]
J Cell Biol. 2003 Nov 10;163(3):597-607
[
14610061.001
]
[Cites]
J Cell Biol. 1969 May;41(2):600-19
[
5783876.001
]
[Cites]
J Cell Biol. 1972 Sep;54(3):507-39
[
4558009.001
]
[Cites]
J Gen Microbiol. 1972 Aug;71(3):525-40
[
4647471.001
]
[Cites]
Methods Enzymol. 1986;134:280-90
[
3821567.001
]
[Cites]
EMBO J. 1987 Feb;6(2):313-8
[
3556163.001
]
[Cites]
Genetics. 1988 Apr;118(4):637-48
[
3366366.001
]
[Cites]
EMBO J. 1989 Oct;8(10):2803-9
[
2583083.001
]
[Cites]
Proc Natl Acad Sci U S A. 1990 Feb;87(3):1228-32
[
2105499.001
]
[Cites]
J Cell Biol. 1993 Aug;122(3):653-61
[
8335691.001
]
[Cites]
Genetics. 1993 Oct;135(2):375-84
[
8244002.001
]
[Cites]
Mol Cell Biol. 1994 Jun;14(6):4011-9
[
8196640.001
]
[Cites]
J Cell Sci. 1994 Mar;107 ( Pt 3):497-506
[
7516341.001
]
[Cites]
Methods Cell Biol. 1995;47:163-9
[
7476482.001
]
[Cites]
J Cell Biol. 1996 Feb;132(3):359-70
[
8636214.001
]
[Cites]
Genetics. 1996 Oct;144(2):569-85
[
8889521.001
]
[Cites]
Genetics. 1998 Feb;148(2):693-702
[
9504917.001
]
[Cites]
Mol Biol Cell. 1998 Dec;9(12):3351-65
[
9843574.001
]
[Cites]
Curr Biol. 2000 Feb 24;10(4):R149-51
[
10704402.001
]
(PMID = 15489537.001).
[ISSN]
0016-6731
[Journal-full-title]
Genetics
[ISO-abbreviation]
Genetics
[Language]
ENG
[Databank-accession-numbers]
GENBANK/ AY298951
[Grant]
United States / NIGMS NIH HHS / GM / R01 GM034437; United States / NIGMS NIH HHS / GM / GM-34437
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
[Publication-country]
United States
[Chemical-registry-number]
0 / DNA, Protozoan; 0 / Protozoan Proteins; 0 / RNA, Protozoan
[Other-IDs]
NLM/ PMC1449559
51.
Na Z, Huipeng Y, Lipan L, Cuiping C, Umashankar ML, Xingmeng L, Xiaofeng W, Bing W, Weizheng C, Cenis JL:
Efficient production of canine interferon-alpha in silkworm Bombyx mori by use of a BmNPV/Bac-to-Bac expression system.
Appl Microbiol Biotechnol
; 2008 Feb;78(2):221-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Efficient production of canine interferon-alpha in silkworm Bombyx mori by use
of a
BmNPV/
Bac
-to-
Bac
expression system.
The recombinant baculovirus harboring canine interferon gene was rapidly generated by the BmNPV/
Bac
-to-
Bac
system that was recently developed.
In B. mori-derived
cell
lines, the expression of the recombinant protein reached maximal levels around 72-96 h post-infection.
[MeSH-minor]
Animals. Baculoviridae / genetics.
Cell
Line.
Cell
Survival. Chromatography, Affinity. Dogs. Electrophoresis, Polyacrylamide Gel. Genetic Vectors. Glycosylation. Larva / genetics. Larva / metabolism. Molecular Sequence Data. Rhabdoviridae Infections / immunology. Sequence Analysis, DNA. Vesiculovirus / immunology
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18066544.001).
[ISSN]
0175-7598
[Journal-full-title]
Applied microbiology and biotechnology
[ISO-abbreviation]
Appl. Microbiol. Biotechnol.
[Language]
eng
[Databank-accession-numbers]
GENBANK/ EF080825
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Germany
[Chemical-registry-number]
0 / Interferon-alpha; 0 / Recombinant Proteins
52.
Aokage K, Ishii G, Yoshida J, Hishida T, Nishimura M, Nagai K, Ochiai A:
Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma.
Pathol Int
; 2010 Dec;60(12):765-73
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Histological progression of small intrapulmonary metastatic tumor from primary
lung
adenocarcinoma
.
Histological typing based on the World Health Organization classification (
bronchioloalveolar carcinoma
, acinar, papillary, and solid subtype) was used to evaluate 234 metastases from the primary
lung adenocarcinomas
of 139 patients.
The predominant subtype of metastasis 3 mm or less in diameter was
bronchioloalveolar carcinoma
when the primary lesion was diagnosed as predominant
bronchioloalveolar carcinoma
, acinar, and papillary subtype.
These findings suggest that implanted
cancer
cells display lepidic growth in the early metastatic phase and recapitulate the morphological heterogeneity of the original tumor as the metastasis enlarges.
[MeSH-major]
Adenocarcinoma
/ secondary.
Lung
Neoplasms / pathology.
Lung
Neoplasms / secondary. Neoplasm Metastasis / pathology
[MeSH-minor]
Aged.
Disease
Progression. Female. Humans. Male. Middle Aged. Neoplasm Staging
MedlinePlus Health Information.
consumer health - Lung Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
© 2010 The Authors. Pathology International © 2010 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.
(PMID = 21091834.001).
[ISSN]
1440-1827
[Journal-full-title]
Pathology international
[ISO-abbreviation]
Pathol. Int.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Australia
53.
Semba S, Iwaya K, Matsubayashi J, Serizawa H, Kataba H, Hirano T, Kato H, Matsuoka T, Mukai K:
Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung.
Clin Cancer Res
; 2006 Apr 15;12(8):2449-54
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in
adenocarcinoma
of the
lung
.
PURPOSE: Highly invasive and metastatic
cancer
cells, such as
adenocarcinoma
of the
lung
cells, form irregular protrusions by assembling a branched network of actin filaments.
In mammalian cells, the actin-related protein 2 and 3 (Arp2/3)
complex
initiates actin assembly to form lamellipodial protrusions by binding to Wiskott-Aldrich syndrome (WASP)/WASP family verproline-homologous protein 2 (WAVE2).
In this study, colocalization of Arp2 and WAVE2 in
adenocarcinoma
of the
lung
was investigated to elucidate its prognostic value.
EXPERIMENTAL DESIGN: Immunohistochemical staining of Arp2 and WAVE2 was done on mirror sections of 115
adenocarcinomas of the lung
from pathologic stage IA to IIIA classes.
Kaplan-Meier
disease
-free survival and overall survival curves were analyzed to determine the prognostic significance of the coexpression of Arp2 and WAVE2.
RESULTS: Immunoreactivity for both Arp2 and WAVE2 was detected in the same
cancer
cells in 78 (67.8%) of the 115
lung cancer
specimens.
The proportion
of cancer
cells expressing both Arp2 and WAVE2 was significantly higher in cases with lymph-node metastasis (P = 0.0046), and significantly lower in
bronchioloalveolar carcinomas
(P < 0.0001).
The patients whose
cancer
cells coexpressed them had a shorter
disease
-free survival time (P < 0.0001) and overall survival time (P < 0.0001).
CONCLUSIONS: Coexpression of Arp2 and WAVE2 is correlated with poorer patient outcome, and may be involved in the mechanism
of cancer
metastasis.
[MeSH-major]
Actin-Related Protein 2 / biosynthesis.
Adenocarcinoma
/ pathology.
Lung
Neoplasms / pathology. Wiskott-Aldrich Syndrome Protein Family / biosynthesis
[MeSH-minor]
Aged.
Disease
-Free Survival. Female. Humans. Immunohistochemistry. Male. Multivariate Analysis. Neoplasm Staging. Prognosis. Survival Analysis
Genetic Alliance.
consumer health - Wiskott Aldrich syndrome
.
Genetic Alliance.
consumer health - WISKOTT-ALDRICH SYNDROME 2
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16638851.001).
[ISSN]
1078-0432
[Journal-full-title]
Clinical cancer research : an official journal of the American Association for Cancer Research
[ISO-abbreviation]
Clin. Cancer Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / ACTR2 protein, human; 0 / Actin-Related Protein 2; 0 / WASF2 protein, human; 0 / Wiskott-Aldrich Syndrome Protein Family
54.
Chen L, Li M, Li Q, Yang X, An X, Chen Y:
Characterization of the bovine immunoglobulin lambda light chain constant IGLC genes.
Vet Immunol Immunopathol
; 2008 Aug 15;124(3-4):284-94
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
To characterize the bovine immunoglobulin lambda light chain constant region (IGLC) genes, we have isolated
a bacterial
artificial chromosome (
BAC
) clone by a PCR based approach from a bovine genomic DNA library, constructed using a genital ridge
cell
line derived from a male Holstein fetus.
The positive
BAC
clone, containing the bovine IGLC genes, was fully sequenced and had a 138 kb insert.
This conclusion was further confirmed by a series
of RT
-PCR amplifications, which also showed that among these four genes the IGLC3 was preferentially expressed in cattle.
[MeSH-minor]
Amino Acid Sequence. Animals. Base Sequence. Chromosomes, Artificial,
Bacterial
. Cloning, Molecular. DNA / chemistry. DNA / genetics. Gene Library. Immunoglobulin Joining Region / genetics. Immunoglobulin Joining Region / immunology. Male. Molecular Sequence Data. Phylogeny. Polymerase Chain Reaction / veterinary. Sequence Alignment
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18538861.001).
[ISSN]
0165-2427
[Journal-full-title]
Veterinary immunology and immunopathology
[ISO-abbreviation]
Vet. Immunol. Immunopathol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / Immunoglobulin Constant Regions; 0 / Immunoglobulin Joining Region; 0 / Immunoglobulin Light Chains; 0 / Immunoglobulin lambda-Chains; 9007-49-2 / DNA
55.
Emond MR, Jontes JD:
Inhibition of protocadherin-alpha function results in neuronal death in the developing zebrafish.
Dev Biol
; 2008 Sep 1;321(1):175-87
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The pcdhalpha/CNR gene comprises a diverse array of neuronal
cell
-surface proteins of the cadherin superfamily, although very little is known about their role in neural development.
Using whole-mount immunocytochemistry and
BAC
-based expression of Pcdh1alpha-GFP fusion proteins, we find that Pcdh1alpha does not appear to form stable, synaptic puncta at early stages of synaptogenesis.
This
cell
death phenotype can be attenuated by the expression
of a
soluble Pcdh1alpha cytoplasmic domain.
[MeSH-minor]
Animals.
Cell
Death. Central Nervous System / cytology. Central Nervous System / embryology. Embryo, Nonmammalian / metabolism. Protein Structure, Tertiary
COS Scholar Universe.
author profiles
.
SciCrunch.
ZFIN: Data: Gene Expression
.
ZFIN.
ZFIN
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18602383.001).
[ISSN]
1095-564X
[Journal-full-title]
Developmental biology
[ISO-abbreviation]
Dev. Biol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Cadherins
56.
Williams LE, Detter C, Barry K, Lapidus A, Summers AO:
Facile recovery of individual high-molecular-weight, low-copy-number natural plasmids for genomic sequencing.
Appl Environ Microbiol
; 2006 Jul;72(7):4899-906
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Sequencing of the large (>50 kb), low-copy-number (<5 per
cell
) plasmids that mediate horizontal gene transfer has been hindered by the difficulty and expense of isolating DNA from individual plasmids of this class.
We report here that a kit method previously devised for purification
of bacterial
artificial chromosomes (
BACs
) can be adapted for effective preparation of individual plasmids up to 220 kb from wild gram-negative and gram-positive bacteria.
Adaptation of this
BAC
method for large plasmid isolation removes one major technical hurdle to expanding our knowledge of the natural plasmid gene pool.
[MeSH-major]
DNA,
Bacterial
/ isolation & purification. Genetic Techniques. Genome,
Bacterial
/ genetics. Plasmids / isolation & purification. Sequence Analysis, DNA
[MeSH-minor]
Chromosomes, Artificial,
Bacterial
/ genetics. Corynebacterium / genetics. Escherichia coli / genetics. Magnetics. Microspheres. Molecular Sequence Data. Staphylococcus / genetics
COS Scholar Universe.
author profiles
.
REBASE - The Restriction Enzyme Database.
gene/protein/disease-specific - REBASE ref# 9912
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Gene. 1977;2(2):95-113
[
344137.001
]
[Cites]
Proc Natl Acad Sci U S A. 1967 May;57(5):1514-21
[
5231757.001
]
[Cites]
J Bacteriol. 1979 Oct;140(1):167-81
[
387721.001
]
[Cites]
Proc Natl Acad Sci U S A. 1981 Jul;78(7):4041-5
[
6270656.001
]
[Cites]
Microbiol Rev. 1988 Dec;52(4):433-51
[
3070319.001
]
[Cites]
Plasmid. 1988 Sep;20(2):155-7
[
2853395.001
]
[Cites]
J Mol Biol. 1990 Oct 5;215(3):403-10
[
2231712.001
]
[Cites]
Antimicrob Agents Chemother. 1993 Apr;37(4):825-34
[
8280208.001
]
[Cites]
Antimicrob Agents Chemother. 1993 Jun;37(6):1297-304
[
8392309.001
]
[Cites]
J Mol Biol. 1994 Jun 24;239(5):623-63
[
8014987.001
]
[Cites]
Nucleic Acids Res. 1994 Oct 25;22(21):4543-4
[
7971285.001
]
[Cites]
Gene. 1995 Aug 30;162(1):157-8
[
7557406.001
]
[Cites]
J Mol Biol. 1997 Aug 8;271(1):13-30
[
9300052.001
]
[Cites]
Nucleic Acids Res. 1997 Oct 1;25(19):3959-61
[
9380525.001
]
[Cites]
Appl Environ Microbiol. 1997 Nov;63(11):4494-503
[
9361435.001
]
[Cites]
Genome Res. 1998 Mar;8(3):175-85
[
9521921.001
]
[Cites]
Microbiol Mol Biol Rev. 1999 Sep;63(3):507-22
[
10477306.001
]
[Cites]
Nat Rev Microbiol. 2005 Sep;3(9):679-87
[
16138096.001
]
[Cites]
Nat Rev Microbiol. 2005 Sep;3(9):722-32
[
16138100.001
]
[Cites]
J Antimicrob Chemother. 2006 Jan;57(1):31-8
[
16339607.001
]
[Cites]
Nature. 2000 May 18;405(6784):299-304
[
10830951.001
]
[Cites]
Biotechniques. 2000 Oct;29(4):786-8, 790, 792
[
11056809.001
]
[Cites]
Genome Res. 2001 Jul;11(7):1269-74
[
11435410.001
]
[Cites]
Plasmid. 2002 Sep;48(2):117-29
[
12383729.001
]
[Cites]
Environ Sci Technol. 2003 Apr 15;37(8):1509-14
[
12731831.001
]
[Cites]
Antimicrob Agents Chemother. 2003 Nov;47(11):3519-24
[
14576111.001
]
[Cites]
Annu Rev Genet. 2003;37:283-328
[
14616063.001
]
[Cites]
Genome Biol. 2004;5(2):R12
[
14759262.001
]
[Cites]
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7118-22
[
15107498.001
]
[Cites]
Plasmid. 1978 Sep;1(4):584-8
[
107540.001
]
(PMID = 16820486.001).
[ISSN]
0099-2240
[Journal-full-title]
Applied and environmental microbiology
[ISO-abbreviation]
Appl. Environ. Microbiol.
[Language]
eng
[Databank-accession-numbers]
GENBANK/ DQ364638/ DQ390454/ DQ390455/ DQ390456/ DQ390457/ DQ390458
[Publication-type]
Evaluation Studies; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
[Publication-country]
United States
[Chemical-registry-number]
0 / DNA, Bacterial
[Other-IDs]
NLM/ PMC1489313
57.
Ingvardsen CR, Xing Y, Frei UK, Lübberstedt T:
Genetic and physical fine mapping of Scmv2, a potyvirus resistance gene in maize.
Theor Appl Genet
; 2010 May;120(8):1621-34
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
We fine mapped Scmv2 to a region of 0.28 cM, covering a physical distance of 1.3426 Mb, and developed six new polymorphic SSR markers based on publicly available
BAC
sequences within this region.
Analysis of the public B73
BAC
library as well as the syntenic rice region did not reveal any similarity to known resistance genes.
[MeSH-minor]
Chromosomes, Artificial,
Bacterial
. Chromosomes, Plant / genetics. DNA, Plant / metabolism. Expressed Sequence Tags. Genes, Plant. Genetic Markers. Models, Genetic. Mosaic Viruses / genetics. Oryza / genetics. Physical Chromosome Mapping. Plant Diseases / genetics. Polymorphism, Genetic
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Mol Genet Genomics. 2005 Jul;273(6):450-61
[
15891912.001
]
[Cites]
Mol Plant Microbe Interact. 2000 Oct;13(10):1130-8
[
11043474.001
]
[Cites]
Trends Plant Sci. 2005 Aug;10(8):376-82
[
16023398.001
]
[Cites]
Plant J. 2006 Nov;48(3):452-62
[
17026540.001
]
[Cites]
Curr Opin Plant Biol. 2004 Dec;7(6):732-6
[
15491923.001
]
[Cites]
Plant Physiol. 2001 Dec;127(4):1667-75
[
11743111.001
]
[Cites]
Arch Virol. 1989;106(3-4):171-200
[
2673154.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11856-61
[
16880399.001
]
[Cites]
Theor Appl Genet. 2004 Dec;110(1):48-57
[
15551042.001
]
[Cites]
Plant Physiol. 2004 Apr;134(4):1317-26
[
15020742.001
]
[Cites]
Theor Appl Genet. 2003 Feb;106(3):485-93
[
12589549.001
]
[Cites]
Plant Cell. 1999 May;11(5):781-92
[
10330465.001
]
[Cites]
Genetics. 2004 Jan;166(1):493-503
[
15020438.001
]
[Cites]
Theor Appl Genet. 2004 Aug;109(3):488-94
[
15067509.001
]
[Cites]
Plant Cell. 1995 May;7(5):549-59
[
7780307.001
]
[Cites]
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6157-62
[
11959909.001
]
[Cites]
Protoplasma. 2008 Dec;234(1-4):51-64
[
18810574.001
]
[Cites]
Theor Appl Genet. 2007 Jul;115(2):159-68
[
17479240.001
]
[Cites]
Theor Appl Genet. 2003 May;106(7):1171-7
[
12748766.001
]
[Cites]
Nature. 2002 Nov 21;420(6913):316-20
[
12447439.001
]
[Cites]
Plant Physiol. 2002 Sep;130(1):138-46
[
12226494.001
]
[Cites]
Mol Gen Genet. 1999 Apr;261(3):574-81
[
10323240.001
]
[Cites]
Plant J. 2000 Jan;21(1):73-81
[
10652152.001
]
[Cites]
Phytopathology. 1999 Aug;89(8):660-7
[
18944678.001
]
[Cites]
Theor Appl Genet. 2002 Dec;105(8):1190-1195
[
12582898.001
]
[Cites]
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):489-94
[
10618445.001
]
[Cites]
Plant J. 2006 Aug;47(3):417-26
[
16774645.001
]
[Cites]
J Virol. 2004 Jun;78(12):6102-11
[
15163703.001
]
[Cites]
Plant J. 2002 Dec;32(5):655-67
[
12472683.001
]
[Cites]
Virology. 1995 Feb 1;206(2):1007-16
[
7856075.001
]
[Cites]
Genome Res. 2001 Oct;11(10):1660-76
[
11591643.001
]
[Cites]
Theor Appl Genet. 2006 Feb;112(4):618-26
[
16402192.001
]
[Cites]
Plant Cell. 2000 Apr;12(4):569-82
[
10760245.001
]
[Cites]
Trends Plant Sci. 2004 Jan;9(1):33-41
[
14729217.001
]
[Cites]
Theor Appl Genet. 2002 Aug;105(2-3):355-363
[
12582538.001
]
[Cites]
Plant Mol Biol. 2003 Jul;52(5):1037-49
[
14558663.001
]
[Cites]
Nature. 2005 Aug 11;436(7052):793-800
[
16100779.001
]
[Cites]
Mol Plant Microbe Interact. 2002 Jul;15(7):717-27
[
12118888.001
]
[Cites]
Theor Appl Genet. 2004 Jul;109(2):305-16
[
14968304.001
]
[Cites]
Plant J. 1998 May;14(4):393-400
[
9670556.001
]
[Cites]
Genome Res. 2005 Sep;15(9):1284-91
[
16109971.001
]
[Cites]
Virology. 2006 Jan 5;344(1):169-84
[
16364748.001
]
[Cites]
New Phytol. 2005 Oct;168(1):51-60
[
16159320.001
]
[Cites]
Plant Cell. 2000 May;12(5):663-76
[
10810142.001
]
[Cites]
Plant J. 2005 May;42(3):392-405
[
15842624.001
]
[Cites]
Theor Appl Genet. 1995 Mar;90(3-4):341-6
[
24173923.001
]
[Cites]
Cell. 1999 Jun 11;97(6):743-54
[
10380926.001
]
[Cites]
J Virol. 1997 Nov;71(11):8624-31
[
9343220.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11844-9
[
17615239.001
]
[Cites]
Curr Opin Plant Biol. 2006 Apr;9(2):164-71
[
16458573.001
]
[Cites]
Genome. 2006 Oct;49(10):1274-82
[
17213909.001
]
[Cites]
Theor Appl Genet. 2005 Jul;111(2):347-59
[
15912344.001
]
[Cites]
Trends Cell Biol. 2006 Oct;16(10 ):530-7
[
16938456.001
]
[Cites]
Phytopathology. 2000 May;90(5):505-13
[
18944557.001
]
[Cites]
Phytopathology. 2006 Feb;96(2):120-9
[
18943914.001
]
[Cites]
Nat Rev Microbiol. 2005 Oct;3(10):789-98
[
16132037.001
]
[Cites]
J Hered. 2002 Jan-Feb;93(1):77-8
[
12011185.001
]
[Cites]
Plant J. 2005 Jun;42(6):912-22
[
15941403.001
]
[Cites]
Curr Biol. 2002 Jun 25;12(12):1046-51
[
12123581.001
]
[Cites]
Theor Appl Genet. 2003 Feb;106(3):411-22
[
12589540.001
]
[Cites]
Theor Appl Genet. 2007 Aug;115(4):501-8
[
17581735.001
]
[Cites]
Plant Cell. 2005 Feb;17(2):343-60
[
15659640.001
]
[Cites]
Theor Appl Genet. 2003 Mar;106(5):840-5
[
12647058.001
]
[Cites]
Trends Plant Sci. 2003 Nov;8(11):554-60
[
14607101.001
]
[Cites]
Plant Physiol. 2003 Jul;132(3):1272-82
[
12857809.001
]
[Cites]
Cell. 1994 Sep 23;78(6):1101-15
[
7923359.001
]
(PMID = 20155410.001).
[ISSN]
1432-2242
[Journal-full-title]
TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
[ISO-abbreviation]
Theor. Appl. Genet.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Germany
[Chemical-registry-number]
0 / DNA, Plant; 0 / Genetic Markers
58.
Pedrosa-Harand A, Kami J, Gepts P, Geffroy V, Schweizer D:
Cytogenetic mapping of common bean chromosomes reveals a less compartmentalized small-genome plant species.
Chromosome Res
; 2009;17(3):405-17
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Cytogenetic maps of common bean chromosomes 3, 4 and 7 were constructed by fluorescence in-situ hybridization (FISH)
of BAC
and a few other genomic clones.
Although all clones were selected with genetically mapped markers, mostly with single-copy RFLPs, a large subset
of BACs
, from 13 different genomic regions, contained repetitive sequences, as concluded from the regional distribution patterns of multiple FISH signals on chromosomes: pericentromeric, subtelomeric and dispersed.
Pericentromeric repeats were present in all 11 chromosome pairs with different intensities, whereas subtelomeric repeats were present in several chromosome ends, but with different signal intensities depending on
the BAC
, suggesting that
the terminal
heterochromatin fraction of this species may be composed of different repeats.
[MeSH-minor]
Chromosome Mapping. Chromosomes, Artificial,
Bacterial
. In Situ Hybridization, Fluorescence. Recombination, Genetic
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Genetics. 2008 Nov;180(3):1319-28
[
18791231.001
]
[Cites]
Genetics. 1996 Dec;144(4):1883-91
[
8978071.001
]
[Cites]
Genetics. 2009 Feb;181(2):405-19
[
19087965.001
]
[Cites]
Plant J. 2006 Sep;47(6):977-86
[
16911585.001
]
[Cites]
Science. 1995 Oct 20;270(5235):480-3
[
7570002.001
]
[Cites]
J Cell Sci. 2001 Dec;114(Pt 23):4207-17
[
11739653.001
]
[Cites]
Genome. 1997 Feb;40(1):138-42
[
18464813.001
]
[Cites]
Theor Appl Genet. 2003 Jan;106(2):251-61
[
12582850.001
]
[Cites]
Plant J. 2001 Jul;27(1):49-58
[
11489182.001
]
[Cites]
Genetics. 2005 Feb;169(2):955-65
[
15489513.001
]
[Cites]
Genetics. 2006 Apr;172(4):2529-40
[
16489216.001
]
[Cites]
Genetics. 1995 Oct;141(2):683-708
[
8647403.001
]
[Cites]
Plant J. 1998 Mar;13(6):867-76
[
9681023.001
]
[Cites]
Nature. 2005 Aug 11;436(7052):793-800
[
16100779.001
]
[Cites]
Genetics. 2000 Jan;154(1):397-412
[
10628998.001
]
[Cites]
Genome. 1999 Dec;42(6):1224-33
[
10659791.001
]
[Cites]
Theor Appl Genet. 2003 Jan;106(2):205-12
[
12582845.001
]
[Cites]
Theor Appl Genet. 2006 Apr;112(6):987-98
[
16404584.001
]
[Cites]
Genetics. 2001 Apr;157(4):1749-57
[
11290728.001
]
[Cites]
Chromosoma. 2001 Jul;110(3):203-13
[
11513295.001
]
[Cites]
Theor Appl Genet. 2006 Mar;112(5):924-33
[
16397788.001
]
[Cites]
Ann Bot. 2005 Jan;95(1):219-27
[
15596469.001
]
[Cites]
Genetics. 1992 Jul;131(3):733-40
[
1352759.001
]
[Cites]
Genome Res. 2001 Dec;11(12):2133-41
[
11731505.001
]
[Cites]
Plant Physiol. 2005 Apr;137(4):1228-35
[
15824285.001
]
[Cites]
Theor Appl Genet. 2007 Sep;115(5):675-82
[
17632699.001
]
[Cites]
Theor Appl Genet. 2008 Feb;116(3):407-15
[
18060540.001
]
[Cites]
Nature. 2000 Dec 14;408(6814):796-815
[
11130711.001
]
[Cites]
DNA Res. 2008 Aug;15(4):227-39
[
18511435.001
]
[Cites]
Chromosoma. 2004 Mar;112(6):288-99
[
14986017.001
]
[Cites]
Genetics. 2008 Nov;180(3):1307-17
[
18791232.001
]
[Cites]
Trends Genet. 1992 Nov;8(11):372-3
[
1440872.001
]
[Cites]
Genetics. 2005 Dec;171(4):1963-76
[
16143604.001
]
[Cites]
Cell. 2000 Feb 4;100(3):367-76
[
10676818.001
]
[Cites]
Genetics. 2002 Aug;161(4):1661-72
[
12196409.001
]
(PMID = 19330455.001).
[ISSN]
1573-6849
[Journal-full-title]
Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology
[ISO-abbreviation]
Chromosome Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Netherlands
59.
Liu D, Kojima T, Ouchi M, Kuroda S, Watanabe Y, Hashimoto Y, Onimatsu H, Urata Y, Fujiwara T:
Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer.
Mol Cancer Ther
; 2009 Apr;8(4):980-7
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human
lung cancer
.
The present preclinical study investigates whether OBP-301 and a chemotherapeutic agent that is commonly used for
lung cancer
treatment, gemcitabine, are able to enhance antitumor effects in vitro and in vivo.
In vivo antitumor effects of intratumoral injection of OBP-301 in combination with systemic administration of gemcitabine were assessed on nu/nu mice s.c. xenografted with human
lung
tumors.
OBP-301 infection combined with gemcitabine resulted in very potent synergistic cytotoxicity in human
lung cancer
cells.
The three human
lung cancer cell
lines treated with OBP-301 for 24 hours tended to accumulate in S phase compared with controls.
Intratumoral injection of OBP-301 combined with systemic administration of gemcitabine showed therapeutic synergism in human
lung
tumor xenografts.
Our data suggest that the combination of OBP-301 and gemcitabine enhances the antitumor effects against human
lung cancer
.
We also found that the synergistic mechanism may be due to OBP-301-mediated
cell
cycle accumulation in S phase.
These results have important implications for the treatment of human
lung cancer
.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ therapy. Antimetabolites, Antineoplastic / therapeutic use.
Carcinoma
, Large
Cell
/ therapy. Deoxycytidine / analogs & derivatives.
Lung
Neoplasms / therapy. Oncolytic Virotherapy. Telomerase / metabolism
[MeSH-minor]
Adenovirus E1A Proteins / metabolism. Animals. Blotting, Western.
Cell
Proliferation / drug effects. Combined Modality Therapy. Drug Evaluation, Preclinical. Female. Humans. Immunoenzyme Techniques. Mice. Mice, Inbred BALB C. Mice, Nude. Ribonucleotide Reductases / antagonists & inhibitors. S Phase / drug effects. S Phase / physiology. Signal Transduction. Tumor Cells, Cultured. Virus Replication / drug effects. Xenograft Model Antitumor Assays
Genetic Alliance.
consumer health - Lung Cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19372571.001).
[ISSN]
1535-7163
[Journal-full-title]
Molecular cancer therapeutics
[ISO-abbreviation]
Mol. Cancer Ther.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Adenovirus E1A Proteins; 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine; EC 1.17.4.- / Ribonucleotide Reductases; EC 2.7.7.49 / Telomerase
60.
Kaplan S, Prato CG:
Impact of BAC limit reduction on different population segments: a Poisson fixed effect analysis.
Accid Anal Prev
; 2007 Nov;39(6):1146-54
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Impact
of BAC
limit reduction on different population segments: a Poisson fixed effect analysis.
Over the past few decades, several countries enacted the reduction of the legal blood alcohol concentration (
BAC
) limit, often alongside the administrative license revocation or suspension, to battle drinking-and-driving behavior.
The present analysis focuses on the evaluation of the impact
of BAC
limit reduction on different population segments.
Model estimates demonstrate that, for alcohol-related single-vehicle crashes, (i)
BAC
laws are more effective in terms of reduction of number of casualties rather than number of accidents, (ii) women and elderly population exhibit higher law compliance with respect to men and to young adult and adult population, respectively, and (iii) the presence of passengers in the vehicle enhances the sense of responsibility of the driver.
MedlinePlus Health Information.
consumer health - Alcohol
.
International Agency for Research on Cancer - Screening Group.
diagnostics - Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers
.
Hazardous Substances Data Bank.
ETHANOL
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17920837.001).
[ISSN]
0001-4575
[Journal-full-title]
Accident; analysis and prevention
[ISO-abbreviation]
Accid Anal Prev
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
3K9958V90M / Ethanol
61.
Barnett NP, Wei J, Czachowski C:
Measured alcohol content in college party mixed drinks.
Psychol Addict Behav
; 2009 Mar;23(1):152-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Standard drink equivalents were calculated and blood alcohol concentrations (
BACs
) for men and women were estimated.
Estimated
BACs
varied widely depending on drink alcohol concentration, but in most cases a heavy drinking episode for both men and women resulted in an estimated
BAC
at or above .08.
MedlinePlus Health Information.
consumer health - Alcohol
.
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
ETHANOL
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19290700.001).
[ISSN]
0893-164X
[Journal-full-title]
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
[ISO-abbreviation]
Psychol Addict Behav
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
3K9958V90M / Ethanol
62.
Makushkin EO, Korsunov VM, Pavlova II:
[The biomass of microbial communities in different types of alluvial soils in the upper reach of the Selenga River estuary].
Izv Akad Nauk Ser Biol
; 2009 Jan-Feb;(1):100-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The bacterial complex
predominated at the beginning of July; actinomycete and spore-fungal
complexes
, at the end of August; and spore-fungal and actinomycete
complexes
, at the beginning of October.
MedlinePlus Health Information.
consumer health - Molds
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19239119.001).
[ISSN]
1026-3470
[Journal-full-title]
Izvestiia Akademii nauk. Seriia biologicheskaia
[ISO-abbreviation]
Izv. Akad. Nauk. Ser. Biol.
[Language]
RUS
[Publication-type]
English Abstract; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Russia (Federation)
63.
Kowalski W, Mierzwa T, Grabiec M, Laskowski R, Walentowicz M:
[Problems in diagnosing breast cancer in women younger than 25 years old].
Ginekol Pol
; 2006 May;77(5):376-82
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Problems in diagnosing breast
cancer
in women younger than 25 years old].
OBJECTIVES: There are several challenges in
the diagnosis
of breast
cancer
in young women.
Special consideration must be given to the woman's fertility and body image issues, but the difficulty in distinguishing benign from
malignant
lesions in this group of patients still exists.
The aim of our study was to show five cases of breast
cancer
in young women.
MATERIALS AND METHODS: Based on 5 cases of breast
cancer
in women younger than 25, several methods used in
diagnosis
in this group of patients were discussed.
The role of USG and
BAC
was analyzed.
RESULTS: Diagnosing and treatment of young patients with breast
cancer
should be performed in specialized oncological centers experienced in dealing with breast
cancer
in very young women.
Because of the possibility of breast
cancer
in women under 25 years old, each case of breast tumor should be precisely diagnosed, especially by ultrasonography and biopsy (
BAC
) 2.
Each case suspected of breast
cancer
in young women should be diagnosed in highly equipped and specialized medical center.
[MeSH-major]
Breast Neoplasms /
diagnosis
[MeSH-minor]
Adult. Age Factors. Combined Modality Therapy.
Diagnosis
, Differential. Female. Humans. Mammography / methods
Genetic Alliance.
consumer health - Breast Cancer
.
MedlinePlus Health Information.
consumer health - Breast Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16958227.001).
[ISSN]
0017-0011
[Journal-full-title]
Ginekologia polska
[ISO-abbreviation]
Ginekol. Pol.
[Language]
pol
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Poland
64.
Rösch C, Eilmus S, Bothe H:
Approaches to assess the biodiversity of bacteria in natural habitats.
Biochem Soc Trans
; 2006 Feb;34(Pt 1):169-73
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Any attempt to characterize
a bacterial
community and their functional genes coding for enzymes of the nitrogen cycle is faced with its extreme biodiversity.
Computer-based assignment tools have now been developed utilizing
terminal
restriction fragments obtained from digestions with multiple restriction enzymes.
Such programs allow the gross characterization
of bacterial
life in any
complex bacterial
community with confidence.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16417513.001).
[ISSN]
0300-5127
[Journal-full-title]
Biochemical Society transactions
[ISO-abbreviation]
Biochem. Soc. Trans.
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
England
[Chemical-registry-number]
0 / RNA, Ribosomal, 16S
[Number-of-references]
37
65.
McCartt AT, Blackman K, Voas RB:
Implementation of Washington State's zero tolerance law: patterns of arrests, dispositions, and recidivism.
Traffic Inj Prev
; 2007 Dec;8(4):339-45
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The present study examined effects of the ZT law on arrests and case dispositions among underage offenders as a function of blood alcohol concentration (
BAC
) and post-law patterns of recidivism.
RESULTS: There was a substantial increase in arrests of underage drivers beginning immediately after implementation of the ZT law, especially among drivers with low
BACs
.
Underage offenders with lower
BACs
became far more likely to receive alcohol-related convictions and/or license suspensions.
However, the percentage of underage offenders with higher
BACs
receiving DUI convictions declined as some of these offenders received the lesser ZT disposition.
After the ZT law, underage offenders with
BACs of
0.10 g/dL or higher were more likely to recidivate than those with lower
BACs
, but appreciable proportions of drivers were re-arrested for another alcohol offense, whatever
the BAC
and however they were penalized.
However, recidivism remains an issue as more than one in four underage drivers arrested with low
BACs
subsequently were re-arrested.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17994486.001).
[ISSN]
1538-9588
[Journal-full-title]
Traffic injury prevention
[ISO-abbreviation]
Traffic Inj Prev
[Language]
eng
[Publication-type]
Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
66.
Kim YK, Kwon JT, Choi JY, Jiang HL, Arote R, Jere D, Je YH, Cho MH, Cho CS:
Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus.
Cancer Gene Ther
; 2010 Nov;17(11):751-60
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Suppression of tumor growth in xenograft model mice by programmed
cell
death 4 gene delivery using folate-PEG-baculovirus.
Cancer
gene therapy using tumor suppressor genes is considered to be an attractive approach for arresting
cell
growth and inducing apoptosis.
Programmed
cell
death 4 (Pdcd4) is a tumor suppressor gene, which prevents tumorigenesis and tumor progression.
Folate-PEG-baculovirus containing Pdcd4 gene (F-P-
Bac
-Pdcd4) was constructed by attachment of F-PEG to the baculovirus surface using chemical modification.
The F-P-
Bac
-Pdcd4 showed enhanced transduction efficiency, efficiently expressed PDCD4 protein, and induced apoptosis in human epidermal
carcinoma
(KB) cells as compared with an unmodified baculovirus.
In a tumor xenograft study, injection of F-P-
Bac
-Pdcd4 into tumors established from the KB
cell
line by subcutaneous implantation significantly suppressed tumor growth and induced apoptosis.
Thus, this study shows a new baculovirus-mediated tumor suppressor gene delivery system for
cancer
therapy.
[MeSH-major]
Apoptosis Regulatory Proteins / metabolism. Baculoviridae / genetics.
Carcinoma
/ therapy. Genes, Tumor Suppressor. RNA-Binding Proteins / metabolism. Transduction, Genetic
[MeSH-minor]
Animals.
Cell
Line, Tumor. Folic Acid / analogs & derivatives. Folic Acid / metabolism. Gene Expression Regulation, Neoplastic. Genetic Therapy. Humans. Male. Mice. Mice, Inbred BALB C. Mice, Nude. Polyethylene Glycols. Xenograft Model Antitumor Assays
Hazardous Substances Data Bank.
FOLIC ACID
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20539318.001).
[ISSN]
1476-5500
[Journal-full-title]
Cancer gene therapy
[ISO-abbreviation]
Cancer Gene Ther.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Apoptosis Regulatory Proteins; 0 / Pdcd4 protein, mouse; 0 / RNA-Binding Proteins; 0 / poly(ethylene glycol)-folate; 30IQX730WE / Polyethylene Glycols; 935E97BOY8 / Folic Acid
67.
Duruisseaux M, Cadranel J, Biron E, Pérol M, Guérin JC, Arpin D:
Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Lung Cancer
; 2009 Sep;65(3):385-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Major and prolonged response to pemetrexed in two cases
of lung
adenocarcinoma
with
bronchioloalveolar carcinoma
features.
Bronchioloalveolar carcinoma
(
BAC
) and
adenocarcinoma
mixed subtype with
bronchioloalveolar
features (ADC-WBF) represent a unique anatomo-clinical entity accounting for some 20% of non-small
cell lung
cancers (NSCLC).
After treatment arrest, the two patients experienced progressive
disease
but responded to retreatment with pemetrexed.
[MeSH-major]
Adenocarcinoma
/ drug therapy.
Adenocarcinoma
/ pathology.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ drug therapy. Antimetabolites, Antineoplastic / therapeutic use. Bone Neoplasms / drug therapy. Bone Neoplasms / secondary. Glutamates / therapeutic use. Guanine / analogs & derivatives.
Lung
Neoplasms / drug therapy.
Lung
Neoplasms / pathology
[MeSH-minor]
Aged. Cough.
Disease
Progression. Dyspnea. Folic Acid / administration & dosage. Humans. Male. Neoplasm Staging. Neutropenia. Pemetrexed. Remission Induction. Renal Insufficiency. Smoking. Tomography, X-Ray Computed. Vitamin B 12 / administration & dosage
MedlinePlus Health Information.
consumer health - Bone Cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
Hazardous Substances Data Bank.
PEMETREXED
.
Hazardous Substances Data Bank.
FOLIC ACID
.
Hazardous Substances Data Bank.
CYANOCOBALAMIN
.
Hazardous Substances Data Bank.
GUANINE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19346028.001).
[ISSN]
1872-8332
[Journal-full-title]
Lung cancer (Amsterdam, Netherlands)
[ISO-abbreviation]
Lung Cancer
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Ireland
[Chemical-registry-number]
0 / Antimetabolites, Antineoplastic; 0 / Glutamates; 04Q9AIZ7NO / Pemetrexed; 5Z93L87A1R / Guanine; 935E97BOY8 / Folic Acid; P6YC3EG204 / Vitamin B 12
68.
Juárez P, Walters ST, Daugherty M, Radi C:
A randomized trial of motivational interviewing and feedback with heavy drinking college students.
J Drug Educ
; 2006;36(3):233-46
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
At an eight-week follow-up, all groups reduced their consumption, peak
BAC
, consequences, and dependence symptoms.
MedlinePlus Health Information.
consumer health - Alcohol
.
MedlinePlus Health Information.
consumer health - College Health
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17345916.001).
[ISSN]
0047-2379
[Journal-full-title]
Journal of drug education
[ISO-abbreviation]
J Drug Educ
[Language]
eng
[Grant]
United States / NIAAA NIH HHS / AA / T32-AA07465
[Publication-type]
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
[Publication-country]
United States
69.
Safár J, Simková H, Kubaláková M, Cíhalíková J, Suchánková P, Bartos J, Dolezel J:
Development of chromosome-specific BAC resources for genomics of bread wheat.
Cytogenet Genome Res
; 2010 Jul;129(1-3):211-23
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Development of chromosome-specific
BAC
resources for genomics of bread wheat.
Its complexity can, however, be reduced by using flow cytometry to isolate individual chromosomes, and these can be exploited to construct chromosome-specific
BAC
libraries.
Each chromosome (arm)-specific library is composed
of a
manageable number of clones, and so represents a practical tool in the area of wheat genomics.
[MeSH-major]
Chromosomes, Artificial,
Bacterial
/ genetics. Chromosomes, Plant / genetics. Triticum / genetics
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2010 S. Karger AG, Basel.
(PMID = 20501977.001).
[ISSN]
1424-859X
[Journal-full-title]
Cytogenetic and genome research
[ISO-abbreviation]
Cytogenet. Genome Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Switzerland
[Chemical-registry-number]
0 / DNA, Plant; 0 / Genetic Markers
70.
Tokiwa H, Sera N, Nakanishi Y:
Involvement of alveolar macrophages in the formation of 8-oxodeoxyguanosine associated with exogenous particles in human lungs.
Inhal Toxicol
; 2005 Oct;17(11):577-85
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Involvement of
alveolar
macrophages in the formation of 8-oxodeoxyguanosine associated with exogenous particles in human lungs.
Lung
specimens were collected from 161 non-smoking male patients with
carcinoma
to determine the deposition of carbon particles and oxidative damage in
lung
tissues.
Morphologically, carbon particles deposited in human lungs with
carcinoma
were similar to those of diesel exhaust like particles, and mass of particles showed a significant increase with the increasing age of the patients.
An increasing age of patient with
carcinomas
was also associated with 8-oxodeoxy-guanosine (8-oxo-dG) formation, which was analyzed using the HPLC-electrochemical detector method.
To determine whether particles in
lung
tissues were associated with 8-oxo-dG formation, carbon particles deposited in
lung
tissues were partially purified by cycling of alkali fusion with 1 M KOH; mutagenic chemicals in particles were extracted and excluded by removal with an equal volume of benzene/methanol and dichloromethane.
These results were also demonstrated by the occurrence of
alveolar
macrophages and neutrophils after intratracheal instillation of particles.
These observations suggest that small particles from
lung cancer
patients further promote oxidative damage when used to treat the mouse
lung
.
[MeSH-major]
Carbon / administration & dosage. Deoxyguanosine / analogs & derivatives.
Lung
/ metabolism. Macrophages,
Alveolar
/ metabolism
[MeSH-minor]
Adenocarcinoma
/ metabolism. Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Animals.
Cell
Line. Child. Dose-Response Relationship, Drug. Female. Humans.
Lung
Neoplasms / metabolism. Male. Mice. Mice, Inbred BALB C. Mice, Inbred ICR. Microscopy, Electron, Scanning. Middle Aged. Monocytes / drug effects. Monocytes / metabolism. Particle Size. Pyrenes / chemistry. Pyrenes / metabolism
COS Scholar Universe.
author profiles
.
Hazardous Substances Data Bank.
1-NITROPYRENE
.
Hazardous Substances Data Bank.
CARBON
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16033753.001).
[ISSN]
0895-8378
[Journal-full-title]
Inhalation toxicology
[ISO-abbreviation]
Inhal Toxicol
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Pyrenes; 5522-43-0 / 1-nitropyrene; 7440-44-0 / Carbon; 88847-89-6 / 8-oxo-7-hydrodeoxyguanosine; G9481N71RO / Deoxyguanosine
71.
Ahsan B, Kobayashi D, Yamada T, Kasahara M, Sasaki S, Saito TL, Nagayasu Y, Doi K, Nakatani Y, Qu W, Jindo T, Shimada A, Naruse K, Toyoda A, Kuroki Y, Fujiyama A, Sasaki T, Shimizu A, Asakawa S, Shimizu N, Hashimoto S, Yang J, Lee Y, Matsushima K, Sugano S, Sakaizumi M, Narita T, Ohishi K, Haga S, Ohta F, Nomoto H, Nogata K, Morishita T, Endo T, Shin-I T, Takeda H, Kohara Y, Morishita S:
UTGB/medaka: genomic resource database for medaka biology.
Nucleic Acids Res
; 2008 Jan;36(Database issue):D747-52
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
This database provides basic genomic information, such as predicted genes, expressed sequence tags (ESTs), guanine/cytosine (GC) content, repeats and comparative genomics, as well as unique data resources including (i) 2473 genetic markers and experimentally confirmed PCR primers that amplify these markers, (ii) 142,414
bacterial
artificial chromosome (
BAC
) and 217,344 fosmid end sequences that amount to 15.0- and 11.1-fold clone coverage of the entire genome, respectively, and were used for draft genome assembly, (iii) 16,519,460 single nucleotide polymorphisms (SNPs), and 2 859 905 insertions/deletions detected between two medaka inbred strain genomes and (iv) 841 235 5'-end serial analyses of gene-expression (SAGE) tags that identified 344 266 transcription start sites on the genome.
[MeSH-minor]
Animals. Chromosomes, Artificial,
Bacterial
. Gene Expression. Genetic Markers. Genetic Variation. Internet. Plasmids / genetics. Polymorphism, Single Nucleotide. Transcription Initiation Site. User-Computer Interface
National BioResource Project.
culture/stock collections - NBRP resources
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Cytometry. 2000 Feb 1;39(2):91-5
[
10679726.001
]
[Cites]
Nat Rev Genet. 2002 Jan;3(1):53-64
[
11823791.001
]
[Cites]
Nature. 2002 May 30;417(6888):559-63
[
12037570.001
]
[Cites]
Mech Dev. 2004 Jul;121(7-8):619-28
[
15210171.001
]
[Cites]
Mech Dev. 2004 Jul;121(7-8):647-58
[
15210174.001
]
[Cites]
Nature. 2007 Jun 7;447(7145):714-9
[
17554307.001
]
[Cites]
J Mol Biol. 1997 Apr 25;268(1):78-94
[
9149143.001
]
[Cites]
Sci Total Environ. 1999 Aug 15;233(1-3):211-20
[
10492907.001
]
[Cites]
Genomics. 2007 Jan;89(1):124-33
[
17067776.001
]
[Cites]
Nucleic Acids Res. 2007 Jan;35(Database issue):D668-73
[
17142222.001
]
[Cites]
Nucleic Acids Res. 2007 Jan;35(Database issue):D610-7
[
17148474.001
]
[Cites]
Nat Biotechnol. 2004 Sep;22(9):1146-9
[
15300261.001
]
(PMID = 17932069.001).
[ISSN]
1362-4962
[Journal-full-title]
Nucleic acids research
[ISO-abbreviation]
Nucleic Acids Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Genetic Markers
[Other-IDs]
NLM/ PMC2238888
72.
Tischer BK, Kaufer BB, Sommer M, Wussow F, Arvin AM, Osterrieder N:
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.
J Virol
; 2007 Dec;81(23):13200-8
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
A self-excisable infectious
bacterial
artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.
In order to facilitate the generation of mutant viruses of varicella-zoster virus (VZV), the agent causing varicella (chicken pox) and herpes zoster (shingles), we generated a full-length infectious
bacterial
artificial chromosome (
BAC
) clone of the P-Oka strain.
Subsequently, mini-F-containing recombinant virus was generated from overlapping cosmid clones, and full-length VZV DNA recovered from the recombinant virus was established in Escherichia coli as an infectious
BAC
.
COS Scholar Universe.
author profiles
.
Addgene Non-profit plasmid repository.
clones/clone libraries - Get Article's Plasmids - Addgene
(subscription/membership/fee required).
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Exp Med. 2006 May 15;203(5):1307-17
[
16651385.001
]
[Cites]
J Virol. 2002 Feb;76(4):1537-47
[
11799148.001
]
[Cites]
J Virol. 2002 Feb;76(4):1959-70
[
11799190.001
]
[Cites]
Virology. 2002 Feb 15;293(2):356-67
[
11886256.001
]
[Cites]
Vet Microbiol. 2002 Apr 22;86(1-2):69-88
[
11888691.001
]
[Cites]
J Virol. 2002 Jul;76(13):6729-42
[
12050386.001
]
[Cites]
Trends Microbiol. 2002 Jul;10(7):318-24
[
12110210.001
]
[Cites]
J Virol. 2002 Aug;76(16):8208-17
[
12134026.001
]
[Cites]
Antiviral Res. 2002 Oct;56(1):1-11
[
12323395.001
]
[Cites]
J Virol. 2002 Nov;76(22):11447-59
[
12388706.001
]
[Cites]
Biotechnol Prog. 2003 Mar-Apr;19(2):373-9
[
12675574.001
]
[Cites]
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12697-702
[
10535985.001
]
[Cites]
J Virol. 2000 Aug;74(15):6964-74
[
10888635.001
]
[Cites]
J Gen Virol. 2000 Sep;81(Pt 9):2219-30
[
10950980.001
]
[Cites]
J Virol. 2000 Dec;74(23):11088-98
[
11070004.001
]
[Cites]
Mol Genet Metab. 2001 Jan;72(1):15-26
[
11161824.001
]
[Cites]
Genomics. 2001 Apr 1;73(1):56-65
[
11352566.001
]
[Cites]
J Virol. 2001 Dec;75(23):11307-18
[
11689611.001
]
[Cites]
J Virol. 2002 Jan;76(2):774-82
[
11752167.001
]
[Cites]
Curr Opin Microbiol. 2006 Aug;9(4):423-9
[
16814597.001
]
[Cites]
J Virol. 2006 Oct;80(19):9481-96
[
16973553.001
]
[Cites]
Herpes. 2006 Nov;13(3):75-80
[
17147912.001
]
[Cites]
J Virol. 2007 Jan;81(2):761-74
[
17079304.001
]
[Cites]
Mol Phylogenet Evol. 2007 Jun;43(3):1066-75
[
17196839.001
]
[Cites]
J Virol. 2007 Oct;81(20):10924-32
[
17670820.001
]
[Cites]
J Virol. 2003 May;77(10):6062-5
[
12719598.001
]
[Cites]
J Virol. 2003 Dec;77(23):12891-900
[
14610211.001
]
[Cites]
Science. 2004 Apr 30;304(5671):734-6
[
15118162.001
]
[Cites]
Vaccine. 2004 Sep 28;22(29-30):4069-74
[
15364458.001
]
[Cites]
J Virol. 2004 Nov;78(22):12406-15
[
15507627.001
]
[Cites]
Lancet. 1974 Nov 30;2(7892):1288-90
[
4139526.001
]
[Cites]
J Invest Dermatol. 1984 Jul;83(1 Suppl):42s-47s
[
6330220.001
]
[Cites]
J Gen Virol. 1986 Sep;67 ( Pt 9):1759-816
[
3018124.001
]
[Cites]
Mol Cell Biol. 1985 Aug;5(8):1997-2008
[
3018543.001
]
[Cites]
J Virol. 1988 Jun;62(6):2191-5
[
2835520.001
]
[Cites]
J Virol. 1988 Dec;62(12):4622-6
[
2460638.001
]
[Cites]
J Virol. 1988 Dec;62(12):4819-23
[
2846893.001
]
[Cites]
Biochimie. 1988 Aug;70(8):1031-43
[
2852507.001
]
[Cites]
J Virol. 1992 Jan;66(1):258-69
[
1309245.001
]
[Cites]
J Infect Dis. 1992 Aug;166 Suppl 1:S7-12
[
1320653.001
]
[Cites]
J Virol. 1992 Sep;66(9):5298-304
[
1323696.001
]
[Cites]
J Gen Virol. 1994 Jun;75 ( Pt 6):1245-58
[
8207391.001
]
[Cites]
J Virol. 1995 Jun;69(6):3863-7
[
7745736.001
]
[Cites]
J Virol. 1996 Aug;70(8):5466-75
[
8764058.001
]
[Cites]
Infect Dis Clin North Am. 1996 Sep;10(3):457-68
[
8856347.001
]
[Cites]
J Gen Virol. 1997 Jun;78 ( Pt 6):1399-403
[
9191936.001
]
[Cites]
Virology. 1997 Jul 7;233(2):382-91
[
9217061.001
]
[Cites]
J Virol. 1997 Sep;71(9):6913-20
[
9261418.001
]
[Cites]
J Virol. 1997 Nov;71(11):8279-88
[
9343180.001
]
[Cites]
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14759-63
[
9405686.001
]
[Cites]
J Virol. 1998 Feb;72(2):1542-51
[
9445058.001
]
[Cites]
J Bacteriol. 1998 Apr;180(8):2063-71
[
9555887.001
]
[Cites]
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50
[
9653172.001
]
[Cites]
Nat Genet. 1998 Oct;20(2):123-8
[
9771703.001
]
[Cites]
J Infect Dis. 1998 Nov;178 Suppl 1:S22-6
[
9852968.001
]
[Cites]
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):127-32
[
9874783.001
]
[Cites]
J Virol. 1999 Aug;73(8):6405-14
[
10400733.001
]
[Cites]
J Virol. 1999 Oct;73(10):8320-9
[
10482582.001
]
[Cites]
J Virol. 2005 Apr;79(8):4730-43
[
15795259.001
]
[Cites]
J Virol. 2005 Aug;79(15):9735-45
[
16014935.001
]
[Cites]
J Virol. 2006 Mar;80(6):2609-20
[
16501071.001
]
[Cites]
Vet Microbiol. 2006 Mar 31;113(3-4):163-9
[
16330166.001
]
[Cites]
Biotechniques. 2006 Feb;40(2):191-7
[
16526409.001
]
[Cites]
Nat Rev Microbiol. 2006 Apr;4(4):283-94
[
16541136.001
]
[Cites]
Virus Res. 2006 Apr;117(1):90-104
[
16490275.001
]
(PMID = 17913822.001).
[ISSN]
1098-5514
[Journal-full-title]
Journal of virology
[ISO-abbreviation]
J. Virol.
[Language]
ENG
[Grant]
United States / NIAID NIH HHS / AI / R21 AI061412; United States / NIAID NIH HHS / AI / 1R21AI061412
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / DNA, Viral; 0 / Viral Structural Proteins
[Other-IDs]
NLM/ PMC2169085
73.
Cadranel J, Lavolé A, Gounant V, Wislez M:
[Clinical types of thoracic cancer. Bronchiolo-alveolar carcinoma and adenocarcinoma with bronchioloalveolar features: a clinico-pathological spectrum].
Rev Mal Respir
; 2006 Nov;23(5 Pt 3):16S158-16S163
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Clinical types of thoracic
cancer
.
Bronchiolo
-
alveolar
carcinoma
and
adenocarcinoma
with
bronchioloalveolar
features: a clinico-pathological spectrum].
[Transliterated title]
Formes cliniques
des
cancers thoraciques.
Carcinome bronchiolo
-alvéolaire (CBA) et adénocarcinome pulmonaire avec composante
bronchiolo
-alvéolaire (ADC-CBA): un continuum anatomo-clinique.
Bronchioloalveolar carcinoma
(
BAC
) is a primary pulmonary
adenocarcinoma
(ADC) arising in the cells of the
terminal
respiratory unit.
Although stage IIIB and IV tumours were excluded from the strict WHO definition
of BAC
the first international workshop on this tumour in 2004 emphasised the clinico-pathological continuum that exists between
BAC
as defined by WHO and ADC with
BAC
features (ADC-
BAC
).
BAC
and ADC-
BAC
are distinguished from other non-small
cell carcinomas
by an increased incidence in women, non-smokers and Asians.
Surgery offers the best treatment for localised
disease
.
The high frequency of epidermal growth factor receptor (EGFR) expression and amplification and/or mutation of its gene, as well as
the finding
in some cases
of a
major response to EGFR tyrosine-kinase inhibitors, have lead to several therapeutic trials of these drugs.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ pathology.
Lung
Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Lung Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17268353.001).
[ISSN]
0761-8425
[Journal-full-title]
Revue des maladies respiratoires
[ISO-abbreviation]
Rev Mal Respir
[Language]
fre
[Publication-type]
English Abstract; Journal Article; Review
[Publication-country]
France
[Number-of-references]
30
74.
Yang Z, Zhang Y:
[The application of nuclear medicine imaging in bronchioloalveolar carcinoma.].
Zhongguo Fei Ai Za Zhi
; 2009 Oct 20;12(10):1123-6
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[The application of nuclear medicine imaging in
bronchioloalveolar carcinoma
.].
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20723354.001).
[ISSN]
1999-6187
[Journal-full-title]
Zhongguo fei ai za zhi = Chinese journal of lung cancer
[ISO-abbreviation]
Zhongguo Fei Ai Za Zhi
[Language]
chi
[Publication-type]
Journal Article
[Publication-country]
China
75.
Tinianow JN, Gill HS, Ogasawara A, Flores JE, Vanderbilt AN, Luis E, Vandlen R, Darwish M, Junutula JR, Williams SP, Marik J:
Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.
Nucl Med Biol
; 2010 Apr;37(3):289-97
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
METHODS: The amino group of desferrioxamine B was acylated by bromoacetyl bromide, N-hydroxysuccinimidyl iodoacetate, or N-hydroxysuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate to obtain thiol reactive reagents bromoacetyl-desferrioxamine (Df-
Bac
), iodoacetyl-desferrioxamine (Df-Iac) and maleimidocyclohexyl-desferrioxamine (Df-Chx-Mal), respectively.
Df-
Bac
and Df-Iac alkylated the free thiol groups of thio-trastuzumab by nucleophilic substitution forming Df-Ac-thio-trastuzumab, while the maleimide reagent Df-Chx-Mal reacted via Michael addition to provide Df-Chx-Mal-thio-trastuzumab.
RESULTS: The chemoselective reagents were obtained in 14% (Df-
Bac
), 53% (Df-Iac) and 45% (Df-Chx-Mal) yields.
Site-specific conjugation of Df-Chx-Mal to thio-trastuzumab was complete within 1 h at pH 7.5, while Df-Iac and Df-
Bac
respectively required 2 and 5 h at pH 9.
Each Df modified thio-trastuzumab was chelated with (89)Zr in yields exceeding 75%. (89)Zr-Df-Ac-thio-trastuzumab and (89)Zr-Df-Chx-Mal-thio-trastuzumab were stable in mouse serum and exhibited comparable PET imaging capabilities in a BT474M1 (HER2-positive) breast
cancer
model reaching 20-25 %ID/g of tumor uptake and a tumor to blood ratio of 6.1-7.1.
MedlinePlus Health Information.
consumer health - Breast Cancer
.
Hazardous Substances Data Bank.
ZIRCONIUM, ELEMENTAL
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2010 Elsevier Inc. All rights reserved.
(PMID = 20346868.001).
[ISSN]
1872-9614
[Journal-full-title]
Nuclear medicine and biology
[ISO-abbreviation]
Nucl. Med. Biol.
[Language]
eng
[Publication-type]
Evaluation Studies; Journal Article
[Publication-country]
England
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Radioisotopes; 0 / Radiopharmaceuticals; C6V6S92N3C / Zirconium
76.
Liu T, Mao D, Zhang S, Xu C, Xing Y:
Fine mapping SPP1, a QTL controlling the number of spikelets per panicle, to a BAC clone in rice (Oryza sativa).
Theor Appl Genet
; 2009 May;118(8):1509-17
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Fine mapping SPP1, a QTL controlling the number of spikelets per panicle, to
a BAC
clone in rice (Oryza sativa).
Finally, it was narrowed down to
a bacterial
artificial chromosome clone spanning 107 kb; 17 open reading frames have been identified in the region.
[MeSH-major]
Chromosomes, Artificial,
Bacterial
. Genes, Plant. Oryza / genetics. Physical Chromosome Mapping. Quantitative Trait Loci
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Plant Cell. 1991 Jul;3(7):677-684
[
12324609.001
]
[Cites]
Planta. 2006 Jan;223(2):315-28
[
16208486.001
]
[Cites]
Genetics. 1997 Feb;145(2):453-65
[
9071598.001
]
[Cites]
Theor Appl Genet. 2002 Dec;105(8):1137-1145
[
12582891.001
]
[Cites]
Nat Genet. 2008 Jun;40(6):761-7
[
18454147.001
]
[Cites]
Nat Genet. 2007 May;39(5):623-30
[
17417637.001
]
[Cites]
Theor Appl Genet. 2002 Apr;104(5):772-778
[
12582636.001
]
[Cites]
Theor Appl Genet. 2003 May;106(8):1467-72
[
12750790.001
]
[Cites]
Science. 2005 Jul 29;309(5735):741-5
[
15976269.001
]
[Cites]
Nucleic Acids Res. 1980 Oct 10;8(19):4321-5
[
7433111.001
]
[Cites]
Genetics. 1989 Jan;121(1):185-99
[
2563713.001
]
[Cites]
Theor Appl Genet. 2003 Nov;107(8):1419-32
[
14513215.001
]
[Cites]
Nat Genet. 2005 Oct;37(10):1141-6
[
16155566.001
]
[Cites]
Genome Res. 2001 Aug;11(8):1441-52
[
11483586.001
]
[Cites]
Plant Physiol. 1995 Oct;109(2):445-55
[
7480341.001
]
[Cites]
Planta. 2004 Jan;218(3):388-95
[
14534788.001
]
[Cites]
Plant Mol Biol. 1999 Jul;40(4):615-22
[
10480385.001
]
[Cites]
Mol Plant Microbe Interact. 1996 May;9(4):233-42
[
8634476.001
]
[Cites]
DNA Res. 2002 Feb 28;9(1):11-7
[
11939564.001
]
[Cites]
Plant J. 2004 Feb;37(4):517-27
[
14756760.001
]
[Cites]
Plant J. 2007 Dec;52(6):1027-40
[
17916112.001
]
[Cites]
Genes Dev. 2006 May 15;20(10):1250-5
[
16648463.001
]
[Cites]
Genetics. 2004 Dec;168(4):2187-95
[
15611185.001
]
[Cites]
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9226-31
[
11038567.001
]
[Cites]
J Plant Physiol. 2004 Apr;161(4):449-58
[
15128032.001
]
[Cites]
Theor Appl Genet. 2006 Jul;113(2):361-8
[
16791702.001
]
[Cites]
Theor Appl Genet. 2002 Aug;105(2-3):248-257
[
12582526.001
]
[Cites]
Theor Appl Genet. 2006 Aug;113(4):619-29
[
16770601.001
]
[Cites]
Plant Mol Biol. 1994 Dec;26(5):1357-77
[
7858195.001
]
[Cites]
Mol Gen Genet. 1993 Oct;241(1-2):225-35
[
7901751.001
]
[Cites]
Theor Appl Genet. 2008 Apr;116(6):789-96
[
18219477.001
]
[Cites]
Biochem J. 1999 Apr 1;339 ( Pt 1):193-9
[
10085244.001
]
[Cites]
Plant Cell. 1994 Oct;6(10):1485-93
[
7994180.001
]
[Cites]
Plant Cell Rep. 2006 Nov;25(11):1133-7
[
16676184.001
]
[Cites]
DNA Res. 2002 Dec 31;9(6):199-207
[
12597276.001
]
[Cites]
Genetics. 2000 Feb;154(2):885-91
[
10655238.001
]
[Cites]
Theor Appl Genet. 2006 Apr;112(6):1164-71
[
16453132.001
]
[Cites]
Plant Cell Physiol. 1999 Feb;40(2):231-7
[
10202817.001
]
[Cites]
Theor Appl Genet. 2003 Aug;107(4):679-90
[
12920521.001
]
(PMID = 19266175.001).
[ISSN]
1432-2242
[Journal-full-title]
TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
[ISO-abbreviation]
Theor. Appl. Genet.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Germany
[Chemical-registry-number]
0 / DNA, Plant; 0 / Genetic Markers
77.
Prior K, Hautefort I, Hinton JC, Richardson DJ, Rowley G:
All stressed out. Salmonella pathogenesis and reactive nitrogen species.
Adv Microb Physiol
; 2009;56:1-28
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Bacterial
pathogens must overcome a range of challenges during the process of infecting their host.
The ability
of a
pathogen to sense and respond appropriately to changes in host environment is vital if the pathogen is to succeed.
Mammalian defense strategies include the use of barriers like skin and epithelial surfaces, the production
of a
chemical arsenal, such as stomach acid and reactive oxygen and nitrogen species, and a highly coordinated cellular and humoral immune response.
Here we focus on the interplay which occurs between Salmonella and the host during the infection process, with particular emphasis on
the complex bacterial
response to reactive nitrogen species produced by the host.
We discuss recent advances in our understanding of the key mechanisms which confer
bacterial
resistance to nitrogen species, which in response to nitric oxide include the flavohemoglobin, HmpA, the flavorubredoxin, NorV, and the cytochrome c nitrite reductase, NrfA, whilst in response to nitrate include a repertoire of nitrate reductases.
MedlinePlus Health Information.
consumer health - Salmonella Infections
.
Hazardous Substances Data Bank.
NITRIC OXIDE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright © 2009 Elsevier Ltd. All rights reserved.
(PMID = 20943123.001).
[ISSN]
2162-5468
[Journal-full-title]
Advances in microbial physiology
[ISO-abbreviation]
Adv. Microb. Physiol.
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
England
[Chemical-registry-number]
0 / Reactive Nitrogen Species; 31C4KY9ESH / Nitric Oxide; EC 1.7.- / Nitrite Reductases
78.
Sziksz E, Tibor Kozma G, Komlósi ZI, Pállinger E, Kardos M, Szebeni B, Losonczy G, Falus A, Szabó A, Tulassay T, Vannay A:
Increased synthesis of vascular endothelial growth factor in allergic airway inflammation in histidine decarboxylase knockout (HDC(-/-)) mice.
Exp Lung Res
; 2010 Sep;36(7):420-30
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
VEGF mRNA expression and protein level were determined in
the lung
.
Number of VEGF-positive immune cells
of bronchoalveolar
lavage (BAL) and their intracellular VEGF content were measured by flow cytometry.
VEGF protein level in
the lung
and in the BAL cells was increased in OVA treated (HDC(-/-)(ova) as well as in WT(ova)) animals compared to their controls.
However, there was no difference in the VEGF levels between HDC(-/-) or WT animals, either in
the lung
or in the BAL cells.
In conclusion, increased VEGF production of the
lung
or BAL immune cells can be induced by allergen provocation independently from the genetic background of the animals.
[MeSH-minor]
Animals.
Bronchoalveolar
Lavage Fluid / cytology. Female.
Lung
/ drug effects.
Lung
/ enzymology.
Lung
/ pathology. Mice. Mice, Knockout. Ovalbumin
MedlinePlus Health Information.
consumer health - Asthma
.
Hazardous Substances Data Bank.
HISTAMINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20715981.001).
[ISSN]
1521-0499
[Journal-full-title]
Experimental lung research
[ISO-abbreviation]
Exp. Lung Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Vascular Endothelial Growth Factors; 820484N8I3 / Histamine; 9006-59-1 / Ovalbumin; EC 4.1.1.22 / Histidine Decarboxylase
79.
Chen WY, Pulukkunat DK, Cho IM, Tsai HY, Gopalan V:
Dissecting functional cooperation among protein subunits in archaeal RNase P, a catalytic ribonucleoprotein complex.
Nucleic Acids Res
; 2010 Dec;38(22):8316-27
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Dissecting functional cooperation among protein subunits in archaeal RNase P, a catalytic ribonucleoprotein
complex
.
Biochemical studies on
the bacterial
holoenzyme, composed of one catalytic RNase P RNA (RPR) and one RNase P protein (RPP), have helped understand the pleiotropic roles (including substrate/Mg(2+) binding) by which a protein could facilitate RNA catalysis.
Exploiting our previous
finding
that these archaeal RPPs function as two binary RPP
complexes
(POP5•RPP30 and RPP21•RPP29), we prepared recombinant RPP pairs from three archaea and established interchangeability of subunits through homologous/heterologous assemblies.
Our
finding
that archaeal POP5•RPP30 reconstituted with
bacterial
and organellar RPRs suggests functional overlap of this binary
complex
with
the bacterial
RPP and highlights their shared recognition
of a
phylogenetically-conserved RPR catalytic core, whose minimal attributes we further defined through deletion mutagenesis.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
FEBS Lett. 2010 Jan 21;584(2):287-96
[
19931535.001
]
[Cites]
J Mol Biol. 2010 Feb 5;395(5):1019-37
[
19917291.001
]
[Cites]
Nucleic Acids Res. 1996 Dec 1;24(23):4775-82
[
8972865.001
]
[Cites]
Biochemistry. 1997 May 27;36(21):6317-25
[
9174346.001
]
[Cites]
Biochemistry. 1998 Feb 24;37(8):2393-400
[
9485387.001
]
[Cites]
Science. 1998 May 1;280(5364):752-5
[
9563955.001
]
[Cites]
J Mol Biol. 1998 Jun 19;279(4):773-93
[
9642060.001
]
[Cites]
Biochemistry. 1998 Jul 14;37(28):10126-33
[
9665718.001
]
[Cites]
Nucleic Acids Res. 1999 Jan 1;27(1):314
[
9847214.001
]
[Cites]
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15212-7
[
9860948.001
]
[Cites]
Biochemistry. 1999 Jul 6;38(27):8612-20
[
10393536.001
]
[Cites]
J Mol Biol. 1999 Jul 9;290(2):433-45
[
10390342.001
]
[Cites]
Protein Expr Purif. 2001 Feb;21(1):224-34
[
11162410.001
]
[Cites]
RNA. 2001 Feb;7(2):220-32
[
11233979.001
]
[Cites]
RNA. 2001 Aug;7(8):1153-64
[
11497433.001
]
[Cites]
J Mol Biol. 2003 Jan 24;325(4):661-75
[
12507471.001
]
[Cites]
RNA. 2003 Jun;9(6):734-45
[
12756331.001
]
[Cites]
Biochem Biophys Res Commun. 2003 Jul 4;306(3):666-73
[
12810070.001
]
[Cites]
Anal Biochem. 2003 Aug 1;319(1):78-87
[
12842110.001
]
[Cites]
Biochemistry. 2003 Nov 25;42(46):13541-50
[
14622001.001
]
[Cites]
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15398-403
[
14673079.001
]
[Cites]
Biochem Biophys Res Commun. 2004 Jul 2;319(3):787-94
[
15184052.001
]
[Cites]
Biochemistry. 2004 Aug 17;43(32):10547-59
[
15301552.001
]
[Cites]
J Mol Biol. 2010 Feb 12;396(1):195-208
[
19932118.001
]
[Cites]
EMBO J. 2010 Feb 17;29(4):761-9
[
20075859.001
]
[Cites]
J Mol Biol. 1988 Aug 20;202(4):835-48
[
2459398.001
]
[Cites]
FASEB J. 1993 Jan;7(1):188-95
[
7678561.001
]
[Cites]
Biochemistry. 1993 May 25;32(20):5273-81
[
8499432.001
]
[Cites]
Nucleic Acids Res. 1994 Oct 11;22(20):4087-94
[
7524035.001
]
[Cites]
EMBO J. 1994 Oct 17;13(20):4870-6
[
7525271.001
]
[Cites]
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12510-4
[
8618931.001
]
[Cites]
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3001-6
[
8610158.001
]
[Cites]
Nucleic Acids Res. 1996 Apr 1;24(7):1252-9
[
8614627.001
]
[Cites]
RNA. 1996 May;2(5):452-62
[
8665412.001
]
[Cites]
RNA. 1996 Jun;2(6):551-63
[
8718684.001
]
[Cites]
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8924-8
[
8799129.001
]
[Cites]
RNA. 2004 Sep;10(9):1423-32
[
15317976.001
]
[Cites]
Cell. 1983 Dec;35(3 Pt 2):849-57
[
6197186.001
]
[Cites]
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7803-8
[
10393902.001
]
[Cites]
RNA. 1999 Aug;5(8):1021-33
[
10445877.001
]
[Cites]
Biochemistry. 2004 Nov 9;43(44):14128-38
[
15518563.001
]
[Cites]
Archaea. 2004 Oct;1(4):247-54
[
15810434.001
]
[Cites]
RNA. 2005 May;11(5):739-51
[
15811915.001
]
[Cites]
Biosci Biotechnol Biochem. 2005 Jun;69(6):1209-12
[
15973057.001
]
[Cites]
Biochemistry. 2005 Sep 13;44(36):12086-93
[
16142906.001
]
[Cites]
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13392-7
[
16157868.001
]
[Cites]
Nature. 2005 Sep 22;437(7058):584-7
[
16113684.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):873-8
[
16418270.001
]
[Cites]
J Mol Biol. 2006 Mar 24;357(2):583-91
[
16430919.001
]
[Cites]
Crit Rev Biochem Mol Biol. 2006 Mar-Apr;41(2):77-102
[
16595295.001
]
[Cites]
Trends Biochem Sci. 2006 Jun;31(6):333-41
[
16679018.001
]
[Cites]
RNA. 2006 Sep;12(9):1661-70
[
16894220.001
]
[Cites]
EMBO J. 2006 Sep 6;25(17):3998-4007
[
16932744.001
]
[Cites]
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16147-52
[
17053064.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2062-7
[
17284611.001
]
[Cites]
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2031-2
[
17287341.001
]
[Cites]
J Mol Biol. 2007 Oct 5;372(5):1149-64
[
17719605.001
]
[Cites]
RNA. 2007 Oct;13(10):1648-55
[
17717080.001
]
[Cites]
Mol Microbiol. 2007 Nov;66(3):801-13
[
17919279.001
]
[Cites]
Nucleic Acids Res. 2008 Jul;36(12):4172-80
[
18558617.001
]
[Cites]
Biochemistry. 2008 Nov 11;47(45):11704-10
[
18922021.001
]
[Cites]
J Mol Biol. 2008 Dec 19;384(3):652-62
[
18929577.001
]
[Cites]
Nucleic Acids Res. 2009 Jan;37(1):231-42
[
19036794.001
]
[Cites]
RNA. 2009 Feb;15(2):224-34
[
19095620.001
]
[Cites]
RNA. 2009 Aug;15(8):1565-77
[
19549719.001
]
[Cites]
J Mol Biol. 2009 Nov 13;393(5):1043-55
[
19733182.001
]
(PMID = 20705647.001).
[ISSN]
1362-4962
[Journal-full-title]
Nucleic acids research
[ISO-abbreviation]
Nucleic Acids Res.
[Language]
ENG
[Grant]
United States / NIGMS NIH HHS / GM / R01 GM067807
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
[Publication-country]
England
[Chemical-registry-number]
0 / Archaeal Proteins; 0 / Protein Subunits; 0 / RNA Precursors; 9014-25-9 / RNA, Transfer; EC 3.1.26.5 / Ribonuclease P
[Other-IDs]
NLM/ PMC3001054
80.
Bosnjak B, Ivetić Tkalcević V, Durić K, Belamarić D, Cuzić S, Ferencić Z, Brajsa K, Glojnarić I, Antolović R, Hrvacić B:
Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory cell accumulation in mouse model of asthma.
Inflamm Res
; 2009 Nov;58(11):773-81
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory
cell
accumulation in mouse model of asthma.
OBJECTIVE: To investigate whether challenge with increasing allergen doses could differently affect allergen-induced airway hyperresponsiveness (AHR) and inflammatory
cell
accumulation in mouse model of asthma, providing an experimental model to investigate their relationship.
MATERIAL AND METHODS: AHR and accumulation of inflammatory cells in
bronchoalveolar
lavage fluid (BALF) and into the lungs were compared in ovalbumin-sensitized mice that were challenged intranasally with 2.5, 10, 25 or 100 microg of ovalbumin/mouse.
RESULTS: Both AHR and inflammatory
cell
accumulation were proportional to the ovalbumin dose used for challenge.
[MeSH-minor]
Animals.
Bronchoalveolar
Lavage Fluid / cytology.
Bronchoalveolar
Lavage Fluid / immunology. Cytokines / immunology.
Disease
Models, Animal. Eosinophil Peroxidase / metabolism. Eosinophils / immunology. Humans. Interleukin-13 / immunology.
Lung
/ cytology.
Lung
/ immunology.
Lung
/ pathology. Male. Mice. Mice, Inbred BALB C
Genetic Alliance.
consumer health - Asthma
.
MedlinePlus Health Information.
consumer health - Asthma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Allergy. 2007 Oct;62(10):1101-10
[
17845579.001
]
[Cites]
Inhal Toxicol. 2004 May;16(5):259-69
[
15371179.001
]
[Cites]
Am Rev Respir Dis. 1989 Oct;140(4):917-23
[
2572192.001
]
[Cites]
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):721-30
[
11254531.001
]
[Cites]
J Allergy Clin Immunol. 1988 Nov;82(5 Pt 1):764-70
[
3192861.001
]
[Cites]
Am J Respir Crit Care Med. 1997 May;155(5):1515-21
[
9154851.001
]
[Cites]
Thorax. 1987 Apr;42(4):302-8
[
3616989.001
]
[Cites]
Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):766-75
[
9309991.001
]
[Cites]
Clin Exp Allergy. 2008 May;38(5):701-3
[
18307532.001
]
[Cites]
Am J Respir Cell Mol Biol. 2002 Feb;26(2):202-8
[
11804871.001
]
[Cites]
Science. 1998 Dec 18;282(5397):2258-61
[
9856949.001
]
[Cites]
Chest. 2006 Jul;130(1 Suppl):21S-28S
[
16840365.001
]
[Cites]
Am J Respir Cell Mol Biol. 2004 Jun;30(6):837-43
[
14742296.001
]
[Cites]
Science. 2004 Sep 17;305(5691):1776-9
[
15375268.001
]
[Cites]
Clin Exp Allergy. 1992 Feb;22(2):219-25
[
1571815.001
]
[Cites]
Int Arch Allergy Immunol. 2004 Jan;133(1):84-100
[
14726635.001
]
[Cites]
J Allergy Clin Immunol. 1992 Apr;89(4):850-7
[
1560168.001
]
[Cites]
Am J Respir Crit Care Med. 2000 May;161(5):1720-45
[
10806180.001
]
[Cites]
J Allergy Clin Immunol. 2006 Sep;118(3):551-9; quiz 560-1
[
16950269.001
]
[Cites]
J Immunol Methods. 1985 Nov 7;83(2):209-15
[
3840509.001
]
[Cites]
Clin Exp Allergy. 2003 Jan;33(1):119-31
[
12534560.001
]
[Cites]
Clin Exp Allergy. 2008 May;38(5):829-38
[
18070158.001
]
[Cites]
Am J Respir Cell Mol Biol. 1997 Mar;16(3):325-34
[
9070618.001
]
[Cites]
Toxicology. 2005 Apr 1;209(1):77-89
[
15725516.001
]
[Cites]
Am J Respir Crit Care Med. 1994 May;149(5):1167-74
[
8173756.001
]
[Cites]
J Allergy Clin Immunol. 1995 Oct;96(4):435-40
[
7560652.001
]
[Cites]
J Immunol. 1999 May 15;162(10):6233-7
[
10229869.001
]
[Cites]
Chest. 2003 Mar;123(3 Suppl):411S-6S
[
12629006.001
]
(PMID = 19440656.001).
[ISSN]
1420-908X
[Journal-full-title]
Inflammation research : official journal of the European Histamine Research Society ... [et al.]
[ISO-abbreviation]
Inflamm. Res.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Switzerland
[Chemical-registry-number]
0 / Cytokines; 0 / Interleukin-13; 9006-59-1 / Ovalbumin; EC 1.11.1.- / Eosinophil Peroxidase
81.
Sipos R, Székely AJ, Palatinszky M, Révész S, Márialigeti K, Nikolausz M:
Effect of primer mismatch, annealing temperature and PCR cycle number on 16S rRNA gene-targetting bacterial community analysis.
FEMS Microbiol Ecol
; 2007 May;60(2):341-50
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Effect of primer mismatch, annealing temperature and PCR cycle number on 16S rRNA gene-targetting
bacterial
community analysis.
In the attempt to explore
complex bacterial
communities of environmental samples, primers hybridizing to phylogenetically highly conserved regions of 16S rRNA genes are widely used, but differential amplification is a recognized problem.
The distortion of the template-to-product ratio was measured using predefined template mixtures and environmental samples by
terminal
restriction fragment length polymorphism analysis.
As a result of additional tests on environmental samples, the use
of a
low annealing temperature is recommended in order to significantly reduce preferential amplification while maintaining the specificity of PCR.
[MeSH-minor]
DNA,
Bacterial
/ chemistry. DNA,
Bacterial
/ genetics. Ecosystem. Electrophoresis, Capillary. Environmental Microbiology. Molecular Sequence Data. Polymorphism, Restriction Fragment Length. Sequence Analysis, DNA. Temperature
SILVA.
SILVA SSU Database
.
StrainInfo.
culture/stock collections - online strain list
(subscription/membership/fee required).
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17343679.001).
[ISSN]
0168-6496
[Journal-full-title]
FEMS microbiology ecology
[ISO-abbreviation]
FEMS Microbiol. Ecol.
[Language]
eng
[Databank-accession-numbers]
GENBANK/ DQ207728/ DQ207729/ DQ207730/ DQ207731
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / DNA Primers; 0 / DNA, Bacterial; 0 / RNA, Ribosomal, 16S
82.
Portnoï D, Sertour N, Ferquel E, Garnier M, Baranton G, Postic D:
A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence.
FEMS Microbiol Lett
; 2006 Jun;259(1):35-40
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Lyme borreliosis is the most important vector-borne
disease
caused by spirochetes within the Borrelia burgdorferi sensu lato (B. burgdorferi sl)
complex
.
There is strong evidence that different species of this group of genetically diverse spirochetes are involved in distinct clinical manifestations of the
disease
.
In order to differentiate species within this
bacterial complex
, we developed a real-time-PCR protocol, which targets the hbb gene.
We designed a fluorescein-labeled probe specific
of a
region of this gene harboring a polymorphism linked to species.
[MeSH-major]
Bacterial
Proteins / genetics. Borrelia burgdorferi Group / classification. Borrelia burgdorferi Group / isolation & purification. DNA-Binding Proteins / genetics. Polymerase Chain Reaction / methods
[MeSH-minor]
Animals.
Bacterial
Typing Techniques. DNA Primers. DNA,
Bacterial
/ analysis. DNA,
Bacterial
/ isolation & purification. Reproducibility of Results. Sensitivity and Specificity. Ticks / microbiology. Transition Temperature
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16684099.001).
[ISSN]
0378-1097
[Journal-full-title]
FEMS microbiology letters
[ISO-abbreviation]
FEMS Microbiol. Lett.
[Language]
eng
[Publication-type]
Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / Bacterial Proteins; 0 / DNA Primers; 0 / DNA, Bacterial; 0 / DNA-Binding Proteins; 0 / Hbb protein, Borrelia burgdorferi
83.
Macfarlane S, Woodmansey EJ, Macfarlane GT:
Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system.
Appl Environ Microbiol
; 2005 Nov;71(11):7483-92
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The human large intestine is covered with a protective mucus coating, which is heavily colonized by
complex bacterial
populations that are distinct from those in the gut lumen.
The establishment
of bacterial
communities in mucin gels was investigated by selective culture methods, scanning electron microscopy, and confocal laser scanning microscopy, in association with fluorescently labeled 16S rRNA oligonucleotide probes.
Mucin gels were rapidly colonized by heterogeneous
bacterial
populations, especially members of the Bacteroides fragilis group, enterobacteria, and clostridia.
Intestinal
bacterial
populations growing on mucin surfaces were shown to be phylogenetically and metabolically distinct from their planktonic counterparts.
MedlinePlus Health Information.
consumer health - Bowel Movement
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Gut. 2001 Feb;48(2):198-205
[
11156640.001
]
[Cites]
Infect Immun. 2001 Feb;69(2):1120-6
[
11160009.001
]
[Cites]
Br J Nutr. 2003 May;89(5):597-606
[
12720580.001
]
[Cites]
Gut. 2004 Apr;53(4):523-9
[
15016746.001
]
[Cites]
Clin Infect Dis. 2004 Jun 15;38(12):1690-9
[
15227614.001
]
[Cites]
Adv Appl Microbiol. 2004;54:261-89
[
15251284.001
]
[Cites]
Gut. 2004 Nov;53(11):1610-6
[
15479681.001
]
[Cites]
Br Med Bull. 1978 Jan;34(1):79-82
[
342054.001
]
[Cites]
Infect Immun. 1979 Jan;23(1):128-32
[
370006.001
]
[Cites]
Microbiol Rev. 1979 Jun;43(2):260-96
[
390357.001
]
[Cites]
Gastroenterology. 1981 Oct;81(4):751-8
[
7262519.001
]
[Cites]
Infect Immun. 1981 Oct;34(1):234-40
[
7298185.001
]
[Cites]
Infect Immun. 1981 Oct;34(1):241-9
[
7298186.001
]
[Cites]
Infect Immun. 1983 Apr;40(1):62-9
[
6339411.001
]
[Cites]
Appl Environ Microbiol. 1983 Mar;45(3):1025-33
[
6847178.001
]
[Cites]
Gastroenterology. 1983 Sep;85(3):589-95
[
6873605.001
]
[Cites]
Appl Environ Microbiol. 1984 Aug;48(2):449-50
[
6486788.001
]
[Cites]
Nahrung. 1984;28(6-7):627-34
[
6493320.001
]
[Cites]
Infect Immun. 1986 Jul;53(1):141-8
[
2873103.001
]
[Cites]
Clin Gastroenterol. 1986 Oct;15(4):815-37
[
3536210.001
]
[Cites]
J Gen Microbiol. 1986 Jun;132(6):1647-56
[
3543210.001
]
[Cites]
Infect Immun. 1988 Sep;56(9):2209-17
[
3044995.001
]
[Cites]
Infect Immun. 1988 Oct;56(10):2610-4
[
3417352.001
]
[Cites]
J Appl Bacteriol. 1989 Nov;67(5):520-7
[
2480341.001
]
[Cites]
J Appl Bacteriol. 1990 Feb;68(2):179-87
[
2318746.001
]
[Cites]
Appl Environ Microbiol. 1990 Jun;56(6):1919-25
[
2200342.001
]
[Cites]
FEMS Microbiol Lett. 1991 Jan 15;61(2-3):289-93
[
1903753.001
]
[Cites]
FEMS Microbiol Lett. 1991 Nov 15;68(2):151-6
[
1778437.001
]
[Cites]
J Appl Bacteriol. 1992 Jan;72(1):57-64
[
1541601.001
]
[Cites]
Biochem Biophys Res Commun. 1992 Mar 16;183(2):506-13
[
1372502.001
]
[Cites]
Infect Immun. 1992 Oct;60(10):3971-8
[
1398908.001
]
[Cites]
Gut. 1993 Jan;34(1):63-7
[
8432454.001
]
[Cites]
Microbiology. 1994 Dec;140 ( Pt 12):3407-12
[
7881558.001
]
[Cites]
Appl Environ Microbiol. 1995 Aug;61(8):3069-75
[
7487040.001
]
[Cites]
Microbiology. 1996 May;142 ( Pt 5):1097-106
[
8704951.001
]
[Cites]
J Med Microbiol. 1997 Jan;46(1):85-91
[
9003751.001
]
[Cites]
Adv Dent Res. 1997 Apr;11(1):59-68
[
9524443.001
]
[Cites]
Proc R Soc Lond B Biol Sci. 1955 Jan 27;143(911):147-58
[
14371602.001
]
[Cites]
J Biol Chem. 1959 Aug;234(8):1971-5
[
13672998.001
]
(PMID = 16269790.001).
[ISSN]
0099-2240
[Journal-full-title]
Applied and environmental microbiology
[ISO-abbreviation]
Appl. Environ. Microbiol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Culture Media; 0 / Fluorescent Dyes; 0 / Mucins; 0 / Oligonucleotide Probes; 0 / RNA, Ribosomal, 16S
[Other-IDs]
NLM/ PMC1287682
84.
Gearhardt AN, Corbin WR:
Body mass index and alcohol consumption: family history of alcoholism as a moderator.
Psychol Addict Behav
; 2009 Jun;23(2):216-25
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
BMI, family history of alcoholism, gender, and race/ethnicity were assessed as predictors of typical drinking frequency and estimated blood alcohol concentration (
BAC
).
MedlinePlus Health Information.
consumer health - Alcohol
.
MedlinePlus Health Information.
consumer health - Alcoholism and Alcohol Abuse
.
MedlinePlus Health Information.
consumer health - Family Issues
.
MedlinePlus Health Information.
consumer health - Obesity
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright (c) 2009 APA, all rights reserved.
(PMID = 19586138.001).
[ISSN]
0893-164X
[Journal-full-title]
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
[ISO-abbreviation]
Psychol Addict Behav
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
85.
Misfeldt AM, Boyle SC, Tompkins KL, Bautch VL, Labosky PA, Baldwin HS:
Endocardial cells are a distinct endothelial lineage derived from Flk1+ multipotent cardiovascular progenitors.
Dev Biol
; 2009 Sep 01;333(1):78-89
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
To distinguish endocardium from other vasculature, we generated an NFATc1-nuc-LacZ
BAC
transgenic mouse line capable of labeling this specific endothelial subpopulation at the earliest stages of cardiac development.
Endocardium is specified as a cardiac
cell
lineage, independent from other vascular populations, responding to BMP and Wnt signals that enhance cardiomyocyte differentiation.
[MeSH-major]
Cell
Lineage / physiology. Embryonic Stem Cells / physiology. Endocardium / embryology. Endothelial Cells / physiology. Multipotent Stem Cells / physiology. Myocytes, Cardiac / physiology. Vascular Endothelial Growth Factor Receptor-2 / metabolism
[MeSH-minor]
Animals. Antigens, Differentiation / metabolism.
Cell
Differentiation / physiology. Cells, Cultured. Hematopoietic Stem Cells / cytology. Hematopoietic Stem Cells / physiology. Mesoderm / cytology. Mesoderm / embryology. Mice. Mice, Transgenic. Muscle, Smooth, Vascular / cytology. Muscle, Smooth, Vascular / embryology. Myocytes, Smooth Muscle / cytology. Myocytes, Smooth Muscle / physiology. NFATC Transcription Factors / genetics
COS Scholar Universe.
author profiles
.
KOMP Repository.
gene/protein/disease-specific - KOMP Repository
(subscription/membership/fee required).
Mouse Genome Informatics (MGI).
Mouse Genome Informatics (MGI)
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19576203.001).
[ISSN]
1095-564X
[Journal-full-title]
Developmental biology
[ISO-abbreviation]
Dev. Biol.
[Language]
eng
[Grant]
United States / NHLBI NIH HHS / HL / RL1 HL092551; United States / NHLBI NIH HHS / HL / RL1HL0952551-01; United States / NIGMS NIH HHS / GM / T32 GM07347
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Antigens, Differentiation; 0 / NFATC Transcription Factors; 0 / Nfatc1 protein, mouse; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2
86.
Shi JJ, Cai DH, Chen XJ, Sheng HZ:
Cloning and characterization of the rabbit POU5F1 gene.
DNA Seq
; 2008 Feb;19(1):56-61
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The rabbit POUSF1 gene was mapped to chromosome 12q1.1 by PCR amplification of DNA from two putative POU5F1-containing
BAC
clones, which were previously mapped to chromosome 12q1.1.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17852331.001).
[ISSN]
1042-5179
[Journal-full-title]
DNA sequence : the journal of DNA sequencing and mapping
[ISO-abbreviation]
DNA Seq.
[Language]
eng
[Databank-accession-numbers]
GENBANK/ EF062856/ EF194086
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Octamer Transcription Factor-3
87.
Titus TA, Selvig DR, Qin B, Wilson C, Starks AM, Roe BA, Postlethwait JH:
The Fanconi anemia gene network is conserved from zebrafish to human.
Gene
; 2006 Apr 26;371(2):211-23
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Fanconi anemia (FA) is
a complex disease
involving nine identified and two unidentified loci that define a network essential for maintaining genomic stability.
To test the hypothesis that the FA network is conserved in vertebrate genomes, we cloned and sequenced zebrafish (Danio rerio) cDNAs and/or genomic
BAC
clones orthologous to all nine cloned FA genes (FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL), and identified orthologs in the genome database for the pufferfish Tetraodon nigroviridis.
Evolutionarily conserved regions identified functionally important domains, since many amino acid residues mutated in human
disease
alleles or shown to be critical in targeted mutagenesis studies are identical in zebrafish and human.
[MeSH-minor]
Amino Acid Sequence. Animals. Chromosomes, Artificial,
Bacterial
. Humans. Molecular Sequence Data. Sequence Homology, Amino Acid
Genetic Alliance.
consumer health - Fanconi Anemia
.
Genetic Alliance.
consumer health - Anemia
.
COS Scholar Universe.
author profiles
.
Gene Ontology.
gene/protein/disease-specific - Gene Ontology annotations from this paper
.
ZFIN.
ZFIN
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16515849.001).
[ISSN]
0378-1119
[Journal-full-title]
Gene
[ISO-abbreviation]
Gene
[Language]
eng
[Grant]
United States / NICHD NIH HHS / HD / HD22486; United States / NCRR NIH HHS / RR / R01RR10715
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / Fanconi Anemia Complementation Group D2 Protein
88.
Suzuki C, Daigo Y, Ishikawa N, Kato T, Hayama S, Ito T, Tsuchiya E, Nakamura Y:
ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Cancer Res
; 2005 Dec 15;65(24):11314-25
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
ANLN plays a critical role in human
lung
carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Gene expression profile analysis of non-small
cell lung
cancers (NSCLC) and subsequent functional analyses revealed that human ANLN, a homologue of anillin, an actin-binding protein in Drosophila, was transactivated in
lung cancer
cells and seemed to play a significant role in pulmonary carcinogenesis.
Immunohistochemical staining of nuclear ANLN on
lung cancer
tissue microarrays was associated with the poor survival of NSCLC patients, indicating that this molecule might serve as a prognostic indicator.
Our data imply that up-regulation of ANLN is a common feature of the carcinogenetic process in
lung
tissue, and suggests that selective suppression of ANLN could be a promising approach for developing a new strategy to treat
lung
cancers.
[MeSH-major]
Carcinoma
, Non-Small-
Cell Lung
/ metabolism. Contractile Proteins / metabolism.
Lung
Neoplasms / metabolism. Phosphatidylinositol 3-Kinases / metabolism. Proto-Oncogene Proteins c-akt / metabolism. rhoA GTP-Binding Protein / metabolism
[MeSH-minor]
Actins / metabolism.
Adenocarcinoma
/ genetics.
Adenocarcinoma
/ metabolism.
Adenocarcinoma
/ pathology.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ genetics.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ metabolism.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ pathology. Adult. Aged. Aged, 80 and over. Blotting, Western.
Carcinoma
, Adenosquamous / genetics.
Carcinoma
, Adenosquamous / metabolism.
Carcinoma
, Adenosquamous / pathology.
Carcinoma
, Squamous
Cell
/ genetics.
Carcinoma
, Squamous
Cell
/ metabolism.
Carcinoma
, Squamous
Cell
/ pathology.
Cell
Movement. Enzyme Activation. Female. Flow Cytometry. Humans.
Lung
/ metabolism.
Lung
/ pathology. Male. Middle Aged. Prognosis. RNA, Small Interfering / pharmacology. Reverse Transcriptase Polymerase Chain Reaction. Signal Transduction. Survival Rate. Tissue Array Analysis. Tumor Cells, Cultured. Wound Healing
MedlinePlus Health Information.
consumer health - Lung Cancer
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16357138.001).
[ISSN]
0008-5472
[Journal-full-title]
Cancer research
[ISO-abbreviation]
Cancer Res.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Actins; 0 / Contractile Proteins; 0 / RNA, Small Interfering; 0 / anillin; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 3.6.5.2 / rhoA GTP-Binding Protein
89.
Moore S, Shepherd J, Perham N, Cusens B:
The prevalence of alcohol intoxication in the night-time economy.
Alcohol Alcohol
; 2007 Nov-Dec;42(6):629-34
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
METHOD: A random sample of 893 people were interviewed and breathalysed in 24 repeated, cross-sectional surveys over the course
of a
year in the city centre streets
of a
European capital city between 11.00 pm and 3.00 am.
RESULTS: Median blood alcohol concentration (
BAC
) in men was 0.13% (min = 0%, max = 0.33%) and in women was 0.09% (min = 0%, max = 0.27%)-which were below the threshold used to indicate 'at risk
BAC
' (0.15%; for men t = 9.32, P < 0.001 and for women t = 17.54, P < 0.001).
Men provided higher
BACs
than women (t = 7.17, P < 0.001).
The relationship between age and
BAC
for men described an inverted 'u', peaking at 29 years, but for women the relationship was positive and linear.
BAC
was inversely related to the ability to remember and report the evening's consumption (z = 4.76, P < 0.001).
Reported consumption predicted only 12% (P < 0.001) of the variance in
BAC
for men and 10% (P < 0.001) for women.
The probability for respondents to recall past consumption diminished as
BAC
increased suggesting self-report data are not suitable to assess consumption in heavy drinkers.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17660522.001).
[ISSN]
1464-3502
[Journal-full-title]
Alcohol and alcoholism (Oxford, Oxfordshire)
[ISO-abbreviation]
Alcohol Alcohol.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
England
90.
Philipp U, Quignon P, Scott A, André C, Breen M, Leeb T:
Chromosomal assignment of the canine melanophilin gene (MLPH): a candidate gene for coat color dilution in Pinschers.
J Hered
; 2005;96(7):774-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
To investigate the genetic cause of the coat color dilution in Pinschers, we isolated
BAC
clones containing the canine ortholog of the known murine color dilution gene Mlph.
RH mapping of the canine MLPH gene was performed using an STS marker derived from
BAC
sequences.
Additionally, one MLPH
BAC
clone was used as probe for FISH mapping, and the canine MLPH gene was assigned to CFA25q24.
SciCrunch.
OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15958794.001).
[ISSN]
0022-1503
[Journal-full-title]
The Journal of heredity
[ISO-abbreviation]
J. Hered.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Proteins
91.
Quoix E:
[Recent development of the standards of treatment of lung cancer].
Rev Prat
; 2007 Feb 15;57(3):239-45
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Recent development of the standards of treatment
of lung cancer
].
[Transliterated title]
Evolutions récentes
des
traitements
de
référence du
cancer
bronchique primitif.
Non-small
cell lung cancer
(NSCLC) knows important changes with the development of the use of chemotherapy not only in the advanced forms but also in a perioperative setting.
In early stage
disease
, a wedge resection seems to be sufficient in the tumours with a diameter less than 2 cm and presenting as ground-glass opacity.
Targeted therapies have been the real novelty in the treatment of non-small
cell lung cancer
.
However, they have proved useful in second line setting and in first line setting in diffuse
bronchioloalveolar carcinoma
.
Regarding small-
cell lung cancer
, there has been no real novelty, the standard treatment remains unchanged.
[MeSH-major]
Carcinoma
, Non-Small-
Cell Lung
/ surgery.
Lung
Neoplasms / surgery. Neoadjuvant Therapy
[MeSH-minor]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ surgery.
Carcinoma
, Small
Cell
/ surgery. Chemotherapy, Adjuvant. Humans. Pneumonectomy. Radiotherapy, Adjuvant
Genetic Alliance.
consumer health - Lung Cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17578022.001).
[ISSN]
0035-2640
[Journal-full-title]
La Revue du praticien
[ISO-abbreviation]
Rev Prat
[Language]
fre
[Publication-type]
English Abstract; Journal Article; Review
[Publication-country]
France
[Number-of-references]
30
92.
Wang YJ, Jiang YL, Tang HF, Zhao CZ, Chen JQ:
Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model.
Int Immunopharmacol
; 2010 Feb;10(2):252-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Chronic obstructive pulmonary
disease
(COPD) is defined as
a disease
state characterized by poorly reversible airflow limitation induced by cigarette smoking and/or other noxious particle and gases.
Phosphodiesterase (PDE) 4 inhibitors are known to elevated cAMP concentrations in inflammatory cells, leading to inhibition of inflammatory response, relaxation of smooth muscle in the airway, and modulation of sensory nerves in
the lung
as well.
To investigate whether Zl-n-91, a new selective PDE4 inhibitor, could decrease inflammation and improve
lung
function in a COPD-like rat model, male Sprague-Dawley rats are used to challenge with lipopolysaccharide (LPS) and cigarette smoking (CS) exposure to induce COPD-like animal model.
Administration of Zl-n-91 at different dosages results in decreases of inflammatory
cell
in
bronchoalveolar
lavage fluid (BALF) as compared with vehicle treatment.
[MeSH-major]
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use. Furans / therapeutic use. Phenyl Ethers / therapeutic use. Phosphodiesterase 4 Inhibitors. Phosphodiesterase Inhibitors / therapeutic use. Pulmonary
Disease
, Chronic Obstructive / drug therapy
[MeSH-minor]
Animals. Cyclic Nucleotide Phosphodiesterases, Type 4 / immunology.
Disease
Models, Animal. Lipopolysaccharides / immunology.
Lung
/ drug effects.
Lung
/ immunology.
Lung
/ physiopathology. Male. Matrix Metalloproteinase 9 / immunology. Matrix Metalloproteinase Inhibitors. Neutrophils / drug effects. Neutrophils / immunology. Peroxidase / drug effects. Peroxidase / immunology. Rats. Rats, Sprague-Dawley. Smoking / adverse effects. Smoking / immunology
MedlinePlus Health Information.
consumer health - COPD
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2009 Elsevier B.V. All rights reserved.
(PMID = 19914404.001).
[ISSN]
1878-1705
[Journal-full-title]
International immunopharmacology
[ISO-abbreviation]
Int. Immunopharmacol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
Netherlands
[Chemical-registry-number]
0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Furans; 0 / Lipopolysaccharides; 0 / Matrix Metalloproteinase Inhibitors; 0 / Phenyl Ethers; 0 / Phosphodiesterase 4 Inhibitors; 0 / Phosphodiesterase Inhibitors; 0 / Zl-n-91 compound; EC 1.11.1.7 / Peroxidase; EC 3.1.4.17 / Cyclic Nucleotide Phosphodiesterases, Type 4; EC 3.4.24.35 / Matrix Metalloproteinase 9
93.
Arenberg D, American College of Chest Physicians:
Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
Chest
; 2007 Sep;132(3 Suppl):306S-13S
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Bronchioloalveolar lung cancer
: ACCP evidence-based clinical practice guidelines (2nd edition).
OBJECTIVES: To review the current evidence on special issues relating to
the diagnosis
, imaging, prognosis, and treatment
of bronchioloalveolar carcinoma
(
BAC
).
METHODS: This guideline focuses on aspects
of BAC
that are unique and ways in which
BAC
differs importantly from other forms of non-small
cell lung cancer
(NSCLC).
The author reviewed published literature reporting on
BAC
using key words "histology," "CT scans," "fluorodeoxyglucose positron emission tomography scan," "sensitivity," "specificity," "surgical resection," "sublobar resection," and "epidermal growth factor receptor tyrosine kinase inhibitor" and selected references from published review articles.
Also included was a review of the 1999 World Health Organization (WHO) revised classification system for
lung
tumors, which established a more restrictive definition
of BAC
to tumors with a pure lepidic spreading pattern and no evidence of stromal, vascular, or pleural invasion.
RESULTS: With the notable exception
of a
lower likelihood
of a
positive positron emission tomography
finding
in the presence
of BAC
, staging,
diagnosis
, and treatment are the same as for other histologic subtypes of NSCLC, but additional treatment options that may prove to be equivalent, if not more effective, for more patients exist (eg, epidermal growth factor receptor tyrosine kinase inhibitor therapy, sublobar resection).
CONCLUSIONS:
BAC
is a form of
adenocarcinoma
with unique clinical, radiologic, and epidemiologic features.
The diagnosis of BAC
should be reserved for tumors that meet the WHO criteria.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/
diagnosis
.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ therapy.
Lung
Neoplasms /
diagnosis
.
Lung
Neoplasms / therapy
Genetic Alliance.
consumer health - Lung Cancer
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17873176.001).
[ISSN]
0012-3692
[Journal-full-title]
Chest
[ISO-abbreviation]
Chest
[Language]
eng
[Publication-type]
Journal Article; Practice Guideline
[Publication-country]
United States
94.
Garfield DH, Cadranel JL, Wislez M, Franklin WA, Hirsch FR:
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
J Thorac Oncol
; 2006 May;1(4):344-59
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The bronchioloalveolar carcinoma
and peripheral
adenocarcinoma
spectrum of diseases.
Bronchioloalveolar carcinoma
(
BAC
) develops from
terminal bronchiolar
and acinar epithelia, growing along
alveolar
septa but without evidence of vascular or pleural involvement.
A final
diagnosis of BAC
can only be achieved from a surgical specimen.
Problematically,
BAC
may exhibit multifocal involvement by means of diffuse aerogenous metastatic spread, making this definition inapplicable for patients with stage IIIB to IV
disease
from whom only small size biopsy or cytological specimens are obtained.
The recent interest and potential importance
of BAC
and the related peripheral
adenocarcinoma
(ADC), mixed subtype, is attributable to mounting evidence that some, perhaps many, of what are called peripheral ADCs have arisen from and often contain
BAC
.
BAC
, in turn, appears to arise from smaller peripheral nodules, called atypical adenomatous hyperplasia.
Interest also stems from the observation that advanced ADC, often with
BAC
features, are responding in surprising fashion to tyrosine kinase inhibitors.
Clinical characteristics often differ from other types of non-small
cell lung
cancers.
These include frequent female occurrence, especially in East Asians; no or less smoking history; an often indolent course; distinctive chest computed tomographic findings; frequent presentation as an asymptomatic, sometimes small, peripheral nodule(s)/mass; multifocal/synchronous primary tumors; and less frequently as pneumonic-type consolidation or diffuse, inoperable lesions, the latter two often with bronchorrhea, and with chest-only
disease
.
Because of frequent
lung
-only recurrences,
lung
transplantation, although performed rarely, may hold promise.
[MeSH-major]
Adenocarcinoma
/ therapy.
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ therapy.
Lung
Neoplasms / therapy
[MeSH-minor]
Female. Humans.
Lung
Transplantation. Male. Neoplasm Invasiveness. Neoplasm Staging. Positron-Emission Tomography. Prognosis. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
ClinicalTrials.gov.
clinical trials - ClinicalTrials.gov
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[ErratumIn]
J Thorac Oncol. 2006 Jun;1(5):405
(PMID = 17409882.001).
[ISSN]
1556-1380
[Journal-full-title]
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
[ISO-abbreviation]
J Thorac Oncol
[Language]
eng
[Grant]
United States / NCI NIH HHS / CA / P50 CA 058187
[Publication-type]
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
[Publication-country]
United States
[Number-of-references]
207
95.
Cupp JS, Wrede JE, Cherry AM, Arber DA, George TI:
Chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type and bronchogenic adenocarcinoma.
Appl Immunohistochem Mol Morphol
; 2008 May;16(3):296-300
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Chromosomal aberrations in a case of synchronous extranodal marginal zone B-
cell
lymphoma of mucosa-associated lymphoid tissue type and bronchogenic
adenocarcinoma
.
We present the chromosomal aberrations in a case of synchronous extranodal marginal zone B-
cell
lymphoma and bronchogenic
adenocarcinoma
with
bronchioloalveolar
features.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18301237.001).
[ISSN]
1533-4058
[Journal-full-title]
Applied immunohistochemistry & molecular morphology : AIMM
[ISO-abbreviation]
Appl. Immunohistochem. Mol. Morphol.
[Language]
ENG
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Immunoglobulin Heavy Chains; 0 / Neoplasm Proteins; EC 3.4.22.- / Caspases; EC 3.4.22.- / MALT1 protein, human
96.
Tischer BK, Smith GA, Osterrieder N:
En passant mutagenesis: a two step markerless red recombination system.
Methods Mol Biol
; 2010;634:421-30
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Bacterial
artificial chromosomes are used to maintain and modify large sequences of different origins in Escherichia coli.
Since foreign sequences, such as antibiotic resistance genes as well as frt- or loxP-sites are often unwanted in mutant
BAC
clones, we developed a Red-based technique that allows for the scarless generation of point mutations, deletions, and insertion of smaller and larger sequences.
[MeSH-minor]
Chromosomes, Artificial,
Bacterial
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20677001.001).
[ISSN]
1940-6029
[Journal-full-title]
Methods in molecular biology (Clifton, N.J.)
[ISO-abbreviation]
Methods Mol. Biol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
97.
Xian HQ, Werth K, Gottlieb DI:
Promoter analysis in ES cell-derived neural cells.
Biochem Biophys Res Commun
; 2005 Feb 4;327(1):155-62
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Promoter analysis in ES
cell
-derived neural cells.
Neural cells derived from ES cells in
cell
culture (ESNCs) have many of the properties of normal neural cells and provide a model of "neurogenesis-in-a-dish."
ES cells are transfected with
bacterial
artificial chromosomes (
BACs
) containing Olig2, a gene with a key role in neural fate choice.
One
BAC
is modified by recombineering to insert a reporter gene and a gene for selecting stably transfected clones.
Another
BAC
contains a deletion
of a
suspected Olig2 promoter.
The combination of ESNCs and
BAC
recombineering will have broad application for analyzing gene transcription in the nervous system and will be applicable to human ES cells.
The general approach should also be applicable to the many other
cell
lineages that can now be derived from mouse and human ES cells in culture.
[MeSH-minor]
Animals. Basic Helix-Loop-Helix Transcription Factors.
Cell
Differentiation.
Cell
Line. Chromosomes, Artificial,
Bacterial
/ genetics. Gene Expression. Mice. Nerve Tissue Proteins / genetics. Phenotype. Sequence Deletion / genetics. Transgenes / genetics. Up-Regulation / genetics
MedlinePlus Health Information.
consumer health - Stem Cells
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15629444.001).
[ISSN]
0006-291X
[Journal-full-title]
Biochemical and biophysical research communications
[ISO-abbreviation]
Biochem. Biophys. Res. Commun.
[Language]
eng
[Grant]
United States / NINDS NIH HHS / NS / NS045809; United States / NINDS NIH HHS / NS / P01 NS39577-03
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
[Publication-country]
United States
[Chemical-registry-number]
0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Nerve Tissue Proteins; 0 / Olig2 protein, mouse
98.
Chouahnia K, Brechot JM, Des-Guetz G, Saintigny P, Morere JF, Breau JL:
[Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].
Rev Mal Respir
; 2006 Apr;23(2 Pt 1):149-51
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Gefitinib treatment for carcinomatous meningitis in non-small
cell lung cancer
].
[Transliterated title]
Géfitinib et méningite carcinomateuse d'un
carcinome
bronchique non à petites
cellules
(CBNPC).
BACKGROUND: Carcinomatous meningitis is a major complication in Non Small
Cell Lung Cancer
(NSCLC).
OBSERVATION: We report a case
of a
female non-smoker with
adenocarcinoma
with
bronchoalveolar
features presenting with carcinomatous meningitis three years after
the diagnosis
of her primary tumour.
[MeSH-major]
Adenocarcinoma
,
Bronchiolo
-
Alveolar
/ drug therapy. Antineoplastic Agents / therapeutic use.
Carcinoma
, Non-Small-
Cell Lung
/ drug therapy. Chemotherapy, Adjuvant.
Lung
Neoplasms / pathology. Meningitis / drug therapy. Protein Kinase Inhibitors / therapeutic use. Quinazolines / therapeutic use
Genetic Alliance.
consumer health - Lung Cancer
.
Genetic Alliance.
consumer health - Non-small cell lung cancer
.
MedlinePlus Health Information.
consumer health - Cancer Chemotherapy
.
MedlinePlus Health Information.
consumer health - Lung Cancer
.
MedlinePlus Health Information.
consumer health - Meningitis
.
Hazardous Substances Data Bank.
CIS-DIAMINEDICHLOROPLATINUM
.
Hazardous Substances Data Bank.
TAXOL
.
Hazardous Substances Data Bank.
CARBOPLATIN
.
Hazardous Substances Data Bank.
VINORELBINE
.
Hazardous Substances Data Bank.
VINBLASTINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16788439.001).
[ISSN]
0761-8425
[Journal-full-title]
Revue des maladies respiratoires
[ISO-abbreviation]
Rev Mal Respir
[Language]
fre
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
France
[Chemical-registry-number]
0 / Antineoplastic Agents; 0 / Neoplasm Proteins; 0 / Protein Kinase Inhibitors; 0 / Quinazolines; 5V9KLZ54CY / Vinblastine; BG3F62OND5 / Carboplatin; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin; Q6C979R91Y / vinorelbine; S65743JHBS / gefitinib
99.
Shao CW, Chen SL, Scheuring CF, Xu JY, Sha ZX, Dong XL, Zhang HB:
Construction of two BAC libraries from half-smooth tongue sole Cynoglossus semilaevis and identification of clones containing candidate sex-determination genes.
Mar Biotechnol (NY)
; 2010 Oct;12(5):558-68
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Construction of two
BAC
libraries from half-smooth tongue sole Cynoglossus semilaevis and identification of clones containing candidate sex-determination genes.
Two
bacterial
artificial chromosome (
BAC
) libraries for C. semilaevis, with large, high-quality inserts and deep coverage, were constructed in the BamHI and HindIII sites of the vector pECBAC1.
The two libraries contain a total of 55,296
BAC
clones arrayed in 144 384-well microtiter plates and correspond to 13.36 haploid genome equivalents.
Thus, the two
BAC
libraries
of C
. semilaevis provided a readily useable platform for genomics research, illustrated by the isolation of sex determination gene(s).
[MeSH-major]
Chromosomes, Artificial,
Bacterial
/ genetics. Cloning, Molecular. Fisheries / methods. Flatfishes / genetics. Gene Expression Regulation / genetics. Gene Library. Sex Determination Processes / genetics
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Mar Biotechnol (NY). 2009 Nov-Dec;11(6):699-709
[
19214631.001
]
[Cites]
Cytometry A. 2003 Feb;51(2):127-8; author reply 129
[
12541287.001
]
[Cites]
Mar Biotechnol (NY). 2008 Jul-Aug;10(4):358-65
[
18283517.001
]
[Cites]
Mar Biotechnol (NY). 2009 Mar-Apr;11(2):243-51
[
18779997.001
]
[Cites]
Mech Dev. 2004 Jul;121(7-8):639-45
[
15210173.001
]
[Cites]
Genetics. 2001 Aug;158(4):1711-24
[
11514457.001
]
[Cites]
Mol Reprod Dev. 2002 Sep;63(1):5-16
[
12211055.001
]
[Cites]
Trends Genet. 2003 Apr;19(4):196-9
[
12683972.001
]
[Cites]
Nature. 2002 May 30;417(6888):559-63
[
12037570.001
]
[Cites]
Sex Dev. 2007;1(2):85-99
[
18391519.001
]
[Cites]
Mar Biotechnol (NY). 2010 Apr;12(2):141-9
[
19585170.001
]
[Cites]
Anim Genet. 2006 Aug;37(4):321-6
[
16879340.001
]
[Cites]
Anim Genet. 2006 Oct;37(5):526
[
16978191.001
]
[Cites]
Genetica. 2001;111(1-3):43-58
[
11841186.001
]
[Cites]
Mar Biotechnol (NY). 2000 Nov;2(6):571-6
[
14961180.001
]
[Cites]
Genetics. 2001 Nov;159(3):1231-42
[
11729165.001
]
[Cites]
Anim Genet. 2003 Oct;34(5):379-83
[
14510676.001
]
[Cites]
Biochim Biophys Acta. 2000 Sep 7;1493(1-2):180-7
[
10978520.001
]
[Cites]
Nucleic Acids Res. 1998 Nov 1;26(21):4901-9
[
9776751.001
]